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Abstract 
Lepidopteran insects like Helicoverpa armigera, more commonly known as the cotton 
bollwonn , are economically important pests of a wide variety of crops throughout the world. 
The Helicoverpa armigera stunt virus (HaS V), a tetravirus with a bipaliite single-stranded 
positive-sense RNA genome, has great potential as a biological pesticide against H armigera. 
The larger genomic strand of this virus (RNA I) encodes the viral replicase, while the other 
(RNA2) encodes the 71 kDa capsid protein precursor (p71). 240 copies of p71 assemble into 
a procapsid with the concomitallt encapsidation of the viral RNA. This is followed by a 
complex maturation event that is characterized by the autoproteolytic cleavage of p71 into the 
64 kDa capsid protein (P64) and a 7 kDa peptide (p7). The rearrangements that occur during 
maturation results in the formation of mature HaSV capsids that can thereupon deliver RNA to 
other susceptible host cells. 
The principal objective of the research described in this study was to demonstrate that this 
virus could be assembled in Saccharomyces cerevisiae. 
S. cerevisiae expression vectors were constructed for the production of p71. This protein was 
detected in cell lysates from two different strains of S. cerevisiae, both containing either 
chromosomal or episomal copies of an expression cassette for P 71. A number of factors 
relating to the expression of P71 (e.g. strains used, expression loci and expression rate) alld 
the preparation of protein extracts from S. cerevisiae (e.g. the presence of various protease 
inhibitors and salt concentrations) were examined to attain optimal levels of soluble p71. A 
small fraction of the optimized soluble p71 was shown to be in the form of virus-like paliicles 
(VLPs), with a yield of :S107 VLPs from a 1.5 I culture of P71+ cells. These particles were 
exclusively in the procapsid form, had a similar buoyant density to that of wild-type HaSV 
and could undergo maturation when the pH was reduced to 5. 
S. cerevisiae vectors were constructed for the episomal expression of the HaSV genomIc 
RNAs. These vectors directed the transcription of RNA 1 and RNA2 trallscripts, which had 
similar sizes to those of the HaSV genomic RNAs. 
Mature HaSV particles were purified from cells, transgenic for P7i, RNA] and RNA2, by way 
of two different virus purification protocols that were developed during this study. RT-PCR 
analyses on RNA-extracts from these particles demonstrated that RNA transcripts, which were 
produced in trans with p71 , could be encapsidated by HaSV capsids in S. cerevisiae. A 
droplet-feed bioassay on H armigera larvae demonstrated that the S. cerevisiae-derived HaSV 
particles caused impaired larval development. This response was correlated with the detection 
of HaSV RNA2 in RNA extractions from larvae that were used in this bioassay. 
The results that were generated through the course of this study, provided proof for the 
concept of the non-host production of infectious HaSV particles from S. cerevisiae. This work 
could serve as a foundation for future research on the development of an expression system for 
the large-scale production ofthis virus as a biopesticide. 
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Literature review 
In 1993 Terry N. Hanzlik and his co-workers at the CSIRO Division of Entomology in Canberra 
(Australia) reported on the isolation of a small RNA virus, the Helicoverpa armigera stunt virus 
(HaSV), from diseased insects in their laboratory colony of Helicoverpa armigera. Lepidopteran 
insects like H armigera (more commonly referred to as the cotton bollworm) are economically 
important pests of a wide variety of crops tlU'oughout the world. The discovery of HaSV, which 
belongs to the virus family Tetraviridae (Figure 1. 1), raised the possibility that this virus could 
be used as a biological pesticide against these insects. One of the major hurdles for such an 
application for HaSV was the lack of a system for the large-scale production of this virus. This 
led to the work described in this thesis, which had the ultimate goal of developing a non-host 
production system for this virus in Brewer's yeast (Saccharomyces cerevisiae). 
A brief discussion on the potential of HaSV as a biological pesticide against H armigera is 
presented in the following section. This is followed by a description of tetraviruses with 
particular reference to the principles relating capsid structure to biological function. The chapter 
is concluded by a discussion on the suitability of S. cerevisiae for the expression of viruses and 
virus-like particles (VLPs). 
1.1 Biotechnological application 
It was estimated in 1997 that, on a global scale, $4 billion (US) was spent per year to control 
lepidopteran insect pests with chemical pesticides (Hanzlik and Gordon, 1997). Biological 
control efforts against these insects have been dominated by the application of an 
entomopathogen from the bacterium Bacillus thuringiensis, called B. t. toxin, and by celiain 
members of the virus family Baculoviridae (Christian et al. , 1993) (Figure 1.1). The application 
of HaSV as a biological pesticide would hold many advantages over existing means of control 
for this insect pest. 
First, unlike chemical pesticides, viral insecticides are not harmful to the environment. The 
application of HaSV would result in the specific eradication of the pests, because this virus 
displays a narrow host range that is limited to a range of species within the lepidopteran family 
Noctuidae (ClU'istian, P., Dorrian, S.D., Gordon, K.H.J. , Hanzlik, T.N., unpublished results). 
Second, HaSV would be more effective, i.e. have a more rapid rate of kill, than baculoviruses 
(ClU'istian et al., 1993). Third, the replication of HaSV in its host results in its ability to mutate 
in order to overcome host resistance to an extent (Christian et al., 1993). A 
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Figure 1.1 Families and genera of viruses infecting invertebrates. The frames separate 
viruses containing double stranded (ds) and single stranded (ss) genomes, while the horizontal 
gray boxes separate taxa of viruses having DNA or RNA genomes. Taxa containing reverse 
transcribing (RT) viruses and the negative (-) and positive (+) ssRNA genomes are also indicated 
(van Regenmortel et aI., 2000). 
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constant feature of chemical control effOits is the target pests' acquisition of resistance to a 
paliicular chemical pesticide that necessitates its replacement by a different one. Selection for 
resistance against B. t. toxin upon its indiscriminate usage is also a common occurrence 
(Christian et al., 1993). For instance, several thousand acres of Bt cotton crops (transgenic 
cotton plants that were engineered to express B. t. toxin) were infested by cotton bollworms when 
these crops were planted for the first time in Georgia and Texas in the USA (Macilwain, 1996). 
Another property of HaSV that makes it very suitable as a biological pesticide against 
H armigera is that it is highly pathogenic to these insects (Clu-istian, P., Dorrian, S.D., Gordon, 
K.H.J., Hanzlik, T.N., lU1published results). Ingestion of as little as 1000 - 5000 virus particles 
by neonate larvae is sufficient to cause severe stunting and death. 
The major drawback to the application of single stranded positive sense (ss +RNA) viruses, like 
HaSV, as insecticides is the lack of a large-scale production system for these viruses. This is 
why there are only a few documented instances where ss +RNA viruses have been successfully 
used as insect control agents. An example comes from the efficient control of Setothosea asigna 
and Darna trima (two oil palm pests) in Malaysia (Tiong and Muruoe, 1977). 86 - 99% 
mOliality was achieved in areas that were sprayed with aqueous extracts of insect cadavers 
infected with Darna trima virus (DtV, a tetravirus) and a possible insect picornavirus. This 
result led to the application of similar extracts for the protection of oil palm and coconut 
plantations in West Africa and South America (Philippe el al., 1997). 
At present, the only reliable means of producing HaSV requires its preparation from HaSV-
infected H armigera larvae within laboratory colonies. Bawden el al. (1999) screened thilteen 
insect cell lines using both infection with HaSV and transfection with HaSV RNA. Not one of 
these cell lines allowed for the propagation of this virus, indicating the lack of certain 
intracellular factors required for replication within these strains. The simplicity of the HaSV 
genome, which consists of two RNAs of 5.3kb and 2.5kb each, presented an intriguing prospect 
for the mass production of HaSV in transgenic organisms. This led to a research project, headed 
by Karl Gordon and Terry Hanzlik (both from the CSIRO Division of Entomology in Canberra, 
Australia), with the objective of producing transgenic HaSV -plants that would be resilient to 
H armigera. Results from this project showed that infectious HaSV particles were assembled in 
tobacco (Nicotiana plumbaginifoliaj protoplasts, as judged by the stunting of H armigera larvae 
that were fed on a diet containing these protoplasts (Gordon et af. , 2001). The presence of non-
host produced HaSV was confirmed by detection of HaS V genomic RNA in RNA extracts from 
stunted insects. However, the engineering of transgenic HaSV -tobacco plants proved to be far 
more problematic. Preliminary tests showed that a number of these plants were able to induce 
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stunting in H armigera (Service, 1996). Despite this initial success, failure to repeat these 
experiments and the lack of detectable HaSV RNAs in plant tissues in subsequent analyses led to 
the suggestion that the expression of the HaSV components in plants was hindered by gene 
silencing (Gordon, K.H.J., personal communication). 
The development of transgenic HaSV -plants is still an exciting possibility for the biological 
control of H armigera. However, currently and in the foreseeable future, the negative public 
perception regarding genetically modified crops would hamper their release into the 
envirorunent. Of major concern is an increased incidence of recombination events between 
insect and plant viral gene pools (Aaziz and Tepfer, 1999). This could result in the rapid 
evolution of viruses with altered properties that could bring about alarming consequences, 
including switching of host species and altered pathogenicity. A second problem associated with 
HaSV -plants is that their distribution tlu'oughout less developed countries would not be 
economically viable. This is especially impOltant when one considers the enormous variety of 
crop cultivars that are cultivated by less sophisticated farmers. It would therefore be ideal to 
provide farmers with an inexpensive source of HaSV for application to their crops. 
1.2 Tetraviridae 
Viruses that infect invertebrates are currently divided into nineteen fami lies (Figure 1.1) and four 
of these families exclusively infect arthropods (van Regenmortel et aI., 2000). These include 
tllIee families with double stranded DNA (dsDNA) genomes (baculo-, asco- and polydnaviruses) 
and one family with an ss +RNA genome (tetraviruses). 
Baculovirus virions aggregate into protein bodies, called occlusion bodies, within infected cells. 
The visualization of these occlusion bodies by a light microscope in diseased silkworms 
(Bombyx mori), led to the first scientific reports on an insect virus in 1856 (Smith, 1973). This 
virus, the Bombyx mori nuclear polyhedrosis virus (BmNPV), was later classified as a member 
of the nucleopolyhedrovirus genus of the baculovirus family. The baculovirus family, which 
includes the nuc1eopolyhedrovirus and granulovirus genera, has since then become one of tlle 
best-studied insect virus families . This is partly due to the fact that these viruses can be 
propagated in cell culture and tlle relative ease with which their large dsDNA genomes can be 
manipulated. 
The situation is, however, different for asco-, polydna- and tetraviruses. The lack of cell culture 
systems for virus propagation has complicated studies on various properties of these virus 
fanlilies (Hanzlik and Gordon, 1997; Miller, 1998; Webb, 1998). Polydnaviruses, which are 
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non-infectious and have been shown to have a symbiotic relationship with their wasp host, 
cannot replicate outside the wasp cells, probably because genes that are essential for virus 
replication are expressed from the wasp genome (Webb, 1998). The development of a wasp cell 
line, which could sustain the replication of polydnaviruses, would therefore be useful for studies 
on these viruses. Cell culture lines for the propagation of ascoviruses would be useful for the 
molecular analysis of viruses of this newly recognized virus family, which also appear to have 
symbiotic relationships with their lepidopteran hosts (Miller, 1998). The advent of molecular 
biological studies on tetraviruses has also been hampered by the lack of cell culture systems for 
the production of these viruses (Bawden et aI., 1999). A considerable amount of molecular 
information has, however, been derived from tetraviruses isolated from their insect hosts 
(Hanzlik and Gordon, 1997). 
1.2.1 History and Taxonomy 
Viruses belonging to the Tetraviridae family are exclusively pathogenic to insects and have 
icosahedral capsids with T = 4 symmetry that encapsidate a ss +RNA genome (Hendry and 
Agrawal, 1994). The Tetraviridae form one of four families of ss +RNA viruses with 
nonenveloped capsids that infect inveltebrates (Figure J.l) . The first tetravirus was isolated 
from diseased larvae of the pine tree emperor moth (Nudaurelia cytherea capensis) in South 
Africa (Struthers and Hendry, 1974). These larvae were found to be infected by at least five 
structurally distinct viruses, designated y, 8, a., E and ~ (Juckes, 1970). Of these, the Nudaurelia 
f3 virus (N~V) was characterized biophysically as the type-member of a new virus group known 
as Nudaurelia ~-like viruses (Juckes, 1979; Mathews, 1982). This virus group was renamed 
Tetraviridae in the fifth report of the International Committee on Taxonomy of Viruses (ICTV) 
(Francki et aI., 1991 ) due to the T= 4 quasi-symmetry of its members' shell. 
In 1985 Hendry et al. reported on the identification of another virus from Nudaurelia larvae, 
designated NcoV. TIllS virus was shown to be serologically distinct from N~V and contained a 
bipartite genome, as opposed to the monopartite genomes of all the previous members of this 
family. Based on this, NcoV became the type-member of a second genus (co-like tetraviruses) 
within the tetravirus family with ~- like tetraviruses being the other genus (Murphy et al., 1995). 
In the latest ICTV report (van RegeruTIortel et al., 2000) these two genera have been renamed 
Betatetravirus and Omegatetravirus containing eight and two species, respectively. The 
Helicoverpa armigera stunt virus (HaS V) is the second species within the Omegatetravirus 
genus (Table J.l). 
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Table 1.1 Species in the BetatetraviJ'lls and Omegatetravirus genera (Adapted from van 
Regenmortel et at. (2000) 
* 
Virus name Abbreviation Host family 
Genus: Betatetravirus 
Nudauretia capensis fJ virus 
Antheraea eucalypti virus 
Darna trima virus 
Dasychira pudibunda virus 
(Calliteara pudibunda virus)* 
Philosamia cythia x virus 
Pseudoplusia includens virus 
Thosea asigna virus 
(Setothosea asigna virus)* 
Trichoplusia ni virus 
Genus: Omegatetravirus 
NDV 
AeV 
DtV 
DpV/CpV 
PxV 
PiV 
TaV/SaV 
TnV 
Nudauretia capensis (j) virus Nro V 
Heticoverpa armigera stunt virus HaSV 
Alternative names are placed between brackets 
Salurniidae 
Saturniidae 
Limacodidae 
Lymantriidae 
Saturniidae 
Noctuidae 
Limacodidae 
Noctuidae 
Salurniidae 
Noctuidae 
Genome sequence 
accession number 
AFI02884 
AF062037** 
RNA2, S43937 
RNA1, U18246 
RNA2, L37299 
** Sequence infOimation for a 2484 base region that includes the capsid gene 
1.2.2 Host-pathogen interactions 
Tetraviruses can be transmitted horizontally, by means of oral ingestion, and veliically, from 
parent to progeny (Hanzlik and Gordon, 1997). The host range of tetraviruses is limited to 
lepidopteran insects and their midgut cells are the primary sites of infection (Figme 1.2). There 
are fom main types of cells in the midgut regions of these insects, differentiated columnar and 
goblet cells, and the basally situated undifferentiated regenerative cells and endocrine cells 
(Davies, 1988). Turnover of cells within the midgut occurs by the sloughing (detachment from 
basal membrane) of differentiated cells and subsequent replacement by regenerative cells. 
Brooks et al. (1998) demonstrated that an increase in the rate of sloughing occurs in the mid guts 
of HaSV -infected larvae, resulting in the depletion of cells. This increased rate of rejection is 
possibly a defense response that has the purpose of clearing the midgut of infected cells. Cross-
sections of the midgut regions of these larvae, which were stained by an immunogold labeling 
technique, revealed that the columnar, goblet and regenerative cells contained large quantities of 
HaSV (Figure 1.2). The degeneration of an infected insect's midgut is therefore enhanced by a 
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decreased ability to replace the sloughed differentiated cells by regenerative cells (Hanzlik and 
Gordon, 1997). 
Figure 1.2 Cross-sections of the midgut regions of H. armigera 
larvae, which were stained by an immw10gold labeling teclmique. 
HaSV (visible as black aggregations) was only detected in the colWl1l1ar 
and goblet cells exposed to the lumen (below) (Hanzlik and Gordon, 
1997). 
Recent studies on HaSV demonstrated that it is highly pathogenic, which makes it favorable as a 
control agent against its heliothine hosts (Christian, P., Dorrian, S.D., Gordon, K.H.J., Hanzlik, 
T.N., unpublished results). Ingestion of as little as 1000 - 5000 virus particles by neonate (first 
instar) larvae is sufficient to cause a rapid cessation of feeding and development, severe stunting 
and ultimately death. Conversely, infection of older larvae (fourth and fifth instar) failed to elicit 
any response to high doses of HaSV. This could reflect a superior ability of the older larvae to 
rid their midguts of infected cells by sloughing (Brooks, E.M., Gordon, K.H.J., Dorrian, S.J., 
Hines, E. and Hanzlik, T.N., unpublished results). 
1.2.3 Tetraviral genomes 
Genome organization 
The genome organization ofN~V, based on the complete sequence of its genome, was recently 
described by Gordon et al. (1999). The 6.6 kb genomic RNA was shown to contain a 5'proximal 
ORF that encodes the viral replicase (215 kDa) and a 3' proximal ORF that encodes the capsid 
protein precursor (70 kDa). The latter protein is expressed by means of a 2.6 kb sub genomic 
RNA that is encapsidated, along with the genomic RNA, by N~V capsids (Hanzlik and Gordon, 
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1997). The capsid protein precursor is cleaved between Asn-536 and Gly-537 to produce 62 kDa 
and 8 kDa proteins that make up the capsid shell. The sequence of the capsid protein gene of the 
Thosea asigna virus (Ta V) indicated that this protein is cleaved at two positions, as compared to 
one for NPV (Pringle el al., 1999). Two of these proteins are the TaV capsid proteins (58.3 kDa 
and 6.8 kDa), but the third N-tem1inal protein (17 kDa) could not be detected in virions. 
For omegatetraviruses, nucleotide sequences are available for the larger genomic strand (RNA I) 
of HaS V (Gordon et al., 1995) and for the smaller genomic strands (RNA2) of HaS V (Hanzlik el 
al., 1995) and NwV (Agrawal and Johnson, 1992) (Appendix I, Figures Al.l and AI.2) . HaSV 
RNA I (53 12 nt) carries a large ORF that encodes the 187 kDa viral replicase, and three smaller 
ORFs at its 3 'end (Figure 1.3). It is uncertain if these three ORFs are expressed in HaSV-
infected cells, and if so, what the functions of the resultant proteins would be. According to 
Hanzlik and Gordon (1997), a subgenomic RNA template would be required for translation fi'om 
these ORFs. HaSV RNA2 (2478nt) has two overlapping ORFs, the first encoding a protein 
(P17) of un.known function, while the second encodes the capsid protein precursor (p71) (Figure 
1.3). Two possible functions have been ascribed to p17. The fom1ation of hexagonal tube-like 
structures upon its expression in Escherichia coli has led to the proposal that it could function as 
a movement protein that allows the virus to migrate to adjoining cells (Hanzlik el aI., 1995). 
Hanzlik and Gordon (1997) also proposed that, since expression of p71 appears to favor 
replication ofRNA2 compared to RNAI, it could play a role in the regulation of replication. p71 
is cleaved between Asn-575 and Phe-576 into the 64 kDa and 7 kDa coat proteins designated p64 
and p7, respectively (Hanzlik et aI. , 1995). 
There is a high level of sequence identity (67%) and an even higher level of sequence similarity 
(76%) between the coat protein sequences of HaSV and Nw V (Agrawal and Johnson, 1992, 
Hanzlik el al., 1995) (Figure 1.4). Two domains of high similarity and three smaller domains of 
lower similarity have been identified by sequence alignments. The latter domains are located at 
the N-terminal (40% identity) and C-terminal (53% identity) regions, and in the center of each 
protein (37% identity). The NPV and Nw V capsid precursor proteins are, however, less similar. 
The sequence identity between specific domains of these two proteins varies from 21 to 29% 
(Gordon and Hanzlik, 1998) (Figure 1.4). A similar Asn/Phe cleavage site on the NwV 
a-protein (70 kDa) yields 62 kDa and 8 kDa proteins designated P and y, respectively. The Nw V 
sequence published by Agrawal and Jolmson (1995) did not show the presence of an overlapping 
ORF comparable to p17. However, according to Hanzlik and Gordon (1997), in vitro translation 
studies on Nw V RNA2 resulted in the expression of a protein with similar properties to that of 
pl7. 
RNA1 
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RNA2 
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Figure 1.3 Genome organization of HaSV RNAI and RNA2. The genomic RNAs are 
represented to the same scale, with their ORFs indicated. Adapted from Hanzlik and 
Gordon (1997). 
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Figure 1.4 Comparison between the protein sequences of three members of the 
Tetraviridae family. The percentage sequence identity in four different domains 
determined for pair-wise sequence comparisons (NcoV - HaSV and NcoV - N~V) is 
provided (Gordon and Hanzlik, 1998). 
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ii RNA secondary structure 
HaSV, N~V and NroV have tRNA-like structures at the 3' ends of the viral RNAs (Gordon et aI. , 
1995; Gordon el al., 1999; Hanzlik et al. , 1995) (Figure 1.5). With the exception of these 
viruses, these structures are solely associated with RNA from plant viruses. There are two 
possible functions for these structures (Hanzlik and Gordon, 1997). They could protect the viral 
RNA from exonucleolytic degradation or play a role in viral replication, or both. The first 
suggestion is based on the absence of poly-A tails at the 3' ends of tetraviral RNAs, which 
protect cellular mRNAs from degradation (Hanzlik et al., 1993; Hendry and Agrawal, 1994). 
The second suggestion is derived from roles in the replication of RNA for similar structures in 
plant virus RNAs (Gordon et al., 1999). 
In addition to the 3 'terminal tRNA-like structures, tbe HaSV genomIc RNAs have another 
secondary structure in common. Both RNAs form hairpin structures downstream of the cap site 
and contain the hexamer sequence GGUAAA (corresponding to nucleotides 19 - 24 and 24 - 29 
for RNA1 and RNA2, respectively) in the loop (Gordon et al., 1995; Hanzlik et al., 1995) 
(Figures AU and A1.2, Appendix 1). Roles in RNA replication have been suggested for these 
stem-loop structures (Gordon and Hanzlik, 1998). 
euk tRNA"" HaSV RNA 1 IRNA2) N~VRNA 
D CD 3' 
D UlJlD YO; GU.\CC~ 
I I I I II I I I I I 
U U ITIlTII ifIl5l A" 
I I 
G A C I I 
GD _ ~D I I ~ - I I = I I D§]BgAC=~J 
D§- Gc 
D A 
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Figure 1.5 tRNA-like structures on HaSV, N~V and plant viral genomic RNA, and eukaryotic 
tRNA Val Only conserved residues are specified for tRNA Val, while residues corresponding to the 
conserved ones in tRNA are specified. HaSV residues shown in parentheses refer to RNA2 
(Gordon and Hanzlik, 1998). 
1.2.4 Structure ofthe tetravirus capsid and pro capsid 
Viruses belonging to the Tetraviridae and Nodaviridae families (Figure 1.1) are the only 
ss +RNA viruses with quasi-equivalent protein shells. Because of the many structural 
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similarities between these two families (Munshi et aI., 1996), comparisons will be made between 
the two throughout this section where relevant. 
Virus structure - the theory of quasi-equivalence 
The arrangement of subunits within spherical viruses is explained by the quasi-equivalence 
theory of Caspar and Klug (1962), which refers to the axes that relate different subunits within 
the quasi-equivalent shells, This theory will be explained in the following section, with special 
reference to the structures of tetra- and nodaviruses, 
The constraint ofT = 1 symmetry 
The simplest virus particles have 60 identical subunits that are arranged in the symmetry of an 
icosahedron (Johnson, 1996) (Figure 1.6 panel A), In such a particle each one of the subunits is 
in an identical environment. These subunits are related by fivefold (vertices), threefold (faces) 
and twofold (edges) symmetry (named 532-symmetry), This form of symmetry represents the 
largest possible shell in which all the subunits lie in identical environments, The subunits of 
simple viruses generally are composed of 200-400 amino acids, but the internal cavity created by 
a shell formed by 60 subunits of this size would be too small to package the viral genome, The 
principles by which icosahedral virus particles are constructed with more than 60 subunits are 
explained by the quasi-equivalence theory, This theory states that the number of identical 
subunits organized in an icosahedral lattice is limited to 60T, and that T is equal to 1,3, 4,7, etc, 
For T values> 1 the subunits are chemically identical, but are structurally quasi-equivalent due 
to T different environments (Caspar and Klug, 1962), 
T = 3 particles 
Nodavirus particles, like most RNA spherical viruses with nonenveloped capsids, have 180 
subunits and are therefore arranged with T = 3 lattice symmetry (Figure 1.6, panel B), The 
trapezoids A, B and C correspond to the same gene product located in three slightly different 
environments within one icosahedral asymmetri c unit (the central triangle) , The rhombic 
triacontahedron geometry of these T = 3 p8.liicles relate A-subunits by true fivefold symmetry at 
the icosahedral fivefold axis (solid pentagon), and B- and C-subunits by quasi-sixfold symmetry 
at the icosahedral threefold axis (solid triangle), A trimer of BC dimers is related by true 
threefold symmetry around the latter axis (Johnson, 1996), 
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Figure 1.6 Comparison ofT = 1 (panel A), T= 3 (panel B), P = 3 (panel C) and T= 4 (panel D) 
capsid shells. Solid eclipses, triangles and pentagons, indicate icosahedral twofold, threefold 
and fivefold symmetrical axes, respectively; while empty eclipses and triangles indicate quasi-
twofold and quasi-threefold axes, respectively. The trapezoids labeled A, B, C and D in panels 
B and D correspond to the same gene product located in different environments within the 
respective icosahedral asymmetric units. The T = I capsid in panel A is also made up of 
identical gene products, but they are all located in the same environments within the shell. 
Conversely, the icosahedral asymmetric units of a picornavirus P = 3 shell (panel C) is made up 
of three different gene products (VPI , VP2 and VP3) which are located in different 
environments. The schematic in panel A was adapted from Johnson (1996), and those in panels 
B, C and D were adapted from Johnson and Reddy (1998). 
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The geometry of the T = 3 structure is the result of a difference between the icosahedral twofold 
axis (solid eclipse), which relates two C-subunits, and a quasi-twofold axis (open eclipse), which 
relates A- and B- subunits (Johnson, 1996). The C-subunits lie in the same plane, but the A- and 
B-subunits are in planes with an angle of 144°. These flat or bent contacts are formed by a 
process called molecular switching, which is required for the generation of quasiequivalent shells 
from identical subunits (Cheng et al., 1994). So-called molecular switches are present at the C -
C contacts, but absent at the A - B contacts, resulting in the different dihedral angles of the 
particle. The icosahedral asymmetric units of picornaviruses consist of three different gene 
products (VPl, VP2 and VP3) in a pseudo T= 3 (P = 3) lattice (Figure 1.6, panel C). The VP2-
VP2 interface and VP 1 - VP3 interface have different protein surfaces that are placed side by 
side and there is thus no need for a molecular switch (Schneemarm et al., 1998). 
T = 4 particles 
Capsids with T = 4 structure have the geometry of a standard icosahedron. The name of this 
geometrical shape is derived from the Greek words "eikosi" (twenty) and "hedra" (seat or base) 
(Hanzlik and Gordon, 1997). The quasi-equivalent surface lattice of a T = 4 icosahedral 
structure therefore consists of twenty triangular faces, each of which are made up of four smaller 
trimers (Figure 1.6, panel D). The icosahedral asymmetric units of this structure consists of four 
identical gene products (designated A, B, C and D), three located in an outer trimer (A, Band C) 
and one in a central trimer (D) (Olson et al. , 1990). 
Similar to the T = 3 structure, the A-subunits are related by true fivefold symmetry at the 
icosahedral fivefold axis (solid pentagon). The D-subunits show true threefold symmetry around 
the icosahedral threefold axis (solid triangle) . Unlike the T = 3 structure, the T = 4 structure 
contains one type of icosahedral twofold axis (solid eclipse) and two types of quasi-twofold axes 
(open eclipses). B-, C- and D-subunits are related by quasi-sixfold symmetry and BCD dimers 
are related by true twofold symmetry at the icosal1edral twofold axis. The one quasi-twofold axis 
relates subunits C and D in the same plane, while the other relates subunits A and B5 in different 
planes with a dihedral angle of 138°. This indicates that a molecular switch, similar to the one at 
the C - C contact in the T = 3 structure (Figure 1.6, panel B), is present at the C - D contact 
(Jolmson and Reddy, 1998). 
ii Tetravirus capsid structure 
Tetraviruses are the only nonenveloped, icosahedral viruses discovered to date that have capsids 
organized in a T = 4 lattice symmetry. The only other lmown virus family with T = 4 symmetry 
is the Togaviridae (Figure 1.1). Viruses in this family, e.g. Sinbis virus and Semliki Forest virus, 
have nucleocapsids with T = 4 symmetry that are surrounded by a lipid envelope containing 
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heterodimeric glycoprotein spikes (Fuller, 1987). These spikes are organized in a T = 4 lattice 
for members of the Alphavirus genus of the Togaviridae family (van RegenmOliel , 2000). 
The first step towards the elucidation of this characteristic structure was made by Polson et al. , 
(1970) who estimated a value of approximately 16.3 x 106 for the molecular weight of NpV. 
Using this data, and the approximate molecular weights of each capsid protein (61 000) and the 
genomic RNA (1.8 x 106), Struthers and Hendry (1974) calculated that the capsid consisted of 
240 subunits, which suggested a T = 4 arrangement according to the theory of quasi-equivalence. 
This was confirmed by three dimensional image reconstructions from electron micrographs of 
negatively stained NPV (Finch et ai., 1974). These reconstructions, and others from frozen-
hydrated NPV (Figure 1.7, panel A), showed that each of the twenty triangular faces of the 
icosahedral shell was composed of twelve protein subunits clustered into four Y -shaped trimeric 
aggregates (Olson et ai., 1990). The arrangement of these subunits into icosahedral asymmetric 
units according to the quasi-equivalence theory is illustrated in Figure 1.7 (panel B) (Olson et ai., 
1990). 
Each one of the triangular faces ofNPV was shown to be nearly planar and was separated from 
neighboring faces by deep grooves (Olson et al., 1990). Apart from their planar appearance, a 
characteristic feature of the icosahedral faces of NPV was the presence of three prominent pits 
between the trimers of each face (Olson et ai. , 1990). Image reconstructions of frozen-hydrated 
NwV (Figure 1.8, right hand side of panel A) revealed that the triangular faces of this virus were 
less planar than those ofNPV and did not contain the pits (Hendry and Agrawal, 1994). 
At present, the majority of structural information for tetraviruses is derived from the Nw V X-ray 
structure at 2.8A resolution (Munshi et ai. , 1996). It is possible that other tetraviruses have 
similar structural features to that of Nw V because: a) their protomers undergo similar 
autocatalytic cleavage events, b) their capsids are arranged with T = 4 symmetry, c) electron 
micrographs and cryoEM reconstructions of tetraviruses have revealed structural relatedness 
(Hendry and Agrawal, 1994), d) NPV and Nw V have similar solution X-ray scattering patterns 
(Johnson et ai., 1994) and e) phylogenetic analysis of available tetraviral capsid protein 
sequences indicated that omegatetraviruses and betatetraviruses are closely related (Hanzlik and 
Gordon, 1997). This presumption is especially valid for HaSV due to the high amino acid 
sequence similarity between N wV and HaSV (Figure 1.4). 
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Figure 1. 7 (A) CryoEM reconstruction of an NPV virion. (B) Close-up view of an NPV 
icosahedral face showing the twofold (2), tlu·eefold (3) and fivefold (5) symmetrical axes. The 
letters A, B, C and D denote the quasi-equivalent subunits that make up each of the three 
asymmetric units in an icosahedral face. The empty triangles denote the quasi-threefold axes, 
and the bar represents Snm. (C) Diagrammatic representation of quasi-equivalent surface lattice 
for T = 4 tetraviruses. Solid eclipses, triangles and pentagons, indicate the icosahedral twofold, 
threefold and fivefold symmetrical axes, respectively; while empty eclipses and triangles 
indicate quasi-twofold and quasi-threefold axes, respectively. T= 4 shells have two types of 
quasi-twofold axes. At one type of quasi-twofold axis, an extended chain and a helix form a 
wedge that forces a flat contact along the line with B- and C-subunits on one side and two 
D-subunits on the other (bottom right of panel C). At the other type of quasi-twofold axis, these 
protein segments are disordered, resulting in a bent contact (138°) along the line with A and C 
on one side and AS and BS on the other (top right of panel B). The images in panels A and B 
were taken from Olson et al. (1990). The schematic representation (C) was taken from Johnson 
and Reddy (1998). 
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Figure 1.8 (A) Three-dimensional, surface shaded NwV procapsid (left) and mature capsid 
(right), (B) Sectioned views ofNwV pro capsid (left) and capsid (right), The threefold and quasi-
threefold axes are indicated by black and white triangles, respectively, A triskelion-shaped 
internal domain is visualized at each of these icosahedral axes, (C) Radial density plots for the 
procapsid and capsid shells in panel B. These plots revealed that the capsid shell spanned 62 A 
with two domains , while the pro capsid shell spmmed 83 A with three domains. (D) An 
SDS-PAGE gel demonstrating that the 70 kDa a-protein (in Im1e labeled "procapsid") is cleaved 
into the ~- and y-proteins (in lane labeled "Capsid") upon a drop in the pH to 5, The latter two 
proteins have molecular weights of 62kDa and 8kDa, respectively, All these images were taken 
from Cm1ady et ai, (2000), 
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Subunit tertiary structure 
The Nw V protomer undergoes an autocatalytic cleavage event at an Asn - Phe peptide bond in 
NwV and HaSV, and an Asn - Gly peptide bond in N~V (Gordon and Hanzlik, 1998). Cleavage 
of the 70kDa capsid protein precursor (a) ofNwV at Asn-570 - Phe-571 yields 62kDa and 8kDa 
proteins, designated ~ and y, respectively (Agrawal and Jolmson, 1992). The NwV a-, ~ - and y-
proteins are analogous to HaSV capsid proteins p71 (7 I kDa), p64 (64kDa) and p7 (7kDa), 
respectively. 
The stereoribbon diagram of an NwV C-subunit in Figure 1.9 (panel A) illustrates that three 
domains are distinguishable for this protein: an internal helical domain, a central ~-sandwich 
domain and an external immunoglobulin-like domain. Residues sequentially preceding (helix I 
and II) and following the ~-sandwich (helix V, VI and VII) form the internal helical domain. 
This domain is therefore composed of the N- and C-terminal ends of the formerly uncleaved 
a-protein. Residues I - 43 and 591 - 607 do not adhere to icosahedral symmetry and are 
consequently not shown in this presentation. In addition, residues 608 - 644 are only ordered, 
and thus visible, in the C- and D-subunits. Helices VI (residues 571 - 590) and VII (residues 
627 - 640) are located on the y-peptide and will henceforth be referred to as Yl- and Y2-helices, 
respectively (Figure 1.9, panel B) (Munshi et ai., 1996). 
Evidence for the interaction of the internal helical domain Witll genomic RNA comes from its 
abundance in positively charged residues (Agrawal and Johnson, 1995). The tetraviral y-peptide 
has a net charge of +8 over ilie last twenty residues. These positively charged residues at the 
C-terminal end, and the net + II charge of the first 40 residues at the N-terminal end, contribute 
to the positively charged character of the internal helical domain. These positively charged 
residues are sufficient to neutralize phosphate groups on over 50% of the genome (Agrawal and 
Johnson, 1995). Further evidence for interactions between the internal helical domain and ilie 
encapsidated RNA is based on a comparison between the amino acid sequences of the Nw V and 
HaSV capsid precursor proteins, which reveals the presence of two low sequence homology 
domains at N- and C-tennini of these proteins (Gordon and Hanzlik, 1998) (Figure 1.4). 
Therefore, the low homology between these domains probably reflects the prerequisite for 
different interactions with the genomes of these two viruses. 
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Figure 1.9 Stereo views of a single N w V protomer positioned in the C location in the diagram 
in Figure 1.7 (panel C). (A) Stereo view ofNwV protomer in which labeled residues point to the 
approximated boundaries of the three domains (internal helical , ~-sandwich and Ig-like) of this 
protein. Asp-44, Phe-121 and Gln-543 facilitate the demarcation of the internal helical domain, 
which consists of residues preceding (residues 44 - 120) and following (residues 544 -641) the 
f3-sandwich (residues 121 - 543); and Gly-279 and Glu-414 point to the boundaries of the Ig-like 
domain (residues 280 - 413). The cleaved-off y-peptide consists of residues 571 to 641. (B) 
Stereo view of only the internal helical and ~-sandwich domains in which secondary structural 
elements and selected residues are labeled. ~B, ~C, ~I, ... denote the various ~ strands, and aI, 
all, alII, ... denote the various a-helices. aVI and aVII are found on the cleaved-offy-peptide 
and are referred to in the text as Yl- and Y2-helices, respectively. Both diagrams taken from 
Munshi et al. (1996). 
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The shell-forming ~-sandwich, which is responsible for the two stretches of high amino acid 
sequence identity (SI % and S5%) between Nw V and HaSV (Figure 1.4), is composed of eight 
antiparallel strands (labeled ~B, ~C, . . . ~I) and two a-helices (labeled aIII and aIV). It contains 
~-sheets composed of strands B, I, D and G on one side and C, H, E and F on the other 
(Figure 1.9) (Munshi et al., 1996). 
The outermost protmsion of Nw V, which forms the external domain of Nw V, occurs as an 
insertion between the ~E and ~F strands. This protmsion is composed of 133 amino acids with 
an immunoglobulin-like (rg-like) fold (Munshi et al., 1996). The stretch of sequence 
corresponding to the extemal domain coincides with the domain of low sequence identity (37%) 
in the center of the capsid protein precursor sequences for NwV and HaSV (Figure 1.4) (Gordon 
and Hanzlik, 1998). The low sequence similarity of these domains is at least partly responsible 
for the specific binding of these two vimses to their respective host cells (Munshi et al., 1996) . 
Quaternary structure 
Quasi-twofold axes: Amino acid residues 60S - 644 in the Nw V capsid, which are disordered 
for A- and B-subwlits, form an extended chain (residues 60S - 626) and a helix (Y2-helix) for C-
and D-subunits (Figure 1.9, panel A). These residues fi.mction as a wedge that forces a flat 
contact along the line with B- and C-subunits on one side and two D-subunits on the other 
(Munshi et aI., 1996) (Figure 1.7, panel C). As a result oftb.is, each of the triangular faces of the 
particle is planar. The disorder of these residues for A- and B-subunits results in a bent contact 
(138°) along the line with A and C on one side and A5 and B5 on the other (Mwlshi et aI., 1996). 
The molecular switch in Nw V therefore consists only of protein as opposed to that of 
nodavimses, which contains a polypeptide arm and duplex RNA (Fisher and Johnson, 1993). 
This exchange of roles between nucleic acid and protein is due to the Nw V Y2-helix fi.Iifilling the 
same task as that of the nodaviral duplex RNA. Another significant difference between the 
nodavirus and NwV molecular switches is that the protein component of the nodavirus molecular 
switch is close to the N-terminus, while an equivalent polypeptide (residues 60S - 626) for Nw V 
lies close to the C-terminus (Munshi et aI., 1996). 
Threefold and quasi-threefold axes: The extemal domains of threefold- and quasi-threefold-
related subunits interact with each other to give Nw V its characteristic appearance in electron 
micrographs (Figme I.S, right hand side of panel A). A surface representation of an N~V 
icosahedral face (Figme 1.7, panel B) demonstrates that the outside trimers have skew 
orientations about the quasi-threefold axes (emptY triangles) , as opposed to the inside trimer, 
which lies on equatorial lines between adjacent threefold and twofold axes (Olson et al., 1990). 
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Twofold (quasi-sixfold) and fivefold axes: A-subunit Yl-helices form pentameric helical 
bundles around the fivefold axes, which are similar to those described for nodaviruses (Cheng et 
al., 1994) (Figure 1.10). Y2-Helices, which are absent at the fivefold axes, completely change the 
interactions among B-, C-, and D-subunit Yl-helices around the twofold axes. As a result, ten 
helices are grouped around these axes: six contributed by B-, C- and D-subunit Yl-helices and 
four contributed by C- and D-subunit Y2-helices (Munshi et al., 1996) (Figure 1.11). 
A 
B 
Figure 1.10 (A) View perpendicular to the fivefold axes of the Black beetle virus 
(BBV), a nodavirus. The residues in blue correspond with residues 55 to 363, and the 
residues in red represent the pentameric helical bundle consisting of fivefold-related YA-
helices. For clarity, only two of the five A-subunits are represented. (B) View 
comparable to that of BBV (in panel A) for NoN. The portion in blue is nearly 
superirnposable with that of BBV with no sequence similarity. The yellow portion, 
however, represents the Ig-Iike domain and is unique to NoN. Fivefold-related Yl-helices 
form part of a pentameric helical bundle that is similar to that for BBV in panel A (Munshi 
et aI., 1996). 
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Figure 1.11 The arrangement of yl helices (residues 571 - 595) and 
Y2-helices (residues 608 - 641) around the icosahedral twofold (2) and 
fivefold (5) axes. The positions of A-, B-, C- and D-subunit helices are 
represented as blue, red, green and orange cylinders, respectively (refer to the 
arrangement of A-, B-, C- and D-subunits into the quasi-equivalent shell in 
Figure I. 7, panel C). At the fivefold axis, A-subunit-associated Y2-helices are 
disordered, while Yl-helices form a pentameric helical bundle. At the twofold 
axis, two Y2-helices, which are associated with C and D subunits, are ordered. 
Ten helices are therefore clustered around the twofold axis: four C- and D-
subunit associated y2 helices, and six B-, C- and D-subunit associated Yl-
helices (two from each of these subunits) (Munshi et at., 1996). 
Tetravirus procapsid structure 
A fundamental difference between nodaviruses and tetraviruses is that, unlike nodavirus capsids, 
the structure of tetravirus capsids is distinct from that of their associated procapsids. This 
distinction translates into procapsid-associated biological functions that are different from those 
of nodavirus procapsids. Canady et at. (2000) revealed several of the differences between 
tetraviral procapsids and capsids through cryoEM and three-dimensional reconstructions ofNwV 
procapsids. NwV procapsids were found to have an internal radius of 240 A, as compared with 
220 A for mature capsids (Figure 1.8, panel A). The procapsids were porous and rounded, while 
the mature capsids were solid and isometric. Further, the procapsid exterior was made up of 
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dumbbell-shaped dimers, as opposed to the trimeric associations of protomer external domains 
described for capsids (Hendry an Agrawal, 1994) (Figure 1.8, panel A). 
Sectioned views through the capsid and pro capsid protein shells showed that the pro capsid shells 
were thicker than those of capsids (Figure 1.8, panel B). Radial density plots revealed that this 
increased width of procapsid shells could be attributed to the presence of an additional (third) 
domain located on the inside of the shell (Figure 1. 8, panel C). These domains were defined by 
the relative density of the capsid shell (Canady et al., 2000) and should not be confused with the 
tlu'ee domains of the capsid protomer, which are paliitioned according to the nature of their 
tertiary structure (Munshi et af., 1996). 
Canady et al. (2000) proposed the pseudo-atomic model to describe the tertiary and quaternary 
structures of an Nco V procapsid. In this model , which is described below, the Nco V X-ray 
coordinates (Munshi et al., 1996) were fitted into the cryoEM map of the procapsid. 
Subunit tertiary structure 
According to the pseudo-atomic model, conformational changes that occur during the maturation 
of pro caps ids into capsids do not result in dramatic changes in the association between the ~­
sandwich and external Ig-like domains, i.e. these two domains are shifted as a unit without 
significant hinging between them. The tertiary structures of these two domains are probably 
relatively similar for procapsid and capsid protomers. This implies that the additional pro capsid 
domain, which is not present in capsids, is responsible for the changes in tertiary and quaternary 
structure during maturation (Figure 1.8, panel C). This domain corresponds with the internal 
helical domain of the proto mer, which contains the YI - and Y2-helices (Figure 1.9, panel B) 
(Canady et al., 2000). 
Each of these internal domains is associated with another two of its threefold-related and quasi-
threefold-related equivalents to form trimers within the procapsid shell (Figure 1. 8, left hand side 
of panel B). These trimers, each of which is in the shape of a triskelion, are fo und at the 
threefold (black triangle) and quasi-threefold (white triangle) axes (described further in the next 
section). The internal helical domains of all the procapsid subunits are most probably equivalent 
due to the threefold symmetry of each of these trimers and the similarity between threefold and 
quasi-threefold-related trimers. The combined effect of equivalent internal domains, as well as 
equivalent ~ sandwich and Ig-like domains, within the procapsid, suggests that all the procapsid 
subunits are similar (Canady et al., 2000). 
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Quaternary structure 
Threefold and quasi-threefold axes: The trimeric associations among threefold- and quasi-
threefold-related internal helical domains are less obvious at the same axes of the mature capsids 
(Figure 1.8, panel A). This corresponds with the observation that the additional domains for 
procapsids were less distinct in cryoEM reconstructions of mature capsids (Figure 1.8, panel C). 
The arrangement of the internal domains in procapsids and capsids is, however, nearly reversed 
for their p-sandwich and externallg-like domains . The Ig-like domains give the exterior of the 
capsid its trimeric appearance (Figure 1.8, right-hand side of panel A). The p-sandwich and Ig-
like domains of pro caps ids, on the contrary, are arranged into dimers that consist of A and B, and 
C and D subunits, respectively. The Ig-like domains of these AB and CD dimers are responsible 
for the dumbbell-shaped protrusions on the exterior of the procapsid (Figure 1.8, left hand side of 
panel A) (Canady et al., 2000). 
Twofold (quasi-sixfold) and fivefold axes: The dimeric arrangement of the procapsid subunits 
results in the formation of ellipsoidal holes at the quasi-sixfold axes of the procapsid 
(Figure 1.12, panel A), which contribute to the porous appearance of the procapsid (Figure 1.8, 
left hand side of panels A and B). Such holes are less pronounced at the icosahedral fivefold 
axes of the procapsid (Figure 1.12, panel B) (Canady et al., 2000). 
Quasi-twofold axes: As described above, the pseudo-atomic model for the Nco V procapsid 
demonstrates that the internal helical domains are found along the threefold and quasi-threefold 
axes of the procapsid. The positioning of the rz-helices and polypeptides (residues 608 - 626) of 
these domains at threefold and quasi-threefold axes of the procapsid therefore suggests that they 
cannot fulfil their functions as molecular switches in procapsids. This brings about the 
hypothesis that the absence of molecular switches at quasi-twofold-related C - D junctions result 
in the rounded, or so-called "truncated icosahedral", geometry of procapsids (Canady et al., 
2000). The Y2-helices and polypeptides (residues 608 - 626), which are disordered around the 
bent A - B junctions in caps ids (Munshi et al., 1996), are most probably associated with the 
internal trimeric domains of pro caps ids in an orderly fashion (Canady et al., 2000). 
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Figure 1.12 The arrangement of quasi-equivalent NroV subunits (key shown on right) around the 
quasi-sixfold (panels A and C) and fivefold (panels B and D) axes of a procapsid (panels A and B) 
or a mature capsid (panels C and D). The arrangements for the NroV procapsid were computed 
using a pseudo-atomic model (as described by Canady et a!., 2000), and demonstrated that there 
were ellipsoidal holes around the quasi-sixfold axes of pro caps ids (Canady et al., 2000). 
1.1.2 Functions of the procapsid and capsid during the tetravirallifecycle 
Compared to nodaviruses, much less work has been done to determine how the structural 
features of tetravirus capsids translate into their biological functions. However, mechanisms for 
autoproteolytic cleavage and RNA translocation are proposed to be nearly identical for these two 
virus families (Munshi et a!. , 1996). 
Provirion assembly 
Role of RNA in assembly: 
As in nodaviruses, tetravirus RNA replication most probably occurs exclusively in the early 
stages in an infected cell, while capsid protein precursor synthesis and particle assembly occurs 
later (Bawden et al. 1999). RNA1 and RNA2 are probably present at high cellular levels, prior 
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to the synthesis of the capsid protein precursor, to ensure that the optimal amount of virions are 
assembled. As in nodaviruses, RNAI is not required for the assembly of omegatetravirus 
capsids (Agrawal and Johnson, 1995; Scl111eemal111 et al., 1993). Complete RNA2 strands are 
also not required, as judged by the expression of the HaSV and Nw V capsid protein precursor 
genes in baculovirus-infected insect cell lines (Agrawal and Jol111son, 1995; Hanzlik and Gordon, 
1997). In both instances, the heterologous expression of these genes resulted in the production 
of VLPs that resembled intact virions. These VLPs furthermore incorporated their own mRNA 
at a high degree of specificity, indicating that specific encapsidation signal(s) exist within the 
ORF of the respective capsid protein precursor genes. 
Tetraviruses do not contain structured RNA components, similar to those of nodaviruses, within 
their capsid shells (Munshi et aI., 1996). However, this does not imply that these capsids could 
assemble into normal virus particles in the absence of RNA, because the highly charged inner 
surface of these particles would almost certainly require some fOID1 of polyanion to allow capsid 
formation (Agrawal and Johnson, 1995). 
Dimers are the building blocks of pro capsid assembly: 
The ClUTent model for the assembly of tetravirus procapsids is schematically represented in the 
top half of Figure 1.13 (Canady et al., 2000). This model relies to a great extent on the evidence 
for the arrangement of SUblU1its with equivalent structures into AB and CD dimers within the 
procapsid shell. The tight associations between the AB and CD dimers lead to the assumption 
that, similar to many plant viruses, the Nw V procapsid is assembled from undifferentiated dimers 
(Canady et aI., 2000). In line with this assumption, the formation of a procapsid assembly 
intermediate for tetraviruses allows these dimers to assemble as nearly equivalent units. 
Functions of internal helical domain in procapsid and capsid geometry: 
The foundation for the construction of a polyhedral nodavirus capsid is most probably laid 
during the recognition phase of its assembly process and involves the interaction of two subunits 
with duplex RNA (Schneemann and Marshall, 1998). This interaction, and similar ones that 
occur throughout the propagation phase, mediate the generation of flat contacts between twofold-
related subunits. As a result of these RNA - protein interactions, a nodaviral procapsid has a 
rhombic triacontal1edral geometry that is similar to that of its capsid (Schneemann et al., 1994). 
In tetraviruses, RNA does not seem to play an important role in the assembly of procapsids. 
Crystallography studies have not revealed interactions, equivalent to those for nodaviruses, 
which assist in the construction of icosal1edral geometry (Munshi et aI., 1996), resulting in the 
rounded shape of the tetraviral pro capsid. This rotmded, or truncated icosahedral particle is an 
unstable assembly intermediate that is stabilized by the internal helical domains, which act as 
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scaffolding proteins that allow AB and CD dirners to be associated as nearly equivalent units in 
the context of a virus particle. Upon the advent of maturation, which will be described in the 
next section, these domains migrate from the threefold and quasi-threefold axes and then reside 
at the quasi-twofold axes. The Y2-helices and polypeptides (residues 608 - 626) of these 
domains, which are positioned between quasi-twofold-related C- and D-subunits, act as 
molecular switches, resulting in flat C - D contacts. On the other hand, these protein segments 
become disordered around the quasi-twofold-related A- and B-subunits, resulting in bent A - B 
contacts. Regions of the internal helical domains, which function as protein scaffolds for the 
rounded geometry of pro virions, therefore also function as molecular switches for the 
icosahedral geometry of mature virions (Canady et ai, 2000) . 
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Figure 1.13 Model for the assembly of tetravirus from equivalent dirners. Trapezoids represent 
individual subunits and purple lines represent the internal helical domains of these subunits. The 
assembly of these domains to form the triskelion-shaped internal domains within the pro capsid is 
illustrated in the top half of the figure. The colour-change of the trapezoids (from gray to purple) 
represents slight structural changes upon assembly into procapsids. The subsequent colour-change 
to blue, red, green and purple, with the concomitant loss of the purple lines represent the 
differentiation of nearly equivalent dirners (in the pro capsid) into the four quasi-equivalent subunits 
of a T = 4 icosahedron. This differentiation is mediated by molecular switches (internal helical 
domains) that produce bent A - B, and flat C - D contacts (bottom right of the figure) (Canady et 
ai. , 2000). 
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ii Maturation 
The two phases oj tetraviral maturation: 
Quaternary interactions, which function in the stabilization of the Nco V provmon, precede 
autoproteolytic cleavage (Canady et al., 2000). These interactions are more extensive in 
tetraviruses as compared with nodaviruses (Schneemann et ai., 1993) because they mediate a 
significant transition in the geometry of the particle (Canady et ai., 2000). This transition can be 
instigated for NcoV procapsids by the lowering of the pH to 5. It occurs rapidly, as judged by 
solution X-ray scattering, and is completed within seconds. The associated autocatalytic 
cleavage, however, is much slower and requires hours for completion. The pH-induced cleavage 
of Nco V procapsids is illustrated in Figure 1.8 (panel D), where only the 70 kDa a-protein was 
detected for VLPs in a solution with neutral pH, while the 62 kDa ~-protein and a low level of a-
protein were detected upon lowering the pH to 5 (Canady et ai., 2000). 
The interactions that bring about transition have not yet been elucidated. However, it is assumed 
that the residue(s), which become protonated at a pH of 6, are integral to this process. This is 
because X-ray solution scattering demonstrated that, upon a reduction of pH, the initial structural 
changes in the Nco V procapsid occurred at a pH of -6 . It was proposed that some of the 
numerous arginine residues, which are found in the internal helical domain, could have 
abnormally low pKa values due to their respective chemical environments. They would 
subsequently become positively charged at pH 6, causing the repulsion that is required for 
structural rearrangement (Canady et ai., 2000). 
Unlike nodavirus procapsids, maturation of tetraviral procapsids does not occur automatically 
after assembly (Agrawal and Jolmson, 1995; Gallagher and Rueckert, 1988). A drop in pH acts 
as an external signal for the structural rearrangement of the tetraviral procapsid, which results in 
the production of an intermediate with the same icosahedral geometry as that of the mature 
capsid. Hereafter autocatalytic cleavage, which is dependent on the formation of the icosahedral 
intermediate, occurs in a time-dependent manner (Canady et ai. , 2000). The tetraviral 
maturation process could therefore be subdivided into two phases: (a) a transition phase in which 
structural rean-angements alter the geometry of the procapsid to yield an icosahedral intermediate 
(dissimilar to nodaviral maturation); and (b) a cleavage phase in which the a-proteins of an 
icosahedral intermediate undergo autocatalytic cleavage in a time dependent manner (similar to 
nodaviral maturation). 
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Equivalent dimers are differentiated during the transition phase: 
Transition is mediated by the migration of internal helical domains from the threefold and quasi-
threefold axes of the procapsid (where they fulfill a scaffolding role), to the quasi-twofold-axes 
of the icosahedral intermediate (where certain segments of these domains act as molecular 
switches). Both teliiary (movement of the a-helices) and secondary (disordering of the a-helices 
at the A - B contacts) structural changes lead to the strengthening of quaternary interactions 
among the subunits of the icosahedral intermediate. This disordering of the internal domains in 
the procapsid results in the differentiation of equivalent AB and CD dimers, which in turn results 
in bent contacts between AB dimers and flat contacts between CD dimers (Figure 1.13). 
Concunent with this differentiation process, all four subunits migrate towards the center of the 
particle due to the degeneration of the protein scaffold. This process explains the smaller 
diameter of capsids, as opposed to that of procapsids. The A and B subunits undergo a rotation, 
due to the "shrinking" of the particle, which results in the trimeric associations among subunits 
within the icosahedral intermediate (Figure 1.13) (Canady et aI., 2000). 
Similarities betvo1een tetraviral cleavage phase and nodaviral maturation: 
Nearly identical dispositions of the cleavage sites of tetra- and nodaviruses suggest similar 
cleavage mechanisms (Figure 1.14) (Munshi et al. 1996). Zlotnick et al. (1994) proposed a 
mechanism for autoproteolytic cleavage of nodavirus particles (Figure 1.15). The bracketed 
numbers in this paragraph refer to the various steps shown in this figure. (1) The hydrophobic 
nature of the cleavage environment has the effect of raising the pKa of Asp-75, which is in close 
proximity to the scissile peptide bond (Figure US, panel A). (2) As a result, this residue is at 
least partially protonated at physiological pH, and forms a hydrogen bond with the carbonyl of 
the Asn-363 - Phe-364 peptide bond. This peptide bond is consequently susceptible to 
nucleophilic attack by water, (3) which results in the fonnation of a tetrahedral intermediate. (4, 
5 and 6) This intermediate relaxes by the loss of the amine group, which constitutes the new N-
terminus of the y-peptide (Zlotnick et aI., 1994). 
In tetravirus capsids, Glu-I03 fulfil s the same role as Asp-75, forming a hydrogen bond with the 
carbonyl group of the Asn-570 - Phe 571 peptide bond (Figure 1.14). Similar to the mechanism 
of cleavage of nodaviruses, the pKa of Glu-I03 is most probably raised by its environment, 
allowing it to be protonated at physiological pH (Munshi et al., 1996). 
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Figure 1.14 Comparison between the cleavage sites in SSV (panel A) and Nco V (panel B). In 
SSV, the cleavage site is between Asn-363 and Ala-364 and Asp-75 appears to form a hydrogen 
bond with the carboxyl group of Asn-363. Similarly, in NcoV, Glu-l03 forms a hydrogen bond 
with the carboxyl group of Asn-570. The alanine residue at the C-terminal-side of the scissile in 
SSV is however replaced with Phe-571 in NcoV (Munshi et ai., 1996). 
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• Figure 1.15 Proposed mechanism for the autoproteolytic cleavage of nodavirus a-proteins. 
Refer to the text for a description of the series of steps (1 - 6) involved in this mechanism 
(Johnson and Reddy, 1998). 
There are, however, a number of other similarities, apart from the proposed cleavage 
mechanisms, tetraviral cleavage phase and nodaviral maturation: First, in both instances, 
cleavage occurs in a time-dependent manner (Canady et al., 2000; Gallagher and Rueckert, 
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1988). To date, a kinetic model, similar to one of the two that has been proposed for nodaviruses 
(Zlotnick et al., 1994), has not yet been proposed for tetraviral autoproteolysis. Second, there are 
probably no substantial structural differences between the uncleaved (tetraviral icosahedral 
intelmediates and nodaviral provirions) and cleaved (mature virions) paJiicles (Canady et aI., 
2000; ScJmeemann et al., 1993). However, for noda- and tetraviruses, N-termini of y-peptide 
helices probably form a closer association aJ'ound fivefold-axes upon cleavage, which results in 
the formation of pentameric helical bundles (Figures 1.1 0 and 1.11). Third, the cleavage sites for 
each of the subunits are located at similar geometrical interfaces in mature noda- and tetraviral 
particles. These sites lie close to the periphery of the three-membered trimeric asymmetric units 
and twelve-membered triangular faces of noda- and tetraviral paJiicles, respectively (Figure 1.6, 
panels B and D) (Hosur et aI., 1987; Munshi et al., 1996), Last, similar to nodaviruses, 
autoproteolytic cleavage also mediates the production of infectious tetravirus particles 
(Schneemann et aI., 1992). Yl-helices are required to "escape" from the capsid protein, so that 
they can participate in the translocation of the viral genome across the host cell's membrane 
bilayer (Johnson and Reddy, 1998). This translocation process, which brings about infection, 
would therefore be impossible if the YI-helices were still covalently attached to the capsid shell. 
Possible roles for RNA during the cleavage phase: 
The proximity of RNA to the cleavage sites within nodaviral particles probably assists 
autocatalytic cleavage (Schneemann et al., 1998). During the tetraviral cleavage phase, 
autocatalytic cleavage events with similar mechanisms occur at similar geometrical locations to 
those of nodaviruses (described above). It follows that it is very likely that there are close 
associations between RNA and the Asn - Phe cleavage sites at the interfaces between the 
tetraviral triangular faces. Therefore, even though a requirement for RNA was not implicated in 
the assembly aJ1d transition phases, non-specific RNA -protein interactions may play important 
roles in the cleavage phase. 
iii RNA delivery 
Analogous mechanisms for delivery of RNA by noda- and tetraviral capsids: 
A-subunit YI -helices form pentan1eric helical bundles around the fivefold axes that are similar to 
those described for nodaviruses (Figures 1.10 and 1.11). The current model for tetraviral RNA 
delivery, which is solely based on the existence of these bundles, is assumed to be analogous to 
that for nodaviruses (Cheng et aI., 1994). The model predicts that, upon attachment, the 
tetraviral bundles migrate along the fivefo ld axes, towing the RNA with them via their C-
terminal ends. Support for interactions between the C-tenninal ends of these bundles and 
encapsidated RNA within the tetravirus particle was obtained from cryoEM representations of 
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N~V (Olson et al., 1990). In these representations, high-density regions, which probably 
represented partially or highly ordered RNA, were detected at a radius of -11.9nm at the fivefold 
axes of the virus. For NOlV, similar RNA - protein interactions at these axes probably involve 
the structurally disordered C-terminal regions of the YA-peptides. 
Proposed studies on the delivery of tetraviral RNA to the host cells: 
Viral un coating: It is unclear if the destabilization of tetravirus virions occurs in a maImer that 
is similar to what was proposed for nodaviruses (Cheng et al., 1994). It has been proposed that 
as yet unidentified "pocket factors" occupy hydrophobic cavities at the fivefold axes of nodaviral 
capsids. These factors have been identified as fatty acids for picornaviruses like Poliovirus and 
Rhinovirus 16 (Olson, et al., 1993; Yafel et al., 1993) and have been shown to playa role in the 
destabilization of picornavirus capsids for the delivery of genomic RNA to the host cell 
(Rossmalm and Johnson, 1989). The pocket factors have a stabilizing effect on the capsids, but 
are lost upon attaclunent to the cellular receptor, membrane, or both, resulting in destabilization 
around the fivefold axis. It has been proposed that an ellipsoidal density, which has been 
observed at the fivefold axis on a cryoEM X-ray model difference map of the Flock House virus 
(FHV) capsid, is an as yet unidentified nodaviral pocket factor, and that this factor could perform 
a similar function to that of its picornavirus counterpart (Cheng et al., 1994). In addition, 
Schneemann et al. (1994) demonstrated via in vitro assembly experiments that factor(s) other 
than viral RNA and protein are involved in the assembly ofnodaviral capsids. Factor(s) required 
for assembly are therefore present in the nodavirus ' host cell and it is possible that these factors 
could be pocket factors. The application of similar in vitro assembly experiments could test if 
tetravirus capsids are also dependent on cellular factors for assembly. Alternatively, analytical 
chromatographic techniques like HPLC and GC could be used for the detection of pocket factors 
in purified tetravirus capsids. The detection of these factors within tetravirus capsids would be 
indicative of similar mechanisms for the destabilization of tetra- noda- and picornavirus capsids 
during viral uncoating. 
Membrane permeabilization: In the absence of helical wheel representations for Yl-helices, it 
is logical to assume that amphipathic characteristics of these helices stabilize tetraviral 
pentarneric helical bundles in a manner that is comparable to that of the nodaviral y-helices 
(Bong et al., 1999). It has been demonstrated that nodaviral y-helices increase the permeability 
of the membrane bilayer for the translocation of the nodaviral genome into the cell (Bong et at. , 
1999). The elucidation of this biological function for nodaviral y-helices was attained through 
physicochemical characterization studies of in vitro-synthesized y-peptides (Bong et at., 1999; 
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Bong et al., 2000). Similar studies for YJ-helices could provide a valuable insight into the 
tetraviral RNA translocation mechanism. 
Cotranslational disassembly: It has been proposed that cotranslational disassembly, which is 
an established mechanism for infection by plant RNA viruses e.g. CCMV (Roenhorst et aI., 
1989), probably contributes to the translocation of nodaviral RNA across the lipid membrane 
(Ball and Johnson, 1998). Accordingly, a stretch of viral RNA containing the ribosome-binding 
site becomes available to the host cell's protein translation machinery. Translation would assist 
in viral uncoating and RNA translocation into the host cell. Hiscox and Ball (1997) provided 
evidence for the contribution of cellular factors in the uncoating process, demonstrating that 
some cytoplasmic factor in cell free extracts could destabilize a small fraction of FHV particles. 
This destabilization resulted in the release of viral RNA to the ribosomes for protein synthesis, 
supporting the possible involvement of cotranslational disassembly in viral entry. Similar 
studies on tetravirus particles could establish whether cotranslational disassembly contributes to 
the translocation oftetraviral RNA across the lipid bilayer. 
1.2.6 Concluding remarks: structure/function comparison between tetravirus and 
nodavirus caps ids 
Capsids that are composed of mUltiple gene products facilitate viruses, like picornaviruses, to 
accomplish the biological functions that are required for their lifecycles. Differences in the 
tertiary structures of three different picornavirus coat proteins allow them to assemble into 
polyhedral virus particles without the need for molecular switches (Cheng et aI. , 1994). Tetra-
and nodaviruses accomplish the same biological functions as picornaviruses through the 
packaging of their identical gene products into quasi-equivalent shells. The assembly of these 
shells is, however, dependent on distinct molecular switching mechanisms which are 
significantly different for the two virus groups. 
Nodavirus capsids are dependent on segments of genomic RNA as molecular switches for the 
assembly of polyhedral capsids (Fisher and Jolmson, 1993). In the structurally more complex 
tetraviruses the assembly of structurally distinct procapsids, which undergo structural transitions 
to form polyhedral capsids, circumvents the requirement for RNA as molecular switches. These 
transitions form the first phase of the tetraviral maturation process. For a number of reasons 
listed in Section 1.2.Sii, the second phase, which involves the autocatalytic cleavage of precursor 
proteins, is very similar to the entire nodaviral maturation process. Based on this similarity, 
tetraviral maturation can be demarcated into transition and cleavage phases, and an analogy was 
made between a tetraviral polyhedral intermediate and the nodaviral procapsid (Section 1.2.Sii). 
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Another instance where the presence of multiple gene products assists capsid function is found 
during cellular binding and RNA delivery. In picornaviruses, the N-tenninus of virus protein I 
(VPI) was shown to interact with the cellular membrane during RNA delivery, which implies 
that VP I plays a distinct role at this stage of the lifecycle, as compared with VP2 and VP3 
(Fricks and Hogle, 1990). Furthermore, the release of internally located VP4 chains from 
picornaviruses has been proposed to facilitate the uncoating process during RNA delivery 
(Rueckert, 1996). Quasi-equivalent capsid shells facilitate noda- and tetraviruses to accomplish 
these RNA delivery functions in ways that have been conserved between these two virus 
families. Similar autoproteolytic cleavage events within tetraviral polyhedral intennediates and 
nodaviral procapsids produce virions with structurally distinct quasi-sixfold and fivefold axes. 
Analogous to the picornaviral VPI subunits, fivefold-related A-subunits are therefore 
sufficiently non-equivalent to the quasi-sixfold-related B, C and D subunits in tetraviral capsids. 
This enables A-subunits, like VP1 subunits, to interact with cellular membranes. In addition, 
release of the noda- and tetraviral y-peptides during viral uncoating is highly reminiscent of a 
similar release of VP4 chains from picornaviruses. 
To conclude, the constraints of a single capsid component have led to the allocation of numerous 
functions to individual structural elements within quasi-equivalent shells. The best example of 
this is the multi-functional tetraviral y-peptides, which are most probably involved in the release 
of the RNA from the virion and the penneabilization of membrane bilayers for the translocation 
of the viral genome. These peptides also form part of protein scaffolds for provirions, where 
they stabilize these truncated icosahedral structures; and are hereafter transformed into molecular 
switches for T = 4 virions. It is also possible that y-peptides could be involved in the specific 
encapsidation of viral RNA in a manner analogous to what has been described for the nodaviral 
y-peptides (Schneemann and Marshall, 1998). 
1.3 Heterologous expression in S. cerevisiae 
The yeast S. cerevisiae is an excellent host for the expression of eukaryotic proteins because it 
has the potential to produce correctly folded proteins that are posttranslationally processed in a 
manner similar to that of higher eukaryotes (Eckart and Bussineau, 1996). It also has the ability 
to grow rapidly to high cell densities on simple media and it can be manipulated genetically 
almost as easily as E. coli (Romanos et al., 1992). Extensive research in the molecular genetics 
of S. cerevisiae, which culminated in the complete sequence of its genome in 1998 
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(http://genome-www.stanford.edu/Saccharomyces), has led to the development of a great variety 
of promoter systems and methods for propagating foreign DNA. 
1.3.1 Expression vectors 
Yeast vectors can be introduced into S. cerevisiae by means of a number of different methods. 
These include electroporation (Meilhoc et al., 1990) and methods in which cells are made 
competent by treatment with lithium acetate (Kaiser et al., 1994) or dimethyl sulfoxide (Hill et 
al., 199 I). Selection of transformants can be achieved by two types of plasmid borne selectable 
markers: drug resistance genes and cloned yeast genes (Romanos et al., 1992). The latter type, 
of which the URA3, TRP 1, LEU2 and HIS3 genes are most commonly used, is transformed into 
S. cerevisiae cells that have a recessive mutation in the corresponding chromosomal copy of the 
cloned gene (Lundblad, 1997). 
There are a number of different vectors for episomal and chromosomal expression III 
S. cerevisiae. These include the ARS vectors, 2fl-based vectors and yeast chromosomal 
integration plasmids (YIps): ARS vectors contain yeast autonomous replication signals (ARS) 
that function as origins of replication (Lundblad, 1997). These plasmids have been shown to be 
mitotically unstable due to a strong bias to segregate to the mother cell (Romanos et aI. , 1992). 
The mitotic stability of ARS vectors can be increased by the incorporation of yeast centromeric 
sequences (CEN) into these vectors (Sikorski and Hieter, 1989). The presence of CEN sequences 
in ARS/CEN vectors ensures a copy number of 1 to 2 vectors per cell (Lundblad, 1997). 
2fl-based vectors contain sequences of the endogenous 2fl circle of S. cerevisiae and are the most 
commonly used vectors for high-level expression in yeast (Romanos et al., 1992). This is due to 
their mitotic stability and high copy number (20-50 copies) (Rose and Broach, 1990). Most 2fl-
based vectors carry only the sequences that are required for their autonomous replication and 
depend on the yeast strain for the REPl and REP2 encoded proteins (Kikuchi, 1983). The 2fl 
circle-encoded REPI and REP2 proteins contribute to the segregation of 2-fl plasmids during cell 
division (Velmurugan et al., 1998). 
YIps are designed to integrate foreign DNA into the genome of S. cerevisiae by homologous 
recombination. These plasmids lack an origin of replication and therefore cannot replicate in 
yeast cells. They do, however, contain a fragment of yeast clu'omosomal DNA to target 
integration as well as a yeast selectable marker, a bacterial origin of replication and an antibiotic 
resistance gene. The yeast chromosomal DNA usually contains a unique restriction site that can 
be cleaved to produce a linear DNA fragment. Upon transformation into S. cerevisiae this 
fragment can be integrated through homologous recombination into the chromosomal target 
sequence, resulting in a duplication of the target sequence (which brackets the rest of the 
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plasmid) (Stearns et al., 1990). This duplication can result in excisional recombination, where 
the integrant "pops out" from the clu'omosome (Llmdblad, 1997). Chromosomal integration is 
nevertheless the most stable method for heterologous expression in S. cerevisiae and less than 
1 % of the vector is lost per generation in the absence of selection (Romanos et al., 1992). 
1.3.2 Expression of VLPs in S. cerevisiae 
It has been demonstrated that S. cerevisiae cells are capable of the assembly of intracellularly 
expressed oligomeric proteins such as the a - and p-subunits of mammalian Na +, K+-ATPase 
(Horowitz et al., 1990) and the functional a2b2 tetramers of the tlu'ee human embryonic 
haemoglobins (Hofman et aI., 1995). S. cerevisiae has also been used for the expression of 
VLPs from viruses belonging to a wide range of virus families. The assembly of VLPs has been 
demonstrated upon the expression of structural genes belonging to Brome mosaic virus 
(Bromoviridae) (Price et aI., 1999), Human papillomavirus (Papillomaviridae) (HofmalID et al., 
1995), Hepatitis delta virus (Deltavirus genus) (Wu, et al., 1997), Poliovirus (Picornaviridae) 
(Rombaut and Jore, 1997), and Rabbit haemorrhagic disease virus (Ca/iciviridae) (Boga and 
Alonso, 1997). However, the best-known application for the expression of VLPs in S. cerevisiae 
comes from the production of the first recombinant vaccine (hepatitis B surface antigen) for 
humans (Miyanohara et aI., 1983, Valenzuela et al., 1982). 
1.3.3 Expression of virus particles in S. cerevisiae 
A recent patent by Price et al. (1999) described the only instances where virus particles have 
been expressed in S. cerevisiae. Proof for the assembly of these particles were presented by the 
detection of viral RNA, other than the mRNA of the capsid protein, in purified virus particles, 
and by demonstrating that the particles were infectious. In this patent, two types ' of 
encapsidation were described for the assembly of virus paIiicles, i.e. replication dependent and 
replication independent encapsidation. 
Evidence for replication dependent encapsidation was provided for FHV and Brome mosaic virus 
(BMV), two viruses that were shown to be capable of replication in S. cerevisiae cells (Janda and 
Ahlquist, 1993, Price et aI. , 1996). For FHV, the transfection of yeast spheroplasts with FHV 
RNAI and RNA2 resulted in the encapsidation of these RNAs, as demonstrated by plaque assays 
on Drosophila monolayers. For BMV, virus particles were formed in S. cerevisiae cells that 
expressed the viral replication proteins 1 a and 2a, and replicated BMV RNA3. Northern blot 
analysis of RNA extracts from these particles demonstrated that the mRNA for proteins 1a and 
2a, as well as RNA3, was encapsidated. 
Alternatively, evidence for replication independent encapsidation was only provided for BMV 
(Price et al., 1999). The co-expression of BMV capsid protein and RNA3 resulted in the 
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synthesis of virus particles that encapsidated capsid protein mRNA and RNA3, as demonstrated 
by NOithern blot analysis. 
1.4 Project proposal 
At the onset of this project in 1996, a number of reports were available on the non-host 
production of HaSV. These included a report in 1995, which stated that H armigera larvae 
became stunted upon ingestion of tobacco protoplasts that were engineered to express HaSV 
(Beckmann, 1995). This work, led to the generation of transgenic HaSV -tobacco plants, which 
were shown to induce stunting in H armigera larvae in preliminary tests (Service, 1996). 
The successful results for the expression of HaSV in plant cells were suggestive of a similar 
outcome for its expression in S. cerevisiae, because yeast cells provided a similar eukaryotic 
cellular environment for the assembly of HaSV virions. One of the main draw cards for the 
expression of HaSV in S. cerevisiae was its potential for the high-level production of this virus 
through a large-scale fermentation process (Romanos et ai., 1992). 
Alternative expression systems for the non-host production of HaSV include E. coli and 
baculovirus expression systems. The former was not ideal for this project because no evidence 
for the assembly of VLPs was detected for the expression of the HaSV and Nw V capsid protein 
precursor genes in E. coli (Agrawal and Johnson, 1995; Hanzlik et aI., 1995). Although a 
baculovirus expression system has been used for the production of tetravirus VLPs (Agrawal and 
Johnson, 1995; Pringle et aI., 2001 ), it is not nearly as commercially applicable as S. cerevisiae 
for this purpose. Cumbersome and time-consuming cell-culture techniques are required for the 
propagation of baculovirus-infected insect cells (O'Reilly et al. , 1992), while S. cerevisiae cells 
can be grown to high densities using convenient fermentation procedures (Romanos et al. , 1992). 
The use of S. cerevisiae for HaSV production would also be far more economical than a 
baculovirus expression system. 
Thus, the principle objective of this project was to demonstrate that HaSV virions could be 
assembled in S. cerevisiae by using a similar strategy to the one that was employed in plant 
protoplasts (Gordon et al., 2001). The ultimate goal was to develop a bioteclmological process 
for the production of a sprayable formulation of HaSV, for application as a biopesticide against 
H armigera. 
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The objectives for the research described in this thesis were as follows: 
• Construction of DNA vectors for the expression of HaSV in S. cerevisiae . Constructs 
that direct the expression of genes for the production of the HaSV capsid protein 
precursor (P71) and the two genomic RNA transcripts are required. 
• Analysis of P71 expression in S. cerevisiae and optimization of the production of soluble 
capsid protein. 
• To determine if the expressIOn of P71 leads to the assembly of HaSV VLPs 111 
S. cerevisiae. 
• Analysis of the expression of HaSV RNA] and RNA2 in S. cerevisiae. 
• To determine if infectious HaSV particles can be purified from S. cerevisiae cells that 
are transgenic for P7], RNA] and RNA2. 
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2 Strategies followed in constructing DNA vectors for the 
expression of HaSV in S. cerevisiae 
2.1 Introduction 
Although the simplicity of the bipal1ite HaSV genome lends itself to its non-host production, a 
few problems that pertain to the novelty of a required expression system have to be addressed. 
The focal point of these problems lies in the requirement for a system that mimics the production 
of infectious virus pmicles in host cells. The criteria for such a system and a brief description of 
each are provided in the next few paragraphs of this section. The objective of this chapter is to 
demonstrate how a heterologous expression system for the assembly of HaSV in S. cerevisiae 
was designed to accommodate each of these requirements. From here on, S. cerevisiae will be 
referred to as yeast, since no reference is made throughout this thesis to any other types of yeast. 
2.1.1 Capsid expression 
Tral1slation in yeast is very sensitive to the secondary structure of the leader sequence (ROmal10S 
et al., 1992). Translation efficiency is also reduced by alterations to the consensus sequence for 
translation initiation (Kozak sequence) and nms of G's or U's in the untranslated leader (Cigan 
and Donahue, 1987; Kozak, 1989; Val1 der Heuvel et aI. , 1990). The first 48 bases of the 365 
nucleotide leader sequence upstream of the P 71 ORF on HaSV RNA2 (Figure A 1.2, Appendix I) 
Cal1 be folded into a stem-loop structure with the hexruner sequence GGUAAA (nucleotides 24 to 
29) (Hanzlik et aI., 1995). The presence of this structure, a foreign Kozak sequence and a run of 
U's at nucleotides 1-14 makes it unlikely that p71 translation would occur from RNA2 
transcripts in yeast cells. 
A second point of concern is that P71 is the second ORF on a bicistronic RNA molecule 
(Hanzlik et aI. , 1995) (Figure 1.3). In the viral host cells, the P71 ORF is most probably 
translated by ribozymes leaking past the P 17 stm codon, which is in poor context for translation 
initiation (Hanzlik et aI., 1993). However, a possible preference for an upstrerun start codon 
further reduces the likelihood of efficient translation in yeast. This presumption is consistent 
with the lack of detectable p71 levels from RNA2 transcripts in transgenic plant protoplasts 
(Gordon, et aI., 2001). 
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2.1.2 Expression of RNA1 and RNA2 
The HaSV RNA! and RNA2 transcripts must be able to interact with the viral replicase, the host 
cell components and the capsid protein domains. Alterations to transcript sequences involved in 
these interactions could result in the loss or lack of infectivity. The presence of nonviral 
nucleotides or absence of viral nucleotides at the extremities of RNA transcripts could also 
greatly affect their infectivity. This is the result of the viral replicases' limited tolerance for the 
structures and/or sequences of the 5' and 3' ends (Boyer and Haenni, 1994). 
5' terminal extensions 
Viral RNA transcripts with accurate 5' ends can be produced from exact fusions between 
transcriptional promoters and the beginning of the viral sequence (Boyer and Haenni, 1994). 
Infectivity can be severely reduced by the addition of only a few nucleotides to the 5' ends, e.g. 
FHV RNA2 transcripts with only I or 2 additional 5' nucleotides resulted in a 10-fold decrease 
in replication efficiency by FHV replicase (Ball and Li, 1993). A similar scenario probably exists 
for HaSV, since H. armigera larvae were not infected when fed protoplasts producing HaSV 
RNAI and RNA2 transcripts with an additional 22 and 26 nucleotides at their 5' ends, 
respectively (Gordon et al., 2001). 
The presence of cap structures at the 5' ends of HaSV genomic RNAs is very important because 
it gives the 5' ends a 3'-like character that protects them against the host cell's nucleases 
(Fraenkel-Conrat el a!., 1988). This structure is also required for efficient translation initiation 
and the absence thereof could result in a reduced level or a complete loss of infectivity (Boyer 
and Haenni, 1994). The HaSV replicase catalyzes the capping of both genomic RNAs in the 
cytoplasm of tlle host cell (Gordon et aI., 1995). Conversely, in a DNA-templated expression 
system, either tlle cellular capping enzymes in the nucleus or the replicase in the cytoplasm could 
perform this reaction. 
ii 3' terminal extensions 
Viral RNA transcripts with accurate 3' termini can be transcribed from DNA templates by the 
accurate positioning of a cis-cleaving ribozyme immediately downstream of the viral sequence 
(Ball and Li, 1993; Ishikawa et al., 1997). Replicases are generally more tolerant of 3' end 
extensions than 5' extensions, but long extensions mostly abolish replication (Ball, 1992; Boyer 
and Haenni, 1994). Ishikawa et al. (1997) demonstrated that BMV RNA3 transcripts with 0 or 3-
nucleotide 3' extensions were replicated more efficiently than those with 19-nucleotide 3' 
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extensions. The 19-nucleotide 3' extensions were, however, still infectious, but transcripts with 
extensions of 42-nucleotides or longer inhibited BMV infectivity (Dzianott and Bujarski, 1989). 
Long 3' end extensions also seem to be detrimental to the replication for HaSV since RNA 
transcripts with >200 nucleotides at their 3' ends were not infective (Gordon et al., 2001). 
Another important consideration is that the HaSV genomic RNAs are not polyadenylated while, 
in yeast, poly-A tails are added to the 3' ends of all the primary transcripts (Egli and Braus, 
1994). Poly-A tails could therefore jeopardize the infectivity of viral RNA transcripts that were 
expressed from DNA templates in yeast. According to Boyer and Haenni (1994) the general rule 
that increased 3' extension length results in decreased infectivity also seems to apply to 
extensions in the form of poly-A tails. 
2.1.3 Assembly of HaSV virions 
During the infection of an insect cell by HaSV, the viral genomic RNA is delivered directly to 
the cytoplasm, where it is replicated to high levels by the viral replicase and other viral and/or 
cellular proteins (Bawden et aI., 1999). The p71 monomers, which are translated from HaSV 
RNA2, associate with the genomic RNAs in the cytoplasm to produce HaSV virions. An entirely 
different process would occur for the successful expression of HaSV from DNA genes in yeast. 
In the cytoplasm, p71 monomers would be translated from mRNA that was transcribed from P7] 
genes in the nucleus. These monomers would associate with RNAI and RNA2, which were 
expOlied to the cytoplasm after transcription in the nucleus, to produce HaSV virions. A nwnber 
of factors are required for the successful application of this process, which was used for the 
expression of HaSV in plant protoplasts (Gordon et aI., 2001). 
First, it is very important that a powerful promoter system is used to drive the expression of the 
RNA], RNA2 and P71 genes. Failed attempts to replicate HaSV in a variety of insect cell lines 
(Bawden et aI., 1999) makes it is highly unlikely that replication will take place in yeast cells. In 
addition, recent results by Gordon et al. (2001) demonstrated that replication was not detected 
upon the transfection of HaSV genomic RNA into plant protoplasts. The expression of the genes 
for the production of viral RNA transcripts and p71 should therefore be placed under the control 
of a powerful promoter, to ensure that these viral components are expressed at high levels in the 
cell. 
Second, the RNA1 and RNA2 transcripts should be polyadenylated for efficient export from the 
nucleus to enable the assembly of HaSV virions in the cytoplasm, because poly-A tails play an 
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important role in the nucleocytoplasmic transport of mRNA (Huang and Carmichael, 1996). 
However, the presence of poly-A-tails at the 3' ends of the viral transcripts could reduce their 
infectivity (described above). Poly-A tails have also been implicated to play roles in mRNA 
stability (Caponigro and Parker, 1996) and translation (Jackson and Standart, 1990). 
2.2 Materials and Methods 
2.2.1 General recombinant DNA techniques 
Unless otherwise stated, general recombinant DNA techniques were essentially as described by 
Sambrook et al. (1989). Restriction and DNA modifying enzymes were used according to the 
suppliers' instructions. In general, Escherichia coli DH5a (Hanahan, 1983) was used as host for 
recombinant plasmids and E. coli JMllO (Yanisch-Perron et al. , 1985) was used as host for 
plasmids carrying methylation-sensitive restriction sites. DNA sequencing was detelmined either 
by manual sequencing (SequiTherm EXCEL™ II DNA sequencing kit, Epicentre) or using an 
ABI automatic sequencer (model 373A). pDHVStuRIHC, pDHCStuR2HP and pDHVCAPB 
(Figures 2.1, 2.2 and 2.3, respectively), plant expression vectors for HaSV RNA 1 , RNA2 and P71, 
were kindly provided by Karl Gordon and Terry Hanzlik (CSIRO Entomology, Canberra, ACT, 
Australia). DNA fragments encoding HaSV sequences were sub cloned or PCR amplified from 
these plasmids for the construction of all the expression vectors used in this study. 
2.2.2 Construction of a vector for the episomal expression of RNAl 
The RNAI expression vector pDHVStuRIHC carries an exact fusion between the Cauliflower 
mosaic virus (CaMV) 35S promoter (P35S) and the 5' end of RNA I, and the hairpin cassette (HC) 
ribozyme from the satellite RNA of Tobacco ringspot virus (ToRSV) (Hampel et al., 1990) 
directly downstream of its 3' end. To enable expression of RNA 1 transcripts with precise 5' and 
3' ends in yeast, P35S was replaced with the S. cerevisiae GAll promoter (PGAL! ) and the RNA1-
encoding DNA fragment was inserted into the ARS/CEN vector pKG6 as follows: 
A 6140 bp Eco RI DNA fragment, carrying P35S, RNA1, the HC ribozyme and the CaMV 
terminator from pDHVStuRI HC, was inserted into pKG6 between PGAL! and the S. cerevisiae 
CYC1 terminator (TcreJ) (Figure 2.1 , Step I) . The resulting construct (pA V8F) was used to 
generate pVH1, where a 6867 bp internal Xba I fragment has been deleted to reduce the plasmid 
size (Figure 2.1, Step II). pVHl calTies the tnmcated 5' end of HaSV RNA1 separated from 
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POAu by a 671bp DNA fragment. This 671bp DNA fragment was deleted by reverse PCR with 
primers AV4 (corresponding to nucleotides -I to -25 of POAU) and AVI (corresponding to 
nucleotides +1 to 25 of RNAl) using the Expand™ High Fidelity PCR System (Roche) (Primers: 
Appendix 4, Thermal cycling programme: Programme I, Appendix 5). The re-ligation of the 
amplified DNA fragment resulted in the construction of pVH4, and the fidelity of the POALr 
RNAl fusion was confirmed by DNA sequencing (Figure 2.1, Step III). 
An 882 bp Sal I - Xho I p VH4 DNA fragment carrying the PoAu-RNAl fusion was excised from 
pVH4 and inserted into pKG6 to produce pAVIO (Figure 2.1 , Step IV). A 5827 bp Xba I - AjI II 
DNA fragment, carrying the remaining 3' end of RNAl missing in pAVIO together with the 
downstream HC ribozyme, was excised from pDHVStuRIHC. The internal Xba I site 
downstream of the AjI II site in this restriction fragment was not digested because it was dam-
methylated in E. coli strain DH5a. This Xba I - AjI II fragment was introduced into pAVIO to 
produce pAV13HC (Figure 2.1, Step V). This vector carried the PoAu- RNAl-HC ribozyme-
T CYCI expression cassette for the production of RNA I transcripts with 5' and 3' ends identical to 
those of the HaSV genomic RNAs. The presence of the correct ribozyme sequence in pAVl3HC 
was confirmed by DNA sequencing. 
An error was discovered for the POAu-RNAI fusion in the RNAI expression vector pAVl3HC 
when these regions were sequenced (at ZENECA Agrochemicals Ltd., Jealott's Hill, UK) for a 
second time. The sequence results indicated that the first G nucleotide of RNA I was not present 
in this construct (Table 2.2). Rachael Blaine (ZENECA Agrochemicals Ltd., Jealott's Hill, UK) 
repaired the PGAL-RNAI fusion in this vector to produce pAV13HC (G+) (bracketed in 
Figure 2.1). Reference is made as to which of the two constructs were used in experiments 
described throughout the remainder of this thesis. 
PSI I (5549) 
Hind III (55371 I BamH I (5557) 
Puu II (55071\ ' EceR I (I) 
PGALl \' i/ Xbal(35) ,TCYCI 
Sac :r;;2(v5) I07) ~-:::.~14' '. Kp" I (342) 
PVll II (4806) 
PMBI ' 
)--
HC Ribozyme 
PSI 1(8437) 
Hind III (8306) \ 
Sac I (80 1 It 
PSI I (7738) 
Xba I (I) 
/,PSti (17) 
'l CaMV poly-A signal 
Kpn I (225) 
Sac 1(231) 
, EccR I (233) 
"' " "',,Hind III (239) 
" 
" PVIJ 1I (334) 
, , 
pKG4 
5566 bp 
Hind III (1252) 
" TRP I 
P"I II (6920) 
PSI 1(6919) pDHVStuR1HC 
8781 bp 
',- Sca I (1149) 
AMP-R 
ORI 
RNA I 
"'_ PUll II (2698) 
-" EccR I (2874) 
P35S 
Sac I (5537) Pst! (3513) 
Sca 1(3257) 
CEN6 ARSH4 Kpn I (5063) / i 
Sad (4679) ! 
Afi II (3728) 
\ Xba I (3827) 
PSI 1(4478) Sac 1(4092) 
-'} Eco Rl digest 
-'} dephosphorylate vector ends with -'} Eco RI digest 
I shrimp alkaline phosphatase (SAP) -'} purify vector fragment 
-'} gel purify 6140bp 
fragment 
-'} ligate 
PVll IJ(J1647) HindllI(11677) 
PGALl \ I Pst! (I 1689) 
" : i BamHI(11697) 
Age 1(11247) \" \ i i EcaR I ( I) 
Sac 1(1 1168) , \" 
PUll ]] (10946) ''..'':\ \: f P35S 
PMBI -- \\~II'-9ti.L, 
AMP-R 
Sca I (9397) 
CEN6 
ARSH4 
Xba 1(7821) ~ 
TRPI ' 
pAV8F 
11706 bp 
'" ~ac 1(121 9) 
"\Pst I (1605) 
\ Sac 1 (1806) 
,", 
'Jpn I (2190) 
Soc 1 (2664) 
RNA 1 
' jst 1(4046) 
, 
Hin d 111 (7392) <-
PUll ]] (6606) 
Kpn I (648if:' ,,'fj<~ •• "'~!"" 
TCYCI , ''. 
PVll ]] (4047) 
PSi I (4865) 
Sac I (5138) Xba 1 (6 175) , ; 1\", \ 
EcoRI(6141) ':' H\ ' \, Hind III (5433) 
Sac 1(6139) : \ Pst I (5564) 
Kpn I (6 133) "'. HC Ribozyme 
CaMV poJyA I Xba 1(5909) 
p" I (5925) 
II -'} Xba I digest -'} re-ligate 
Afi II (474 11 
RNAI 5' ! ,A'bG! (I) 
Psli (4526>-_._ \ 
p35S ::.II"'~--.. 
, 
EccR I (3887) 
BamH I (3877)\ 
PSI 1 (3869)\ 
H.,.,) III (3857i~ 
Pvull(3827) \ 
PGALl 
Ago I (3427), 
pVH1 
4839 bp 
Sac 1 (3348) \ 
Pvu II (3126) ~ 
L-___ _ _ __ -. " _, 
PMBI ""==--
Figure 2,1 A flow diagram of the cloning steps for the construction of a vector for the 
episomal expression of HaS V RNA], 
CEN6 
1----------------------------- ----------------------------- ---- -------- ----, 
1 PGAL1-RNA1 5' in pVH1 1 
PGALI AV4 : 
.... p35S RNAI 5' i 
r-------~----~ , 
~ 
AVI 
-+ Reverse PCR with primers A V I and A V 4 
III -+ phosphorylate 5' ends with T4 polynucleotide kinase (PNK) 
-+ re-ligate 
PGALl Psll (108) 
Age 1(3848 ) .. -, / RNA I 5' 
Sad (3769) ' .. ', :;;> - .~' 
.p'" 
Pvu II (3 547L:I 
PMBI -I 
\ 
" 
pVH4 
4169 bp 
............. '1~ 
AMP-R Sca 1 (1 998) 
A;: II (J2J) 
Xbc I (422) 
" ARS H4 
-+ Sac I / Xba I digest 
AMP-R 
Sea 1 (3906) 
Sad (I) Ag. I (80) 
PVn II (5 455~ " PGAL I 
PMB I ~=I=t:- Pvn II (480) 
I -----~ .Hmd 1II (510) " ,,~~ Psll (522) ~ , BamH I (530) , ' , , , EeeR I (540) 
'i . Xb.1 (574) 
' -:rCYC I 
ARS H4 
pKG6 
5676 bp 
" Kpn I (881) 
Pvnll (1005) 
URA3 
Sea I (2156) 
PSI I (2490) 
-+ Sac I / Xba I digest 
-+ gel purify 822bp DNA fragment -+ dephosphorylate 
IV 
-+ ligate 
RNA 1 5' A;: II (5827) 
Psll (56 12) Xba I (I) TCYC 1 
PGALl ' I..i 
. ,-...!A ..... Mr-"j ,j ' . . 
Age I (5 183) . .• :;.. .. -'- 7'7, . Kp" I (3 08) 
Sa" (5104)...· . "\ Pvull (43 2) 
, 
Pvu II (4882). 
PMBI pAV10 
5925 bp 
URA3 
\, Sca I (1583) / "PsII(1917) 
" , J AMP-R .' 
Sea I (3333) 
a ....... ARSH4 
CEN6 
Figure 2.1 Continued ... 
vector ends with 
SAP 
-+ gel purify 5103 bp 
DNA fragment 
RNA I 5' Aft II (5827) 
. Xbal(1) 
Pstl (5612) " 
PGALI ~ .... ~s 
Agel (5 183) 
Sac 1(5104) 
Pv" II (4882) 
PMBI ' 
TCYCI 
... Kpn I (308) 
Pv" II (432) 
. URA3 
XbGI(I) Pstl( 17) 
HC Ribozyme ; ! CaMV poly-A signal 
PSI I (8437) ,! i K n I (225) 
Hind III (8306) ~~.: ... S~d (231) 
,
< £:ecR I (233) 
. ... :, Hind III (239) 
, Pvu II (334) 
. Scal(1149) 
Pv" II (6920) AMP-R ~ pAV10 5925 bp . Sea I (1583) PsJi (6919) pDHVSluR1 He I \ 
" AMP-R ,..,.., .... - ... ~ 
" Pstl(1917) 
Sca 1(3333) 
8781 bp -I- ORI 
r Pvu II (2698) 
' EccR I (287{ 
P35S 
Sad (5537) PsJi (3513) 
Kpn I (5063) - ..... -i!JIIII ... ;, ~~ II (3728) 
Sac I (4679) Xba I (3827) 
PSI I (4478) Sac I (4092) 
-> )(ba I / Ajl II digest -> Xba I / Aft II digest 
-> dephosphorylate -> gel purify 5054bp DNA 
V vector ends with fragment 
SAP 
-> gel purify 582 7bp 
DNA fragment 
-> ligate 
Psi I (10666) 
PGALI Aflll ( I) 
Age 1(10237) . \ I Xba 1(100) 
Sac 1(10158) , \ , \ 'J'iI.'.' ...... I..- Sac 1(365) 
PI'" II (9936) =~:. Psi I (751) 
AMP-R: 
Sca 1(8387) 
CEN6 
ARSH4 
Psi I (697 1) 
Sca 1(6637) 
URA3 
4 ' 
pAV13HC 
10880 bp 
. Sac I (952) 
Kpn 1(1336) 
Sac 1(1810) 
RNA I 
Pst 1(3192) 
PUll II (3 193) 
Psi 1(40 11 ) 
'Sac I (4284) 
Hin d III (4579) 
PI'" II (5486) , \\ Pst 1(4710) 
. '\" 
\ HC Ribozyme 
Xba 1(5055) 
TCYCI 
Kpn 1(5362) 
Figure 2,1 Continued .. , 
PSi I (10667) , 
PGALI Afl II (I) 
Age 1(10237) , ' :' );ba 1(100) 
Sac 1(10158) \. '~"~",,,,,,, Sac 1(365) 
PV" II (9936) / ,.\\ PSi I (75 1) 
AMP-R 
Sea 1(8387) 
CEN6 
ARS H4 
. Sac 1(952) 
,Kpn 1(1336) 
Sac I (1810) 
pAV13HC (G+) 
10881 bp 
, RNAI 
Pst 1(3192) 
PI'" II (3193) 
Pvu II (5486) 
Hin d III (4579) 
, " 
, '; \, PSi I (47 10) 
\ HC Ribozyme 
Xba 1(5055) 
TCYCI 
Kpn 1(5362) 
2-48 
2.2.3 Construction of a vector for the episomal expression of HaSV RNA2 
pDHVR2HP is a plant expression vector that contains the 5' end of RNA2 flanked by a Bam HI 
site. A 2588 bp Bam HI -Xba I DNA fragment carrying HaSV RNA2, the HC ribozyme and 
the CaMV terminator was excised from pDHVR2HP, and inserted into the ARS/CEN vector 
pKG5 (Figure 2.2, Step I). The resulting construct (PML Y2) was used to generate pML Y3, 
where a 4306 bp internal Eco RI fragment has been deleted to reduce the plasmid size 
(Figure 2.2, Step II). The PGALI -RNA2 fusion was constructed in a manner similar to that 
described for RNA] expression module above. pMLY3 carries the truncated 5' end of HaSV 
RNA2 separated from PGAL1 by an 133bp DNA fragment. This DNA fragment was deleted by 
reverse PCR with primers AV4 (corresponding to nucleotides - 1 to -25 of PGALl) and AV2 
(corresponding to nucleotides +1 to 25 of RNA2) using the Expand™ High Fidelity PCR 
System (Roche) (Primers: Appendix 4, Thel1l1al cycling programme: Programme I, 
Appendix 5). The re-ligation of the amplified DNA fragment resulted in the construction of 
pVH5, and the fidelity of the PGALI-RNA2 fusion was confirmed by DNA sequencing 
(Figure 2.2, Step III). 
A 993 bp Sac I - Eco RI DNA fragment, carrying the PGALrRNA2 fusion in pVH5, was inserted 
into the ARS/CEN vector pKG3 (Figure 2.2, Step IV). The truncated RNA2 sequence in the 
resulting plasmid, pAVII was repaired by the insertion of a 1951bp Eco RI-Xba I DNA 
fragment from pDHVStuR2HP to produce pAVI4HP (Figure 2.2, Step V). The HIS3 selectable 
marker on pAVI4HP did not complement his3 in the S. cerevisiae JRYI88 strain (MATa, his3, 
leu2, trpJ, ura3) (Table A6.1, Appendix 6) . The PGALI- RNA2-HC ribozyme-TcyCi expression 
cassette was therefore sub cloned into pKG4, which carries the TRP 1 selectable marker 
(Figure 2.2, Step VI). The resulting plasmid, pAVI4HPTrp, was used for the heterologous 
expression ofRNA2 transcripts in yeast. 
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2.2.4 Yeast expression vectors for P71 
pAV3, a multi-copy yeast expression vector for P7I, was constructed by inserting an 1954 bp 
Bam HI DNA fragment encoding the amino acid sequence ofp71 in the plant expression vector 
pDHVCAPB (Gordon et al., 2001) into the 2fl-based vector pYES2 (Invitrogen) (Figure 2.3). 
pAV3 carries the p71 coding sequence flanked by PGALI and Tcrci together with a URA3 
selectable marker. 
An integration vector for chromosomal expression of P7I , YlpLacVCAPB320 (Figure 2.4, 
panel B), was constructed by Rachel Blaine (Syngenta, Jealott's Hill Research Station, 
Berkshire, UK) as follows: first, the PGALI-P7I-Tcrci expression module of pA V3 (Figure 2.3) 
was PCR-amplified using primers PGALFOR (5' -GCGCTCGAGACGGATTAGAAGCC 
GCCGAGC-3 ') and TCYCREV (5'-CGGGAGCTCGCAAATTAAAGCCTTCGAGCG-3') 
using VENT® polymerase (New England Biolabs) and inserted into the 3' T-overhang sites of 
the cloning vector pCR®2.1 (Invitrogen). Two Sac I sites, one introduced by TCYCREV 
adjacent to the 3' end of Tcrci (underlined) and the other in the multiple cloning site of 
pCR®2. 1, were used to subclone the expression module into the Sac I site of YIplac128 
(Figure 2.4, Panel A). The PGALI-P7I -TcYCI cassette of the resulting plasmid, YlpLacVCAP320, 
was fully sequenced to confirm that no errors were introduced by PCR. An unique Cia I site 
within the LEU2 selection marker can be used to create DNA fragments with LEU2 flanking 
regions for the integration into the leu2 clu'omosomallocus. 
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Figure 2.3 Diagrammatic representation of the construction of a multi-copy expression vector 
for HaSV P7], 
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Figure 2.4 The YIpLac128 vector (panel A) for chromosomal 
integration into the leu2 locus and the YlpLac VCAPB320 vector (panel 
B) for the integration of the P GAU-P 71 -TCYCI cassette into the leu2locus 
of the yeast chromosome, 
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2.3 Results and Discussion 
2.3.1 Separate expression vector for P71 
The low probability of P71 expression from RNA2 transcripts 111 yeast necessitated the 
construction of an independent expression cassette for the production of p71 (Figure 2.5). P71 
expression in yeast should result in P7l mRNA with a 5' untranslated leader sequence that is 
mainly derived from pYES2 (Figure 2.3), a vector constructed for high-level protein expression 
in yeast. The leader therefore contains little secondary structure and no runs of G or U 
nucleotides. The 3 nucleotides directly downstream of the stmi codon are derived from the plant 
expression vector pDHVCAPB (Figure 2.3) and place the start codon into the plant consensus 
context for translation initiation (Gordon, et al., 200 I). The yeast and plant consensus 
sequences are fairly similar with an exception at the -2 position (Table 2.1). This alteration 
would most probably not have an adverse effect on the trmlslation efficiency because the only 
alteration to the AUG context that seems to have such an effect is the lack of an A nucleotide at 
-3 (Romanos et aI., 1992). 
-I +1 HC Ribozyme 
r-->-:] L-.c 
.' 
Jt;iI 
PGALl RNAl TCYCI 
-I +1 HC Ribozyme 
L v , 
I 
PGALl RNA2 TCYCI 
---", 
/ 
POALl P7i TCYCi 
Figure 2.5 Expression cassettes for HaSV RNAl, RNA2 and P7l. (+1) and 
(-1) indicates the fusions between the -1 nucleotide of P GALI and the +1 
nucleotides of RNAl or RNA2. The schematics are not drawn to scale. 
2.3.2 Choice of promoter 
The expression of RNAl , RNA2 and P71 was placed under the control of PGAL/, since it is a 
powerful and tightly regulated promoter. P GALl is one of three promoters involved in the 
regulation of GAL gene expression that, collectively, drives the expression of 0.3 to 1.5% of 
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total cellular protein and 0.25 to 1% of total mRNA (Johnston, 1987). PGALl -driven 
transcription is also subject to dual control : it is induced by galactose and repressed by glucose. 
The presence of glucose in a culture medium causes a complete shutdown of expression through 
carbon catabolite repression (Gancedo, 1998). This allows one to avoid potential toxicity 
problems during biomass production prior to induction of protein (P7l) expression. 
Table 2.1 Comparison of sequences surrounding the start codons of HaSV 
RNA2 and P71 mRNA (transcribed from pAV3) to that of the 
S. cerevisiae translation initiation consensus sequence. 
Origin 
S . . I . cerevlszae consensus 
P 17 (HaSV RNA2)4 
P71 (HaSV RNA2)4 
P71 (PAV3)s 
Sequence around start codon 
-4 -3 -2 -I +1 +2 +3 +4 +5 +6 
AAAAAUGUCU 
or or 
y3 U 
AUUUAUGAGC 
CAGGAUGGGA 
~ACAAUGGGA 
-4 -3 -2 -I +1 +2+3 +4+5 +6 
Leader 
length 
282 
365 
134 
Nucleotides that match S. cerevisiae consensus sequence are underlined. 
1 Cigan and DonallUe (1987) 
2 Romanos et al. (1992) 
3 CIU 
4 Figure A1.2, Appendix 1 
5 Figure 2.3 
2.3.3 RNA transcripts that mimic viral RNA 
Plasm ids engineered to produce exact 5' termini 
Val Hodgson (Department of Biochemistry and Microbiology, Rhodes University) produced 
exact fusions between PGALI and the HaSV RNAI and RNA2 sequences by using reverse PCR. 
The primers that were used for reverse PCR directed the amplification of linear DNA fragments 
that should be able to re-ligate to produce plasmids carrying exact fusions between PGALI and the 
HaSV genomic RNA sequences. After the re-ligation step, the ligation reactions for the 
construction of PGALI-RNAI and PGALrRNA2 fusions were transformed into E. coli DH5a.. 
Plasmid DNA preparations from the resultant colonies were screened by restriction digests for 
the absence of DNA fragments separating the PGALI -1 nucleotide, and RNAl and RNA2 +1 
nucleotides, on the plasm ids pVHl and pML Y3 , respectively (pVHl: Figure 2 .1; pML Y3: 
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Figure 2.2). For RNA I , a Pvu II / Xba I digest of a plasmid that contains the correct fusion 
would result in 3125 and I044bp restriction fragments as compared to the 3125, IOl3 and 
70lbp restriction fragments for pVHI (Figure 2.6, panel A). Likewise, for RNA2 an 
Eco Rl / Pst I digest would result in a 4904bp restriction fragment as compared to the 4433 and 
604bp restriction fragments for pVHl (Figure 2.6 panel B). Restriction digests of a number of 
the plasmids that were for screened for correct PGALrRNA1 and PGAL/ -RNA2 fusions produced 
promising results (indicated by arrows in Figure 2.6). 
A 
3125bp ~ 
10l3bp ~ 
70lbp ~ 
M CI I 2 3 4 5 6 7 8 9 10 
II
· -~ .... ----------
-n 
-
-
t 
+-3125bp 
+- I044bp 
B M C2 I 2 3 4 5 6 7 8 9 10 I I 12 l3 14 15 16 
4433bp ~ +- 4904bp 
604bp~ 
Figure 2.6 Restriction analyses of potential PGAL/-RNAl (panel A) and PGAL/-RNA2 (panel B) 
fusion clones. The plasmids were either digested with Pvu II and Xba I (A) or Eco Rl and Pst I 
(B). The restriction fragment sizes for restriction digests of pVHI (Cl) (Figure 2.1) and 
pML Y3 (C2) (Figure 2.2) are displayed on the left-hand side of each gel. The expected 
restriction fragment sizes for restriction digests of potential clones are displayed on the right-
hand side of each gel. The up-arrows indicate potential clones. A Pst I digest of lambda-DNA 
was used as a molecular weight marker (M). These results were generated by Val Hodgson 
(Dep8.liment of Biochemistry and Microbiology, Rhodes University). 
The promoter-viral RNA fusion regions of these plasmids were sequenced to verify that the 
fusions were correct and to establish whether any mutations were introduced through PCR. 
Manual sequencing results showed that one out of two of the RNAI-derived plasmids that were 
selected contained the anticipated fusion (p VH4 in Figure 2. I). However, subsequent sequence 
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analysis of this fusion region in RNAI expression vector pAV13HC (Figure 2.1) indicated that 
first G nucleotide of RNA1 was not present (Table 2.2). The erroneous PGAL-RNA1 fusion 
was prepared by Rachael Blaine (ZENECA Agrochemicals Ltd., Jealotl's Hill, UK) (Table 2.2) 
to produce pAV13HC (G+) (bracketed in Figure 2.1). Automated sequencing results showed 
that one out of three of the RNA2-derived plasmids that were selected contained the anticipated 
fusion (pVH5 in Figure 2.2) (Table 2.2). 
Table 2.2 Nucleotide sequences around the junctions between PGAL1 and the 5' 
ends of GALl, HaSV RNAl and RNA2, BMV RNA3 and FHV 
RNAl 
mRNA species Promoter-RNA junction 
GALli T G T A A T A A A A G TAT C A A C A A A 
HaSV RNAl T G T A A T A A A T T C T G C C T C C C C 
(pAV13HC) 
HaSV RNA 1 T G T A A T A A A G T T C T G C C T C C C 
(pAV13HC G+) 
HaSV RNA2 T G T A A T A A A G T T T T T C T T T A C 
BMV RNA32 T G T A A T A A A A..O .. I .. A .. C G T A A A A T 
FRY RNAl3 T G T A A T A A A A..O .. I .. A .. C .. .I .. .o ... C .. A G T T 
Underline denotes the 5' ends of GALl mRNA cDNA and viral RNA cDNA. 
Dotted underline denotes the promoter - viral RNA linkages for BMV and FRY 
RNA. 
Nucleotides in blue font denote transcriptional starts upon in vivo transcription in 
the absence of replication. 
I Johnson and Davis, 1984 
2 Ishikawa ct ai., 1997 
3 Price et aI., 2000 
The transcription initiation sites in the PCALI-HaSV RNA fusions of pVH4 and pVH5 were 
designed to be the same as that published for the GALl gene (Table 2.2) (Johnson and Davis, 
1984). These fusions are however different to those used for the expression of replicative BMV 
and FHV RNA transcripts in yeast (Ishikawa et ai., 1997; Price et ai., 2000). In these studies, 
the promoter linkages consisted of an additional 5 and 9 nucleotides for BMV and FHV, 
respectively (dotted underlined nucleotides in Table 2.2). Expression of these fusion constructs 
in the absence of replication resulted in transcripts with incorrect transcription starts as 
determined by primer extension analyses (denoted by blue font in Table 2.2). These extended 
transcripts, however, served as templates for the replication of a much-increased amount of 
secondary transcripts with exact 5' ends in the presence of the respective viral replicase 
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enzymes. Other significant results from these experiments were that doublets were obtained at 
positions -2/-3 and -8/-9, and at positions -6/-7 and -12/-13 for BMV- and FHV-derived 
transcripts, respectively (Table 2.2). -1/+1 doublets were also obtained for both BMV- and 
FHV -derived transcripts expressed in the presence of the replicase enzymes. The first member 
of each of these doublets is most probably representative of a 5'-methylated cap. 
It is therefore unlikely that the PoALI-viral RNA fusions used for the research described in this 
thesis would result in the exclusive production of RNA transcripts with precise 5' tennini in the 
absence of an active replication system. It is more likely that a heterogeneous transcript 
population (similar to the ones describe above) would be produced, which would depend on a 
yeast - or insect-based replication system for the high-level production of secondary transcripts 
with exact 5' ends. The primary function of these fusions is therefore to produce transcripts 
with near-perfect 5' ends that would not inhibit replication to the same extent as longer 5' 
extensions. 
ii Plasmids engineered to produce exact 3' termini 
To generate transcripts with 3' ends identical to those of viral RNA a cis-cleaving ToRSV 
hairpin cassette (HC) ribozyme was placed directly behind the last nucleotide of viral sequence. 
This ribozyme was shown to cleave at an efficiency comparable to hammerhead and Hepatitis 
delta virus (HDV) ribozymes when tested in vivo (Chowrira et al., 1994). The yeast expression 
cassettes for RNA] and RNA2 (Figure 2.5) contained identical HaSV RNA - HC ribozyme 
constructs to the ones used for the expression of HaSV RNA transcripts in plant protoplast 
(Gordon et ai., 2001) (Figure 2.7, panel A). The ribozyme portions in these constructs were 
based on the minimal wild-type sequence as determined by Hampel et al. (1990). The 
constructs were shown, by means of RNase protection assays, to generate RNAI and RNA2 
transcripts with precise 3' ends in plant protoplasts (Gordon et al., 2001). 
An HC ribozyme contains two domains (A and B) that are necessary for its activity (Figure 2.7, 
panel A). Domain A contains the cleavage site and interacts side by side with domain B to 
create a buried active site, held together by tertiary contacts (Doherty and Doudna, 2000). This 
interaction aligns the cleavage site and should result in cleavage at the 5' phosphodiester bond 
between the 3' terminal nucleotide of HaSV RNA and the following nucleotide (James and 
Turner, 1995). During cleavage, the 2' hydroxyl of the 5' nucleotide acts as a nucleophile that 
attacks the adjacent phosphate in the RNA backbone, resulting in cleavage products with 2'3'-
cyclic phosphate and 5' hydroxyl telmini (Figure 2.7, panel B). 
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Figure 2.7 (Panel A) HC ribozyrne used for the generation of 
HaSV RNAI and RNA2 transcripts with precise 3' termini. The 
arrow indicates the site of cleavage and the double·sided arrow the 
tertiary folding that causes the stacking of domains A (A) and B 
(B). The viral sequence is indicated with bold script. Adapted 
from Doherty and Doudna, 2000. (Panel B) Mechanism of 
phospho diester bond cleavage at the site of cleavage. Adapted 
from James and Turner (1995)" 
Combined evidence for successful implications of cis· cleaving ribozyrnes in yeast (Egli and 
Braus, 1994; Ishikawa et al. , 1997; Price et al., 2000) makes it plausible to believe that the 
HaSV RNA - HC ribozyrne constructs described above would be functional. The stability of the 
cleaved transcripts in yeast could most probably be increased by their 3' terminal tRNA·like 
structures. According to Hanzlik and Gordon (1997) these structures could have the purpose of 
replacing poly-A tails for protection against exonucleolytic degradation. Experimental evidence 
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suggests that cis-cleaving ribozymes could be used for the expression of stable RNA transcripts 
with a cytoplasmic locus in yeast. Ishikawa et al. (1997) used an HDV ribozyme for the 
expression of BMV RNA3 transcripts with precise 3' ends. These transcripts, which also 
contain 3' terminal tRNA-like structures, were exported to the cytoplasm since they were 
available for replication by the viral replicase. Price ef al. (2000) obtained similar results for 
FHV RNAI with an HDV ribozyme. 
2.3.4 HaSV expression strategy 
For the stable expression of HaSV RNA 1 and RNA2 transcripts , their respective expression 
modules were cloned onto ARS/CEN vectors carrying the URA3 and TRP 1 selectable markers 
(Figure 2.1 and 2.2). The P71 expression module was cloned into a YIp carrying the LEU2 
selectable marker (Gietz and Sugino, 1988) (Figure 2.4). The LEU2 selectable marker of this 
YIp has a unique restriction site that can be cleaved to produce a linear DNA fragment with 
LEU2 flanking regions (Lundblad, 1997). Tllis fragment can therefore be integrated via 
homologous recombination into the leu2 locus of a mutant yeast strain to produce a p71 + strain. 
The success of the expression strategy illustrated in Figure 2.8 is limited by the factors that have 
been considered in this chapter. In accordance with this strategy, chromosomal expression of 
P 71 and episomal expression of the viral RNAs (from expression modules depicted in 
Figure 2.5) should direct the assembly of virus particles in the cytoplasm . 
••••• --::::>o'~' • •• 
Assembly 
Figure 2.8 A generalized diagrammatic representation of the 
expression strategy for the non-host production of HaSV in yeast. 
The question mark symbolizes a potential role of the HaSV replicase 
in the amplification of RNAI and RNA2 transcripts. 
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3 The expression of P71 in S. cerevisiae 
3.1 Introduction 
In the previous chapter, it was proposed that mRNA transcribed from the P71 expression 
cassette (Figure 2.5) would serve as an efficient template for the translation of this protein in 
yeast. Protein translation is, however, followed by a number of other steps that form part of 
the complex multi-step expression process. These steps include the folding and post-
translational processing of the newly synthesized polypeptide. In addition to the potential 
problems relating to expression, certain properties of the final expression product could lead to 
its instability in yeast. 
3.1.1 Polypeptide folding 
In E. coli, the over-expression of foreign proteins often results in the formation of insoluble 
complexes, called inclusion bodies, which consist of only certain conformations of folding 
intermediates of the over-expressed protein (Speed et ai., 1996). The solubilization, 
denaturation and renaturation of these intermediates have proved to be an effective way to 
purify large quantities of different foreign proteins from E coli (Fischer et aI., 1993). In 
contrast with E. coli, few problems relating to the folding of over-expressed proteins have 
been experienced for yeast (Romanos et aI., 1992). Binder et ai. (1991), however, 
demonstrated that the over-expression of catalase A induces inclusion body formation in yeast, 
and Weik et al. (1998) reported on the denaturation and refolding of yeast-expressed ali in 
lyase from inclusion bodies. 
There is, however, another method for the production of a higher level of protein in its native 
conformation (apart from in vitro renaturation) in the event of an insoluble over-expressed 
protein. The over-expression of a protein places a high demand on factors required for protein 
folding to act on abnormally high levels of newly synthesized polypeptides. Inclusion bodies 
are formed when polypeptides fold incorrectly due to a lower than threshold concentration of 
these factors. Accordingly, expression conditions conducive to a decreased rate of translation 
(i.e. a lower growth temperature during induction or a reduced induction rate) could result in a 
cellular enviromnent that is more favorable for the proper folding of a protein (Nilsson and 
Anderson, 1991). There are some examples where lower expression rates increased product 
solubility in yeast. The level of soluble pertactin (a bacterial membrane protein) was 
increased IO-fold as a result of a decreased expression rate in Pichia pastoris (Romanos et ai., 
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1991). In addition, a much greater proportion of hepatitis B surface antigen particles were 
purified from P. pastoris when produced in a strain that grew slowly during induction (Cregg 
et al., 1987). 
3.1.2 Post-translational processing 
In yeast, all the different forms of posttranslational processing generally occur in a manner 
similar to that of higher eukaryotes (Romanos et al., 1992). Two types of amino-terminal 
modifications occur: removal of the N-terminal Met residue (catalyzed by methionine 
aminopeptidase) and N-acetylation (catalyzed by Na-acetyltransferase). There is a preference 
for Ser as the second residue in yeast proteins (Romanos et al., 1992). This is indicative of the 
N-end rule for S. cerevisiae whereby certain "destabilizing" residues at the N-terminal ends of 
proteins targets them for degradation by the ubiquitin pathway (Finley, 1992). Destabilizing 
residues are penultimate amino acids that are either defined as charged (type I) or bulky 
(type II). This rule is however limited in its application, because methionine aminopeptidase 
only cleaves if the second residue is of the stabilizing kind. Accordingly, most cytosolic 
proteins have stabilizing N-terminal residues. It would therefore be expected that the N-
terminal Met residue of p71 would be cleaved off, because a Gly residue, which is classified 
as a stabilizing type (type III), follows it (GGA codon for Gly in Table 2.1). It is unclear 
whether p71 will be N<l-acetylated in yeast. It is however safe to assume that it will be 
processed in a way that is similar to that in insect cells, because the rules governing 
acetylation seem to be conserved among eukaryotes (Romanos et al., 1992). 
3.1.3 Protein stability 
Heterologously expressed proteins could be degraded endogenously through the ubiquitin 
pathway as a result of their instability (as defined by the N-end rule and other factors), toxicity 
to the cell, or tendency to form insoluble protein aggregates (or inclusion bodies) (Finley, 
1992). In these instances, 76-residue ubiquitin molecules are covalently attached to specific 
lysine residues on these proteins. More ubiquitin molecules are thereafter linked to the Lys-48 
residues of the attached ubiquitin molecules to form extended ubiquitin chains. The resulting 
"multi-ubiquinated proteins" are then the targets for the rapid proteolytic breakdown by yeast 
proteasome enzymes. According to Romanos et al. (1992) intracellular proteolysis could be 
reduced by (i) inducing at a lower temperature, (ii) harvesting at exponential growth phase, 
(iii) using protease inhibitors during extraction and (iv) using a rapidly induced promoter. 
Vacuolar proteases do not pose a problem for foreign proteins within the cell, because they 
only degrade stable proteins (tll2 = approximately 160 hours) and there are endogenolls 
protease inhibitors for them (Jazwinski, 1990). These proteases are predominately responsible 
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for the proteolytic activities in yeast protein extracts (Jones, 1991). According to Jazwinski 
(1990) there are three types of vacuolar proteases: A, B and C. Protease A is an acid-protease 
that could be inactivated to a great extent by maintaining the pH above 6. Proteases B and C 
are serine proteases and could therefore be inactivated by the presence of serine protease 
inhibitors. For optimal yields of a heterologously expressed protein it is however advisable to 
use as wide a range of protease inhibitors as possible. 
The objective of the work described in this chapter was to develop a yeast expression system 
for the high-level production of HaSV capsid protein in its native form. This would, in turn, 
increase the likelihood for the assembly of HaSV VLPs. The effect of a number of factors , 
which could increase the production of native protein in a yeast expression system, will be 
described. These include expression conditions (e.g. strains used, expression loci and 
expressIOn rate) and protein extract preparation (e.g. the presence of various protease 
inhibitors and salt concentrations). 
3.2 Materials and methods 
Recipes for the preparation of complex (YPD) and supplemented minimal media (SMM), 
which was used for selection of plasmid-containing yeast strains, are described in Appendix 7. 
All the yeasts strains that were used for this study are listed in Table A6.l (Appendix 6). 
3.2.1 Construction of YIps for RNA2 and P71 
To draw a comparison between the. respective efficiencies for the production of p71 from 
RNA2 and P71 expression cassettes (Figure 2.5), YIps were constructed for the chromosomal 
expression of RNA2 and P7I. 
RNA2: The plasmid 5.66/5(G+) (constructed by Rachel Blaine from Syngenta, Jealott' s Hill 
Research Station, Berkshire, UK) is an intermediate construct for the cloning of a YIp for 
RNAl that directs the transcription of RNA I molecules with precise 5' ends. A 2056bp DNA 
fragment harboring PGAL! fused to the 5' end of RNA] was subcloned from 5.66/5(G+) into 
YipLac204 to produce YipLac204/5.66(G+) (Figure 3.1, Step I). An unique Age I restriction 
site within P GAL1 was used to swap an Age I - Kpn I fragment carrying the 3' end of PGAL! 
fused to the 5' end of RNA] for a 3213bp Age I - Kpn I fragment carrying the RNA2 
expression module of pAVI4HPTrp (Figure 3.1, Step II). The resulting plasmid, 
YipLac204IHaSVRNA2, was used for the chromosomal expression of RNA2 in yeast. 
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Figure 3.1 A flow diagram of the cloning steps for the construction of a yeast chromosomal 
integration vector for the expression of RNA2. 
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Figure 3.2 Diagrammatic representation for the construction of the yeast chromosomal 
integration vector pMJ2 for the expression of P 71 . 
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P71: The PGALI-P71-TcYCI cassette was subcloned from YIpLacVCAP320 into YipLac211, 
which carries the URA3 selection marker, to produce pMJ2 (Figure 3.2). This plasmid can be 
linearized by a Csp 451 restriction digest for integration into the ura3 chromosomal locus. 
3.2.2 Yeast transformations 
The yeast strains INVSc l (Invitrogen) and JRYl88 were used for the expression of P71 
(Table A6.1 , Appendix 6). Plasmids were transformed into these strains using the Frozen-EZ 
Yeast Transformation II kit (Zymo Research). For the selection of transform ants, amino acids 
or uracil were omitted from the SMM used to select for transformants 
3.2.3 Generation of yeast strains for the chromosomal expression of P71 and RNA2 
YIps were digested at unique restriction sites within selection marker genes to produce DNA 
fragments that could integrate into the chromosomal mutant allele of the respective selection 
markers used. These fragments were transformed into INVScl, JRYl88 or strains that were 
generated during the course of this study. A list of these strains and their respective genotypes 
are displayed in Table A6.1 (Appendix 6). The YIps that were used for the generation of each 
of these strains are also listed. Cia I was used to linearize YipLacl28 (Figure 2.4) and 
YIplacVCAP320 (Figure 2.4), while Csp 451 was used to linearize pMJ2 (Figure 3.2). 
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ECD RV was used to linearize all the other YIps that were used in this study. The presence of 
P71 chromosomal expression modules in the strains INVScl 3#20.1 and JRY188 3#20.1 was 
verified by Western analyses of protein extracts from cells induced for P71 expression. The 
presence of RNA2 chromosomal expression modules was verified using PCR amplification of 
yeast genomic DNA. 
3.2.4 Growth characteristics of yeast in batch culture 
INVScl cells were inoculated into 400ml SMM containing 2% glucose. The culture was 
incubated at 30 DC, shaking at a speed of 200rpm. 10m! aliquots were taken at various time 
intervals and the OD600nm (UNICAM Helios Alpha spectrophotometer) and cell count (using a 
hemocytometer) of each aliquot was determined. 
3.2.5 Confirmation of episomal expression of P71 
Uracil was omitted from SMM when appropriate to maintain selection for pA V3 or p YES2. 
The cells were grown at 30DC in SMM containing 2% glucose up to mid log phase (OD600nm of 
approximately 0.5), centrifuged for 10 min at 4000rpm in a Beckman JA20 rotor and 
resuspended in SMM containing either 2% galactose or 2% raffinose. The cells were then 
grown for a further 4h at 30D C and harvested as described above. Yeast protein extractions 
were carried out by vortexing in the presence of glass beads as described in Section A8.1 
(Appendix 8). 
3.2.6 Testing yeast strains for chromosomal expression of P71 
Putative P71+ strains were transferred from agar plates to Eppendorf tubes containing Iml 
sterile ddH20 and the OD60Onm values of these cell suspensions were determined. A volume of 
each of these suspensions was added to 5ml YPD medium to make the OD600nm approximately 
0.5. The strains were grown in YPD medium containing either 2% glucose or 2% galactose 
for 4 hours at 30DC. The cultures were then centrifuged as described above, and yeast protein 
extractions were carried out as described in Section A8 .1 (Appendix 8). 
3.2.7 Protein analysis 
The protein concentration of samples was estimated using the Bradford protein assay (Smith, 
1988). BSA was used as a protein standard and protein standard curves (with R2 values of at 
least 0.99) were generated for each protein determination. Protein samples were subjected to 
SDS-PAGE in 7.5% polyacrylamide gels according to the procedure of Laemrnli (1970). 
Electrophoretic transfer to Hybond-C+ membranes (Amersham) and immunoblot processing 
was according to Towbin et al. (1979). Premixed protein molecular weight markers from 
Roche were used for molecular weight estimation of bands visualized on gels (stained with 
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Coomassie Brilliant Blue R250 from Sigma) and membranes (stained with Ponceau-S, as 
described by Sambrook et at., 1989). The Chemiluminescence Western Blotting Kit (Roche) 
was used for immunological detection. 
The anti-HaSV antiserum used for preliminary experiments was obtained from Karl Gordon 
and TeITY Hanzlik (CSIRO Entomology, Canberra, ACT, Australia). This antiserum 
interacted nonspecifically to yeast proteins and was preadsorbed with yeast cell lysates as 
follows. The yeast cell lysate was prepared from 250ml INVScI cells grown in SMM to an 
OD600nm of 0.5. The cells were centrifuged for 10min at 3000rpm in a Beckman JAI4 rotor 
and resuspended in 6ml 50mM Tris-HCl buffer (PH 7.4) with 1mM phenyl methyl-sulfonyl 
fluoride (PMSF) and ImM DTI. The resuspended cells were transferred to a JA20 centrifuge 
tube and 6 g of O.2mm acid-washed glass beads (Section A8.2, Appendix 8) were added. Cell 
disruption was carried out by vortexing for 30 sec periods with 30 sec intervals (on ice) and a 
total homogenization time of 5 min. The lysate was diluted 3.3-fold with Tris-HCI buffer and 
centrifuged at 12S00rpm for 15 min at 4°C in a Beckman JA20 rotor. For preadsorption, the 
antiserum was incubated for 1 hour at room temperature in 1 ml of the supernatant from the 
previous centrifugation step, which contained 0.25% total yeast protein. This mixture was 
thereafter diluted in O.IM Tris-HCl (PH 7.6) containing 0.15 M NaCl, 1 % BSA and 0.5% 
Tween 20, and added to the blot for the primary antibody immwlodetection step. 
Three antibody preparations, two polyclonal (HaSV -RB I IgG and HaSV -RB2 IgG) and one 
monoclonal (HaSV-35), with little or no cross-reactivity with yeast proteins were obtained 
from Andrew Dinsmore (Syngenta, 1ealott's Hill Research Station, Berkshire, UK). 
3.2.8 Preparation of soluble protein fractions 
After induction, 301-11 of ice-cold SOmM Tris-HCl (PH 7.4) containing ImM DTI and ImM 4-
(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF) (Roche Molecular Biochemicals) were 
added to every 2 OD600nm units of yeast cells. The cells were vortexed with O.lg glass beads 
for 30 sec periods with 30 sec intervals (on ice) and a total homogenization time of S min. 20 
to 401-11 of the protein extracts were transfeITed to Eppendorftubes and 2.3 volumes of SOmM 
Tris buffer were added to the remainder. The homogenates were briefly vortexed and then 
microfuged for S min. Sx SDS-PAGE loading buffer was added to each of the yeast protein 
extracts and supernatant fractions . An equivalent volume of SOmM Tris buffer to that of each 
supernatant fraction and S x SDS-PAGE loading buffer were added to the pellets. The protein 
extracts, supernatants (or soluble fractions) and pellets (or insoluble fractions) were separated 
on SDS-PAGE and transfeITed electrophoretically to nitrocellulose membranes for 
immunoblotting. 
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3.2.9 peR analysis of genomic DNA 
To verify that RNA2 expression modules were integrated into yeast genomlc DNA, 
approximately IJlg of yeast chromosomal DNA preparations (extracted as described in 
Section 8.3, Appendix 8) was used as a template for PCR with the primers RNA2F3 
(corresponding to nucleotides 52 - 72 of RNA2) and RNA2R2 (complementary to nucleotides 
530 - 550 of RNA2). The Expand™ High Fidelity PCR System (Roche) was used for these 
reactions and the parameters described for Programme 2 (Appendix 5) were used for thermal 
cycling. 
3.3 Results 
3.3.1 Growth of INVScI cells in batch culture in SMM 
It was necessary to characterize growth of INVScI cells in SMM to determine when the cells 
were in exponential growth phase for induction of P71 expression. This characterization 
would also provide the strain's generation time, which could be used to estimate the time 
required for a culture to reach mid-log phase. OD600nm values were correlated with the number 
of cells per milliliter using a hemocytometer. 
A growth curve for INVScI demonstrated that mid-log phase was reached at an OD6oo value of 
approximately 0.5 (Figure 3.3, panel A). According to a correlation between OD600nm and cell 
counts per milliliter (Figure 3.3, panel B), this equates to a concentration of 3xl07 cells/m!. 
The generation time of this strain was estimated as 2.7hrs from the portion of the growth curve 
that represented exponential growth (which had an r2 value of 0.965). 
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Figure 33 (A) Growth curve for the yeast strain INVScI in SMM. The growth 
conditions are described in Section 3.2.4. (B) Correlation between OD600nm and the 
concentration of cells in the culture. (r2 = 0.975) 
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3.3.2 Episomal expression of P71 
To determine whether PGALI driven expression of P71 was occurring, total protein extracts 
from induced and uninduced INVScl cells, transformed with either pYES2 (Figure 2.3) or 
pAV3 (Figure 2.3), were separated on 10% SDS-PAGE gels. Staining of one of these gels 
with Coomassie R-250 showed that the band intensities in the different lanes were equivalent, 
indicating that the same amount of protein was loaded in each lane (Figure 3.4, panel A). No 
protein bands of the expected sizes were however detected for cells that were induced for the 
expression of P71. The proteins were electroblotted to a nitrocellulose membrane and probed 
with anti-HaSV antiserum, which was preadsorbed with a yeast cell lysate to reduce cross-
reaction with yeast proteins. This preadsorption technique did not eliminate cross reactivity, 
because a number of proteins with MR-values smaller than 64 IcDa were detected in extracts 
from cells that were not induced for the P71 expression (lanes 1 - 3 in Figure 3.4, panel B). A 
protein that migrated at a MR of 71kDa was, however, exclusively detected in induced 
INVSc1 cells transformed with pA V3 (lane 4 in Figure 3.4, panel B). In addition, a very low 
level of a protein co-migrating with p64 from wild-type virus was detected. 
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Figure 3.4 Coo massie-stained gel (panel A) and Western analysis (panel B) of 
total protein extracts from yeast cells. The blot in panel B was probed with 
anti-HaSV polyclonal antibodies preadsorbed with yeast cell lysate. INVScI 
cells were transformed with either p YES2 (lanes 1 and 2) or pA V3 (lanes 3 and 
4), and grown in either raffinose (lanes 1 and 3) or galactose (lanes 2 and 4) 
during the induction phase. (+), 5ng wild-type HaSV. 
3.3.3 Chromosomal expression of P71 
After the transformation of linear YlplacVCAP320 (Figure 3.2) fragments into JRYI88, four 
of the transformants (designated as strains 3#20.1, 2#37.1,1#41.1 and 2#54.1) were tested for 
the presence of P71 chromosomal expression modules. PGALI-dependent P71 expression was 
either induced or repressed by the presence of galactose or glucose as the sole carbon source, 
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respectively. Protein extracts from these strains were mn on 10% SDS-PAGE gels and 
examined for the presence of p71 by Westem analysis (Figure 3.5). Two new anti-HaSV 
antibodies, which were specially selected as detection antibodies for yeast expression 
experiments, were also tested in this experiment. The blots were probed with either a 
polyclonal (HaSV-RB2 IgG) or a monoclonal (HaSV-35) antibody. 
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Figure 3.5 Westem analysis total protem extracts from JRY188 
3#20.1,2#37.1,1#41.1, and 2#54.1 cells. P71 expression was either 
galactose induced (I) or glucose repressed (R). The blots were probed 
with the antibodies HaSV-RB2 IgG (panels A and B) or HaSV-35 
(panels C and D). The arrows identify bands that migrate at a similar 
molecular weight as p71. (+), 5ng wild-type HaSV. Taken from 
Venter (1998). 
The cross-reactivity with yeast proteins for HaSV-35 (Figure 3.5 , panels C and D) and 
absence thereof for HaSV-RB2 IgG (Figure 3.5, panels A and B) was unexpected. HaSV-35 
interacted with several proteins that migrated at molecular weights lower than that of the 
HaSV capsid proteins in cell extracts from uninduced yeast cells. Both the antibodies, 
however, interacted with a protein that migrated at a molecular weight of approximately 
71kDa for protein extracts from JRYl88 3#20.1,2#37.1 and 2#54.1 cells that were grown in 
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galactose during the induction stage. No p71 was however detected by either of these 
antibodies for the 1#41.1 strain. PGALl-directed expression of P71 in the 3#20.1, 2#37.1 and 
2#54.1 strains resulted predominately in the production of p71 since no p64 was detected for 
any of these strains. HaSV-RB2 IgG detected a smaller protein with an MR of approximately 
55 kDa in extracts from the latter strains subsequent to growth in galactose (Figure 3.5, panels 
A and B). This protein, which was detected in all the other western analyses described in this 
chapter, was probably a proteolytic degradation product ofp71. 
This result is similar to that described above for the production of p71 in INVScl cells 
transfonned with pAV3. HaSV-RB2 IgG was used for further Western analyses due to its 
superior specificity to yeast expressed p71. The JRY188 3#20.1 strain was in tum selected for 
subsequent expression experiments. 
3.3.4 The effect of induction period on P71 expression 
The effect of induction period on p71 production was exan1ined for JRY188 3#20.1 cells over 
48 hours (Figure 3.6, panel A). Protein production increased with time, with maximal 
production at 12 hours post induction (hpi). No protein could, however, be detected after 12 
hours . 
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Figure 3.6 (A) Western analysis of protein extracts from JRY188 3#20.1 cells that were 
grown at 30°C in SMM containing 2% galactose for 0-48h for the induction of P71 
expression. (+), 1ng wild-type HaSV. (B) Graph comparing cell counts from JRY188 3#20.1 
cultures that were either plated out on plates containing (.), or not containing (. ), L-leucine 
during the 48 hour induction period for P71 expression (Taken from Jiwaji , 1999). 
Several possible explanations could account for the disappearance of P71 from JRY188 
3#20.1 cells at 12 hpi. Since integration of YipLac128 into the LEU2 locus results in 
duplication of the LEU2 sequence, selective pressure against P71 expression could result in 
loss of the P71 expression module through homologous recombination (Romanos et al. , 
1992). After induction, cells were plated onto SMM either containing, or not containing, L-
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leucine to look for the progressive loss of the Leu + phenotype during induction (Jiwaji, 1999). 
There was no significant difference in the number of colonies on both sets of plates, even at 48 
hpi (Figure 3.6, panel B), indicating that no loss of LEU2 occurred. The possibilities of 
lethality of P71 expression or transcriptional repression were excluded since no difference in 
growth rate was detected between JRYI88 and JRYI88 3#20.1 in SMM containing galactose. 
3.3.5 Optimization of soluble p711evels 
The growth conditions described for the preparation of yeast celllysates (SMM containing 2% 
galactose and induction at 30°C for 4 hours) resulted in the expression of insoluble p71, as 
most of this protein was found in the pellet fractions when cell lysates were microfuged for 5 
min (results not shown). Experiments were therefore designed to determine whether or not a 
decrease in the rate of P71 expression would increase protein solubility. Two factors that 
would bring about reduced expression rate were tested: a reduction in the galactose 
concentration and a decreased incubation temperature during the induction period. 
POAL/-driven expression was very sensitive to galactose concentration since p71 was detected 
at the lowest concentration tested (0.01%) (Jiwaji, 1999) (Figure 3.7). The amount of p71 
produced reached a maximum at a concentration of 0.1 %, and seemed to taper off at higher 
concentrations. 0.01% galactose was used for further expression experiments. 
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Figure 3.7 Western analysis of protein extracts from JR Y 18 8 
3#20.1 cells that were grown in different galactose 
concentrations for 4 hours. (+), Ing wild-type HaSV. Taken 
from Jiwaji (1999). 
In the experiments described up to this point, cells were grown with 2% glucose prior to 
induction (according to the protocol in Section 3.2.5). After the addition of galactose, it takes 
3 to 5 hours for the glucose to be depleted from these cells before expression was initiated 
(Johnston, 1987). An alternative is to grow the cells on a non-catabolite repressing source 
(5% glycerol and 0. I % glucose) before induction. There are two advantages for this strategy: 
,. 
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no centrifugation steps for the purpose of media changes are necessary and the cells become 
induced within 10 - 20 min after the addition of galactose (Johnston, 1987). 
This was confirmed by the detection of p 71 after only I hour when cells were grown on the 
optimal galactose concentration (0.1%) at 30°C (Jiwaji, 1999) (Figure 3.8, panel A). P71 
expression was at a maximum 2-4 hpi and decreased until nothing was detected 16 hpi. The 
disappearance of p71 after prolonged expression is in agreement with the results displayed in 
Figure 3.6 (panel A). The "window period" for p71 production was however shifted to a 
stretch of time that was closer to the onset of induction (Jiwaji, 1999). This shift is due to a 
reduced lag-period in which PGAL/-dependent expression was repressed. The lag period 
increased upon decreasing the galactose concentration from 0.1 to 0.01 % (Figure 3.8, panels A 
and B), and increased even further when the growth temperature was reduced (Figure 3.8, 
panels C and D). 
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Figure 3.8 Western analysis of protein extracts from JRY188 3#20.1 cells that were 
grown in SMM containing 0.1 % galactose at 30°C (panel A), 0.01 % galactose at 30°C 
(panel B), 0.01% galactose at 25°C (panel C) or 0.01% galactose at 20°C (panel D) for 
0-16 hours during induction. The cells were grown on 5% glycerol and 0.01% glucose 
at 30°C prior to the addition of galactose. (+), lng wild-type HaSV. Taken from Jiwaji 
(1999). 
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The solubility of the p71 production within the "window periods" for growth at 20°C and 
25°C was tested (Jiwaji, 1999). Western analyses of protein extracts, soluble fractions and 
insoluble fractions of samples within the respective "window periods" demonstrated that 
proteins, which interacted with HaSV antibodies, were only detected in the soluble fractions 
for 8- and 16-hpi at 20°C (Figure 3.9). The 8-hpi fraction showed a more prominent protein 
band at 71kDa than at 64kDa, while the 16-hpi fraction showed a more prominent band at 
64kDa. Numerous proteolytic-breakdown products were however detected for both these 
soluble fractions. 
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Figure 3.9 Westem analysis of total protein extracts (p), soluble (s) and insoluble (i) 
fractions from JRYI88 3#20.1 cells that were induced for different time periods at 
either 20°C or 25°C. The protocol described in Section 3.2.8 was followed for the 
preparation of these fractions. The arrows indicate lanes in which soluble HaSV capsid 
proteins were detected. (+), Ing wild-type HaSV. Taken from Jiwaji (1999). 
3.3.6 The effect of two different serine protease inhibitors on p71 production 
The detection of numerous proteolytic breakdown products in p71 preparations led to the 
testing of an altemative protease inhibitor to the one that was used for the cell lysis at that 
point in time, being AEBSF. PMSF protected p71 during yeast cell lysis to a far greater extent 
than AEBSF and concomitantly a much higher level of p71 was detected in soluble fractions 
derived from JRY188 3#20.1 cells (Figure 3.10, panel A). Furthermore, there were fewer 
proteolytic breakdown products, compared to earlier attempts (Figures 3.8 and 3.9), for the 
protein extracts and soluble fractions in the presence of PMSF. However, a considerable 
amount of insoluble p71 was still obtained from cells that were lysed in the presence of PM SF. 
Similar results were also obtained for the production ofp71 in the lNVScI cells (Figure 3.10, 
panel B). The exposure time of the film during chemoluminescent detection was not sufficient 
for the detection ofp71 in soluble fractions from both JRYI88 3#20.1 and lNVScI cells that 
were lysed in the presence of AEBSF (Figure 3.10). It was, however, detected in these 
fractions after longer exposure times (results not shown). 
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Figure 3.10 Western analysis of protein extracts 
(p), soluble (s) and insoluble (i) fractions that were 
prepared using cell buffers containing either PM SF or 
AEBSF (the protocol described in Section 3.2.8 was 
followed). These fractions were derived from JRYI88 
3#20.1 cells (panel A) and INVScI cells transformed 
with pAV3 (panel B). (+), Ing wild-type HaSV. 
These findings led to the re-examination of the effects of growth temperature and inducer 
concentration on the expression of soluble p71. The level of soluble p71 produced after the 
optimum induction periods for the high expression rate system (30°C, 0.1 % galactose) was 
compared with that for the low expression rate system (20°C, 0.01 % galactose). Protein 
determinations on the protein extracts used for this experiment showed that equivalent 
amounts of protein were loaded into each well. Western analysis of soluble fractions of these 
extracts showed that the minor effect of a decreased expression rate (shown in Figure 3.9) was 
surpassed by the much greater effect of the presence of PMSF in cell lysis buffers 
(Figure 3.11). The only difference between the soluble fractions from cells induced under 
these two conditions was that more proteolytic breakdown products were detected at 30°C. 
This observation, together with the slight effect on p71 solubility, let to the decision to 
continue with the lower expression rate system for further experimentation. 
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Figure 3.11 Western analysis of protein extracts of duplicate soluble 
(s) and insoluble (i) fractions that were prepared from JRYI88 3#20.1 
cells that were either induced for 4 hours at 30°C in 0.1 % galactose or 
for 8 hours at 20°C in 0.01 % galactose. These fractions were prepared 
using cell lysis buffers containing ImM PMSF. (+), Ing wild-type 
HaSV. 
3.3.7 Additional optimization experiments 
It was recently demonstrated that baculovirus-expressed N CD V procapsids could be purified 
from an insect cell line (Canady et al. , 2000). A Tris-HCI buffer containing 2S0mM NaCI was 
used during this purification process, due to an apparent increased stability of these procapsids 
in buffers with a high ionic strength (M. Canady, personal communication). Experiments 
were performed to test whether high NaCI concentrations could increase the stability of yeast 
produced p 71. 
A [NaCI] (mM) B [NaCI] (mM) 
o 31 63 125 250 500 + o 31 63 125 250 500 + 
... 
.. -
Figure 3.12 Western analysis of soluble fractions prepared from JRYI88 3#20.1 cells by 
lysis in SOmM Tris pH7.4 containing different concentrations of NaCl, ImM DTT and either 
ImM PMSF (panel A) or ImM AEBSF (panel B). +, lng and 2ng wild-type HaSV in panels 
A and B, respectively. 
NaCI concentrations as high as 500mM did not seem to have any effect on the solubil ity of 
p71 when cells were lysed in the presence of PMSF (Figure 3.12, panel A). In contrast, when 
AEBSF was used as a protease inhibitor, a NaCI concentration as low as 31 mM resulted in a 
decreased level of soluble p71 and no soluble protein was detected at a concentration of 
2S0mM (Figure 3.12, panel B). 
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A comparison of the levels of soluble p71 production in JRY188 and INVSC1 from episomal 
and chromosomal expression modules demonstrated that the highest levels of p71 were 
detected in soluble fractions from INVSCI cells transformed with pA V3, and JRY 188 3#20.1 
cells (Figure 3.13, lanes 1 and 4). Low levels of P 71 expression were observed in JRY188 
cells transformed with pA V3 (Figure 3.13 , lane 2). 
kDa 
97~ 
66~ 
39~ 
27~ .-' 
1 2 3 4 5 
-
-
Figure 3.13 Western analysis of 
soluble fractions prepared from JRY188 
3#20.1 cells (lane 1), JRY188 cells 
transformed with pA V3 (lane 2), 
INVScl 3#20.1 cells (lane 3) and 
INVSc 1 cells transformed with pA V3 
(lane 4). Lane 5 contains lng wild-type 
HaSV. 
3.3.8 Production of p71 from RNA2 transcripts 
A direct comparison between the P71 expression efficiencies of the RNA2 and P71 expression 
cassettes (shown in Figure 2.5) necessitated the transcription of RNA2 mRNA from a 
chromosomal copy of the RNA2 expression cassette. Accordingly, YIps for the expression of 
RNA2 (YIpLac204IHaSVRNA2) and P71 (pMJ2), as well as YlpLacl28, YlpLac204 and 
YlpLac211 , were transformed into INVScI cells to produce a variety of yeast strains, the 
genotypes of which are listed in Table 3.1 (YIpLac204IHaSVRNA2: Figure 3.1; pMJ2: 
Figure 3.2; YIpLacl28: Figure 2.4; YIpLac204: Figure 3.1; YlpLac21l: Figure 3.2). The 
YIps that were used for the generation of each of these strains are also listed in Table 3.1. 
Ylplacl28, YIpLac204 and YIpLac2l1 do not contain expression modules for RNA2 and P71 , 
and carry the LEU2, TRP 1 and URA3 selectable markers, respectively. 
3-81 
Table 3.1 Yeast strains for the chromosomal expression of P71 and RNA2 
Yeast strain Genotype* Yip(s) 
INVScI his3, leu2, trp1, ura3 
INVScI R2 his3, leu2, R2::TRPl , ura3 YlpLac204IHaSVRNA2 
INVScI T+ his3, leu2, TRPl , ura3 YipLac204 
INVScI R2 L+ his3 , LEUl, R2::TRPl , ura3 YlpLac204IHaSVRNA2 
YipLac128 
INVScI L+T+ his3, LEUl, TRPl , ura3 YipLac128 
YlpLac204 
INVScI U+ T+ L+ his3 , LEUl, TRPl, URA3 YipLac128 
YlpLac204 
YlpLac211 
INVScI CAP T+ L+ his3, LEUl, TRPl , P71::URA3 pMJ2 
YipLac128 
YlpLac204 
INVScI R2 U+ L+ his3, LEUl, R2::TRPl , URA3 YlpLac204IHaSVRNA2 
YipLac128 
YlpLac211 
INVScI CAP R2 L+ his3, LEUl, R2::TRPl, P71::URA3 pMJ2 
YlpLac204IHaSVRNA2 
YipLac128 
* Boldface text denotes dorrunant alleles generated Via mtegratJon of Yips 
Green text denotes plasmids and genes for the expression of P71 
Blue text denotes plasmids and genes for the expression of RNA2 
Proof for the presence of chromosomal copies of the RNA2 expression cassette was obtained 
through PCR analysis of genomic DNA preparations from the putative RNA2+ strains. 
(Figure 3.14). A 498bp PCR product was amplified by an RNA2-specific primer pair for 
strains that were transformed with YIpLac204IHaSVRNA2 (INVScI R2), while no product 
was detected for strains that were transformed with YIpLac204 (INVScI T+) (Table 3.1). 
INVScI R2 was used for subsequent transformation experiments that led to the generation of 
the INVScI R2 L+, R2 U+ L+ and CAP R2 L+ strains (Table 3.1). INVScI T+ was, in turn, 
used for subsequent transformation experiments that led to the generation of the 
INVScI L+ T+, U+ T+ L+ and CAP T+ L+ strains (Table 3.1). 
The p71 production levels among P71 + (Figure 3.15, lanes 2.1 and 2.2), RNA2+ (Figure 3.15, 
lanes 3.1 and 3.2) and P71 +/RNA2+ strains (lanes 3.15, lanes 4.1 and 4.2) were compared by 
Western analysis. Protein extracts from two of each of the (TRP 1, LEU2, URA3)-strains were 
analyzed in an attempt to obtain a more accurate assessment. A very low level of p71 
production was obtained from the RNA2+ strains as compared with the P71+ strains (bands co-
migrating with p71 in lanes 3.1 and 3.2, Figure 3.1 5, were clearly visible on the original 
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autoradiography film, but did not reproduce well on subsequent copies). The co-expression of 
RNA2 and P 71 did, however, not result in a detectable increase in the level ofp7!. A protein 
with an MR of approximately 39 kDa, which was detected for extracts from all the strains that 
were tested (Figure 3.15), was probably from yeast origin and was detected due to a low level 
of cross-reactivity by anti-HaSV-RB2 IgG. 
~498bp 
Figure 3.14 PCR of genomic DNA 
preparations from two RNA2+ lNVScI strains 
(Rl) and two TRP+ INVScI strains (T+) using the 
primers RNA2F3 and RNA2R2 (Appendix 4). 
The expected size of PCR products from HaSV 
RNA2 eDNA templates is indicated on the right-
hand side of the gel. pA V 14HPTrp (pRl) was 
used as a DNA template for a PCR positive 
control. The negative control (-) for these 
reactions contained all the required PCR 
constituents, except for a DNA template. A PsI I 
digest of lambda-DNA was used as a molecular 
weight marker (M) . 
kDa + 1.1 kDa + 3.1 3.2 4.1 4.2 
97~ 97~ 
66~ 66~ 
39~ 39~ 
~p71 
~p64 
Figure 3.15 Western analysis of total protein in yeast extracts from the 
lNVScI yeast strains U+T+L+ (1.1&1.2), CAP T+L+ (2 .1 &2.2), R2 U+L+ 
(3.1&3.2) and CAP R2L+ (4.1&4.2) (refer to Table 3.1). The expression 
and protein extraction methods that were followed are the same as those 
described in Section 3.2.6. (+). lng wild-type HaSV. 
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3.4 Discussion 
3.4.1 Detection of p71 in yeast celllysates 
Evidence for the necessity of expression modules for P71 independent from those for RNA 2 is 
provided in Figure 3,15, A much higher level of HaSV capsid protein was produced from 
these expression modules than from those for RNA2. These results differed from similar 
studies in plant protoplasts where no P71 expression was detected from RNA2 transcripts 
(Gordon, et al., 2001). 
The experiments also demonstrated that a very low amount (if any) of p71 autocatalytic 
cleavage occurs under the expression conditions in yeast (Figures 3.4). This was not an 
encouraging result because the autocatalytic cleavage of capsid precursors could be used as 
evidence of assembly. This observation differs from that obtained for the expression of the 
NoN capsid precursor protein gene in insect cells by baculovirus vectors (Agrawal and 
Johnson, 1995). Crude protein preparations from these cells contained mixtures of processed 
and unprocessed capsid proteins. 
3.4.2 Stability of yeast-expressed p71 
Prolonged induction with galactose resulted in a disappearance of p71 in yeast cell lysates 
(Figure 3.6, panel A). This could have been due to a loss of the P71 gene from the genome of 
yeast cells after 12 hours' growth in galactose. Evidence was provided that the disappearance 
ofp71 was probably not the consequence of the excision of the P71 expression module from 
the chromosome through homologous recombination (Figure 3.6, panel B) (Jiwaji, 1999). 
There was no difference in the number of colonies that were obtained when cells were plated 
onto SMM either containing, or not containing, L-Ieucine to look for progressive loss of the 
Leu+ phenotype during induction (Jiwaji, 1999). This indicated that no loss of LEU2 occurred, 
and therefore the P71 expression module was not either likely to have been lost. It is, 
however, possible that recombination occurred at a position in the chromosomal selectable 
marker that led to the looping out of leu2 together with the P71 expression module. The 
possibility that the P71 expression module was lost from the genome by homologous 
recombination could therefore not be ignored completely. 
Furthermore, the repression of PGAL1-driven transcription was most probably not responsible 
for the disappearance of p71. A reduced cell growth rate would have been expected for cells 
that could not catabolize galactose (their sole carbon source) due to the repression of the 
galactose utilization pathway. There was however no difference in cellular proliferation 
between cells expressing and those not expressing P71 . 
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Altemative explanations for the disappearance of p71 are that it was either synthesized at a 
decreased rate or degraded at an increased rate. A decreased rate of protein synthesis could 
have been responsible for a reduction in p71 levels, but not for the complete depletion thereof. 
Proteolytic degradation was therefore to a certain extent responsible for the complete depletion 
of p71. Two main pathways of protein degradation occur in S. cerevisiae: vacuolar 
degradation and degradation by the ubiquitin pathway (Romanos et al., 1992). The former is 
responsible for the degradation of long-lived proteins (ty, approximately 160 h), while short-
lived proteins (ty, less than 2.5 h) are degraded by the latter (Finley, 1992). 
The disappearance of p71 after 12 hours' growth demonstrated that this protein could be 
classified as a short-lived protein in yeast. It is therefore highly probable that p71 was 
targeted for degradation by the ubiquitin pathway. This hypothesis is supported by evidence 
for the production of insoluble p71 in yeast cells (Figure 3. 10). The insolubility of p71 was 
most probably the result of the formation of p71-containing aggregates (or inclusion bodies) 
within the yeast cell. According to Finley (1992) the presence of these aggregates elicit a 
heat-shock response that results in the rapid degradation of the aggregated proteins by the 
ubiquitin pathway. 
It was attempted to increase the yield of p71 by (i) determining the optimum time period for 
induction, (ii) reducing the rate of expression, and (iii) testing the effects of different protease 
inhibitors. The optimal induction periods for the expression of P71 under conditions 
conducive to a reduced expression rate were determined (Figure 3.8). The solubility of p71 
was slightly increased when cells were grown at 20°C in SMM containing 0.01 % galactose 
(Figure 3.9). This effect was, however, minor compared to that of the serine protease inhibitor 
PMSF (Figure 3.10). This was quite an unexpected result because AEBSF, another sulfonyl 
fluoride-type serine protease inhibitor, did not provide any protection against this degradation. 
AEBSF has a reported range of protection similar to that of PMSF and has the added 
advantage in that it is much more stable than PMSF in aqueous buffers (Mintz, 1993). 
It was demonstrated that cell lysis buffers with high NaCl concentrations did not have a 
significant effect on the levels of soluble p71 when cells were lysed in the presence of PMSF 
(Figure 3.12, panel A). Conversely, NaCl concentrations as low as 31 mM had a significant 
effect on the amount of p71 in soluble fractions from cells lysed in the presence of AEBSF 
(Figure 3.12, panel B). There are two possible explanations for this result: First, it is possible 
that the soluble p 71 obtained from a decreased expression rate differed from the protein 
protected by PMSF in its stability at high ionic strength. In accordance, this protein probably 
represented unstable expression products that were "salted out" from solution (Englard and 
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Seifter, 1990). Second, it is possible that the protein obtained from a decreased expression 
rate was degraded by a salt-dependent AEBSF-insensitive protease. 
3.4.3 Reasons for the formation of insoluble p71 protein aggregates: impaired folding 
or assembly? 
The heterologous expression of insoluble protein is an indication of a cellular environment 
that is not suited for its proper folding (Speed et aI., 1996). This is generally the case for the 
expression of monomeric globular proteins, but could potentially be different for the 
expression of capsid proteins, which have the propensity to assemble into VLPs. If this 
assembly process is impaired, these proteins could form insoluble protein aggregates within 
the cell. As discussed in the previous paragraph, these proteins would be defined as unstable 
due to the relatively short half-lives of proteins that are incorporated into insoluble aggregates. 
This interpretation is in agreement with the minor effect (described in the previous paragraph) 
of a decreased expression rate on the levels of soluble p71 (Figure 3.11), and the infrequent 
occurrence of problems associated with the improper fold ing of polypeptides in yeast 
(Romanos, et aI., 1992) 
The tendency of capsid proteins to form insoluble aggregates during assembly was 
demonstrated in experiments in which FHV particles were assembled in vitro from dissociated 
pro virions (Schneemann et al., 1994). In these experiments, a considerable fraction of the 
dissociated capsid proteins formed insoluble a-protein aggregates and was therefore not 
available for assembly. Impaired assembly could possibly also explain why the amount of 
Nco V VLPs produced from a baculovirus expression system did not correlate with the high 
levels of a-protein that were detected in the insect cells (Agrawal and Johnson, 1995). 
3.4.4 Chromosomal vs. episomal P7J expression 
Expression in two different yeast strains from either episomal or chromosomal expression 
modules was compared in order to maximize the amount of soluble p71 produced 
(Figure 3.13). In INVScI, P71 expression from a 2~-based vector (pAV3: Figure 2.3) 
produced a much higher level of p71 than chromosomal expression. These different levels 
were due to the much higher copy-number of the pAV3 (approximately 50) (Rose and Broach, 
1990). The opposite was true for JRY188 where chromosomal P71 expression produced 
equivalent (or higher) levels to that of pA V3 in INVScI, while episomal expression was barely 
detectable. This anomaly could be due to the lack of genes for the stable propagation of pA V3 
in the genome of JRYI88 . Two 2~-plasmid-borne genes (REPI and REP2) in conjunction 
with a cis-acting locus (STB) contribute to the segregation of 2-~ plasmids during cell division 
(Velmurugan et al., 1998). pA V3 carries the ORI-STB yeast selectable marker but depends on 
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a 2!l-host strain (like INVScI) that supplies REP] and REP2 (Kikuchi, 1983). The much 
higher level of p71 production from JRY188 3#20.1, as compared to INVScI 3#20.1, most 
probably reflects differences in the regulation of galactose metabolism between these strains. 
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4 The assembly of HaSV procapsids in S. cerevisiae and 
the pH-dependent maturation of these particles 
4.1 Introduction 
Heterologous expression systems have been used to study the cellular and viral factors that are 
involved in the assembly of capsids from a variety of ss +RNA viruses (Agrawal and Johnson, 
1995; Sclmeemann el ai" 1993), Non-structural virus proteins are often not a requirement for 
the non-host production of ss +RNA virus capsids, This seems to be the norm for simpler 
viruses like nodaviruses and omegatetraviruses, because the expression of FHV and Nco V 
capsid protein precursors in baculovirus expression systems resulted in the assembly of VLPs 
(Agrawal and Jolmson, 1995; Sclmeemann el ai" 1993), Exceptions are found in more 
complex viruses, like picornaviruses, where post-translational processing of capsid protein 
precursors by viral proteases is required, Jore el al. (1994) demonstrated that Poliovirus VLPs 
were assembled in yeast upon simultaneous expression of PI (capsid protein precursor gene) 
and 3eD (nonstructural gene), 
The presence of RNA has been shown to be a requirement for the assembly of the capsids of 
some ss +RNA viruses, It does not seem as if picorna- and caliciviruses require viral RNA for 
assembly, as judged by the production of empty Poliovirus (Jore et ai" 1994), Hepatitis E 
virus (Li et al., 1997) and Rabbit hemorrhagic disease virus (Boga and Alonso, 1997) VLPs in 
heterologous expression systems, Conversely, an RNA component plays a very important role, 
in nodavirus capsid assembly, Schneemalm el al. (1994) demonstrated that dissociated FHV 
provirions could riot re-assemble in the absence of an encapsidatable component. Re-
assembly was however not solely dependent on FHV -derived RNA, because it also took place 
in the presence of heterologous RNA, ss DNA and polyanions, such as dextran sulfate, 
Omegatetravirus capsids seem to encapsidate viral RNA with a high degree of specificity, 
Baculovirus expression of Nco V capsid protein precursor genes resulted in the specific 
encapsidation of a. mRNA (Agrawal and Johnson, 1995), This result demonstrated that the 
encapsidation signal for NcoV resided within the capsid protein precursor ORF, In addition, 
the baculovirus expressed NcoV VLPs consisted of mixtures of pro caps ids and capsids, 
In the previous chapter Western analysis data showed that processing, in the form of the 
autoproteolytic cleavage, was not detected for yeast-produced p71. A similar result for the 
bacterial expression of the closely related NcoV capsid protein precursor (a.), led Agrawal and 
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Jolmson (1995) to suggest that NroV VLP assembly did not occur. The main objective of the 
work described in this chapter is to demonstrate that the expression of P71 is all that is 
required for the assembly of VLPs in yeast and that these VLPs are able to mature in vitro. 
4.2 Materials and methods 
4.2.1 Purification of VLPs 
Two different protocols for the purification of HaSV VLPs from yeast cell pellets are 
summarized in Figure 4.1. In the first protocol, VLPs were sedimented through a 30% sucrose 
cushion; in the second, the particles were purified by centrifugation through a glycerol 
gradient (adapted from a method used by Agrawal and Johnson, 1995). 
The cell pellets were obtained as follows: Shake flask cultures of P71 + yeast cells in SMM 
containing 5% glycerol and 0.1 % glucose up to a combined volume of 2 to 51 were grown to 
midlog phase at 30°C. 10% galactose was then added to these cultures to a final concentration 
of 0.01 % and the cultures were grown at 20°C for a further 8 hours. The cells were 
centrifuged at 4000rpm for 10 min at 4°C in a Beckman JAIO rotor. Cell lysis by bead 
beating (Figure 4.1) was performed according to the instructions provided with the Bead-
Beater (Biospec Products). 
Glycerol and CsCI gradients were fractionated using an ISCO Model 640 density gradient 
fractionator, and refractometry was carried out using an ABBE-type refractometer 
(Bellingham and Stanley, Ltd., England). 
4.2.2 Standardization of density gradient centrifugation techniques 
For the determination of the glycerol concentration at a paliicular refractive index, the 
refractive indices of solutions with lmown glycerol concentrations were measured. The data 
from this experiment was used to construct a standard curve relating glycerol concentration to 
refractive index, which had an r2 value of 0.998 (results not shown). The slope and y-intercept 
of this curve (0.130 ml g-l and 1.339, respectively) were used for the calculation of glycerol 
concentration at a given refractive index. 
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I Yeast cell pellets (from LSI yeast cell culture) I 
*- Resuspend in 2 vol. 50mM Tris-HCI buffer (PH 7.4), 0.25M NaCI, ImM PMSF, 
ImM DTT (lysis buffer) 
*- Homogenize by bead beating or by vortexing in the presence of glass beads for lOx 30 
sec with 30 sec intervals 
*- Dilute 3.3-fold with lysis buffer 
*- Centrifuge: 12500rpmll5 min (4°C) in Beckman JA20 rotor 
I 
I Supernatant 1 I 
I 
I Pellet 1 I 
Discard 
For centrifugation through sucrose 
cushions 
*- Transfer to Beckman SW28 tubes 
*- Layer upon 2ml 30% (w/v) sucrose 
cushions 
*- Centrifuge: 27000rprnl3 hrs (12°C) 
in Beckman SW28 rotor 
I Pellet 2 
I 
Supernatant 2 
Discard 
*- Resuspended in Imllysis buffer 
*- Store overnight at 4°C. 
*- Microfuge: 5 min (4°C) 
I 
I Supernatant 3 I I Pellet 3 I 
Discard 
For glycerol gradient ultracentrifugatior 
*- Transfer to Beckman SW41 tubes 
containing (bottom to top): 
400lli 100% glycerol 
400lli 90% glycerol 
500ili each 75, 50 and 30% glycerol 
*- Centrifuge: 30000rprnl1.5 hrs (4°C) in 
Beckman SW41 rotor 
*- Collect 0.2ml fractions using density 
gradient fractionator 
*- Measure refractive indices of fractions 
using a refractometer 
*- Combine fractions with buoyant 
densities cOlTesponding to glycerol 
concentrations <:: 30% 
*- Layer upon a 30% CsCI / 60% CsCI discontinuous gradient in SW41 tube (both CsCI 
solutions made up in 50mM Tris-HCI (pH 7.4)) 
*- Centrifuge: 30000rpm/18 hrs (l8°C) in Beckman SW41 rotor 
*- Collect O.4ml fractions using density gradient fractionator 
*- Measure refractive indices and A260nm and A280nm of the fractions 
*- Dialyze selected fractions overnight against 50mM Tris-HCI pH 7.4 at 4°C 
*- Western and TEM analysis of fractions 
I HaSV VLP preparation I 
Figure 4.1 A flow diagram for the purification of HaSV VLPs from yeast by way of glass bead 
homogenization. 
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The data from Dawson et al. (1987) was used to construct a plot of CsCl concentration versus 
buoyant density. The slope of this curve was used to construct a density calibration curve 
()'2 = 0.999) relating refractive indices of known CsCl concentrations to their respective 
densities (results not shown). The slope and y-intercept from the density calibration curve 
(0.096 ml g-I and 1.237, respectively) were, in turn, used for the calculation of the buoyant 
densities of CsCl density gradient fractions. The presence of 50mM Tris-HCl did not interfere 
with the measured refractive index at a particular CsCl concentration (results not shown). 
4.2.3 Electron microscopy 
Yeast-derived VLP preparations were applied to carbon-coated copper grids and allowed to 
absorb for 1 - 2min. The grids were blotted dry with filter paper, stained with 1 % 
phosphotungstic acid and viewed in a JEMI OOCX transmission electron microscope. 
4.2.4 Maturation protocols 
Three different experiments were attempted to demonstrate the pH-dependent maturation of 
HaSV procapsids. In one of these experiments, sucrose cushion pellets were microfuged for 
5 min (as described in Figure 4.1) and loaded onto discontinuous sucrose gradients in 
Beckman SW 41 tubes. The gradients consisted of 2.5m! each of 5, 10, 15, and 20% sucrose, 
which were made up in 70mM sodium acetate (NaAc) (pH 5 and 5.5), 70mM sodium citrate 
(PH 6 and 6.5) and 70mM Tris-HCl (PH 7 and 7.4). The buffers were selected for their pKa 
values (within I pH unit of the desired pH values). The gradients were centrifuged at 
30000rpm for 3hr at 4°C in a Beckman SW41 rotor. The pellets were then resuspended in 
equivalent volumes of 50mM Tris pH7.4 to that of the original resuspended sucrose cushion 
pellets. In other experiments, the pH of p71-containing HaSV VLP preparations (Figure 4.1) 
was dropped by ovemight dialysis (at 4°C) against 70mM NaAc (PH 5), or by the addition of 
five volumes of the same buffer. In the latter instance, samples were left on ice for at least 2 
hours after the addition of NaAc, prior to the next step of experimentation. pH measurements 
carried out subsequent to the addition of NaAc were used to ensure that the expected pH 
change (i.e. from 7.4 to 5) was achieved. 
4-2.5 Analysis of encapsidated RNA 
RNA was extracted by vortexing a mixture containing equal volumes of the sample and 
phenol (equilibrated with 2M NaAc, pH 4) for I min. The mixture was microfuged for 5 min 
and the resultant aqueous layer was washed twice with chloroform-isoamyl alcohol (24: I). 
0.1 volumes of 3M NaAc (PH 5.2) and 2.5 volumes of ethanol were added to the aqueous 
layer and it was left at -20°C for at least 2 hours. The RNA precipitate was collected by 
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centrifugation for 10 minutes at 4°C in a microfuge. The pellet was air-dried and resuspended 
in a small volume of DEPC-treated water. 
RNA extracts were used as templates for RT-PCR using the Titan™ One Tube RT-PCR 
System (Roche). The primers RNA2F6 (corresponding to nucleotides 502 - 522 of RNA2) 
and AV9 (complementary to nucleotides 1351 -1368 ofRNA2) were used for the detection of 
P71 mRNA (primers: Appendix 4; thermal cycling programme: Programme 3 in 
Appendix 5). The RNA extracts were subjected to PCR (using the Expand™ High Fidelity 
PCR System from Roche) to ensure that amplified products were not the result of genomic 
DNA contamination. 
4.3 Results 
4.3.1 Establishment of techniques for determination of VLP buoyant density 
Wild-type HaSV was subjected to CsCI density gradient centrifugation as described 111 
Figure 4.1. Fractions were collected across the gradient and dialyzed overnight against 50mM 
Tris pH7.4. Western analysis of the dialyzed fractions showed that the largest amount of 
HaSV was detected in a fraction with a density of 1.290 glml (Figure 4.2), which is identical 
to that obtained for HaSV by Hanzlik et al. (1993). This result indicated that reliable buoyant 
density determinations could be obtained through the use of this technique. 
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Figure 4.2 (A) Western analysis of fractions collected subsequent to CsCI density gradient 
centrifugation of wild-type HaSV. 100ng HaSV was loaded upon a discontinuous CsCI 
gradient, as described in Figure 4.1. 2111 of each fraction were separated by SDS-PAGE. (+), 
1 ng wild type HaSV. (B) Profile of the densities of these fractions. 
4.3.2 Yeast VLP preparations 
To determine whether HaSV VLP assembly occurs in yeast, VLP preparations were 
performed on INVScI cells (transformed with pAV3) and JRY188 3#20.1 cells, since these 
two combinations were shown to express the highest levels of soluble p71 (Figure 3.13; 
pA V3: Figure 2.3). Low expression rate conditions were used during the induction phase (as 
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described in Section 3.3.5) to optimize the production of correctly folded p71 molecules. 
250mM NaCI was added to cell lysis buffers due to its reported stabilizing effect on 
procapsids (M. Canady, personal communication). 
i Preparation of VLPs from INVScI cells (transformed with pA V3) using the sucrose 
cushion centrifugation procedure 
In the previous chapter, it was shown that a fraction of the total p71 expressed in INVScI cells 
from pAV3 was soluble (Figure 3.10, panel B). If tlle p71 molecules in this fraction were 
monomeric proteins, they would remain in the supernatant when sedimented through a 30% 
sucrose cushion (as described in Figure 4.1). Alternatively, the sedimentation coefficient for 
omegatetravims particles (S20w = 194-217) dictates that these proteins should pellet under 
these conditions if they are associated with VLPs (van Regenmortel et aI., 2000). Equivalent 
amounts of yeast cell lysate (representative of total amount of p71 produced) and the 
resuspended pellet (after centrifugation through a 30% sucrose cushion) were separated on an 
SDS-PAGE gel for western analysis (Figure 4.3 , panel B). A considerable portion of the total 
p71 produced in yeast was detected in the resuspended pellet, suggesting the presence of 
HaSVVLPs. 
No distinct bands were, however, observed when the resuspended pellets were subjected to 
CsCI density gradient centrifugation. Fractions were collected across the CsCI gradients to 
determine whether p71 or p64 was present in these fractions at the expected buoyant density 
range for HaSV VLPs (Figure 4.3, panels A and B). Two protein species that contained p71 
were separated by the CsCI gradient. The low-density type was found in fractions that 
contained the highest protein concentrations (as estimated from ilie UV -trace in Figure 4.3 , 
panel D) and had buoyant densities ranging from 1.209-1.232 glml (Figure 4.3, panels A, 
fraction no. 10- 12, and D). These p71 species were, however, found to be insoluble since it 
was found in pellet fractions when it was microfuged for 5 min (Figure 4.3, panel C). The 
high-density type contained much lower amounts of p71 and had a buoyant density of 1.267-
1.287 glml (Figure 4.3, panels A, fraction no. 14 and 15, and D). At least a fraction of the 
p71-containing species in fraction 15 (with a density of 1.287 g/ml) remained soluble after 
being microfuged for 5 min, while no soluble p71 was detected for fraction 14 (Figure 4.3, 
panel C). As with previous experiments, no p64 could be detected, indicating very low levels, 
if any, of maturation. 
The band detected for the Ing HaSV positive control in the Western blot in Figure 4.3 
(panel C) represents an approximate virus particle (vp) concentration of 109 vplml. It follows 
that if the band detected in fraction 15 (Figure 4.3 , panel C) is estimated to represent 1I10th of 
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that obtained for the positive control, then there would be at most 108 vp/ml in this fraction , 
which had a total volume of 400fll. This sample was prepared from a 0.5/ yeast culture, which 
had an OD600nm of 0.738 prior to cell lysis. From the standard curve in Figure 3.3 (panel B) it 
is therefore estimated that about 4xl07 VLPs were purified from 2.5 x10 1o INVScI cells, 
equating to a very low maximum yield of approximately 2 VLPs from every 1000 yeast cells . 
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Figure 4.3 Vip preparation from INVScI cell cultures with a total volume of 0.51. Yeast 
pellets were subjected to the sucrose cushion centrifugation purification procedure described 
in Figure 4.1. 20fll of each of the dialyzed CsCI fractions were separated by SDS·PAGE. 
Panels A and B: Western analysis of fractions that were collected from the CsCI gradient. 
(Y) and (P2) denote yeast cell lysate and "Pellet 2" (in Figure 4.1), respectively. (+), Ing wild 
type HaSV. Panel C: Western analysis of p71-containing fractions (a) and their respective 
supernatants (b) after centrifugation for 5 min in a rnicrofuge. (+), Ing wild type HaSV. 
Panel D: Profile of the A2 80nm readings (.) and densities (e) of the fractions. 
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Figure 4.4 Electron micrographs of VLPs derived from INVScI cells that were transformed 
with pA V3 (panels A and C) and JRYl88 3#20.1 cells (panels D and E), and wild-type HaSV 
(panel B). The VLPs in panels A, B and D were purified by centrifugation through sucrose 
cushions, followed by CsCI density gradient centrifugation (Figure 4.1). The particles in 
panel E (indicated by arrows) were prepared by glycerol gradient centrifugation (Figure 4.1). 
Bar represents SOnm. 
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In spite of this low yield of VLPs from INVScI, an attempt was made to visualize these 
particles by TEM analysis. Accordingly, fraction IS was diluted in 50mM Tris pH7.4, spun 
down in an ultracentrifuge (27000 rpm for 3hrs in an SW41 rotor), and resuspended in 25111 of 
the same buffer. Vips, with an approximate diameter of 40nm were detected in this 
concentrated sample at amounts that exceeded the estimated concentration of HaSV VLPs by 
at least one order of magnitude (Figure 4.4, panels A and C). A very high estimate for the 
VLP concentration in the concentrated fraction 15 would be in the region of 109 VLP/ml, 
while the abundance of VLPs that were observed under the electron microscope reflected a 
concentration of at least 1O,ovp/ml. These particles appeared to be slightly larger and more 
rounded than HaSV (Figure 4.4, panel B), and their inner cores were less electron-dense. 
Some particles, however, appeared to contain single electro-dense spots in their viral cores. A 
second VLP preparation from INVScI cells (transformed with pAV3) produced similar results 
with no marked increase in the yield of fractions analogous to fraction IS (results not shown). 
ii Preparation of VLPs from JRY188 3#20.1 cells using the sucrose cushion 
centrifugation procedure 
In Figure 4.5 (panel A), a typical Westem blot of CsCl density gradient fractions derived from 
JRY188 3#20.1 cells is shown. There was a remarkable degree of similarity in the pattems 
I. ". 
that were obtained for the bands on the Western blots from three separate experiments (results 
not shown). Based on these results, three different protein species that interacted with anti-
HaSV antibodies were categorized. Type I (Figure 4.5, panel A: fractions 10- 11) is most 
probably similar to the low density-type that was obtained from INVScl cells (described 
above), because it had a similar buoyant density range with values of up to 1.245 glml 
(SEM ±0.002, n = 3). In addition, no VLPs were detected in any of the fractions that contained 
this protein species. Type II (Figure 4.5, panel A: fraction 12) consists of a protein that 
seemed to be slightly smaller than p71. Bands representative of this protein migrated on SDS-
PAGE gels at a molecular weight of approximately 69kDa. This species had a characteristic 
buoyant density of 1.266 g/ml (SEM = 0.001, n = 3). No VLPs were detected, when these 
fractions were examined under TEM. Type III (Figure 4.5, panel A: fractions 13 - IS) had a 
buoyant density range of 1.278 - 1.310 g/ml (Figure 4.5, panel C). VIps, identical to those 
described above, were visualized when these fractions were pooled, concentrated with PEG, 
and visualized by TEM (Figure 4.4, panel D). 
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Figure 4.5 VIp preparation fromJRYI88 3#20.1 cultures with a total 
volume of 1.51. Yeast pellets were subjected to the sucrose cushion 
centrifugation purification procedure described in Figure 4.1. 20~1 of each of 
the dialyzed fractions were separated by SDS-PAGE. (A) Western analysis of 
fractions that were collected from the gradient. I , II and III denote the three 
different proteins species described in the text, while (+) and (++) denote 0.1 
and Ing wild type HaSV, respectively. (B) Western analysis of fractions that 
were stored at 4°C for one week. (C) Profile of the densities of these 
fractions. 
The yield of the Type III protein species was estimated from the blot in Figure 4.5 (panel A) 
by comparison with different known amounts of HaSV (O.lng-Ing) that were run alongside 
the CsCI fractions on an SDS-P AGE gel. Within the limits of accuracy for this type of 
assessment, there was no significant increase in the levels of the higher density p71 fractions 
from JRYI88 3#20.1 cells to that from INVScI cells transformed with pA V3. In line with the 
HaSV expression strategy discussed in Section 2.3.4, JRYI88 3#20.1 was selected for fuliher 
experimentation. Accordingly, a purification protocol for the preparation of an optimal 
amount of functional HaSV VLPs would be established using this LEU2 strain (Table A6.1, 
Appendix 6). This strain would be transformed with the pAVI3HC and pAVI4HPTrp vectors 
bearing URA3 and TRP] markers, respectively, for the co-expression of P7], RNA] and 
RNA2. 
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iii Preparation of VLPs from JRY188 3#20.1 cells using the glycerol gradient 
ultracentrifugation procedure 
Western analysis of samples that were taken at the various steps of the sucrose cushion 
protocol (Figure 4.1) is shown in Figure 4.6. Equivalent aliquots were electrophoresed in an 
SDS-PAGE gel to ensure that a direct comparison could be drawn among these samples. This 
Western blot demonstrated that the level of p7l diminished with each successive purification 
step, and that a very small fraction of the p71 detected in the yeast cell lysate was available for 
CsCl density gradient centrifugation (lane 4 in Figure 4.6, panel B). This result also indicated 
that the majority of the p71 in sucrose cushion pellets was in an insoluble form, and did not 
form part of HaS V VLPs. 
A B 
1 2 3 4 + 1 2 3 4 + 
Figure 4.6 Western analysis of samples taken at the various purification steps of the 
sucrose cushion centrifugation procedure for the preparation of VLPs from JRY188 
3#20.1 cells (Figure 4.1). Panels A and B represent 1 and 5 min periods for the 
exposure of films during chemoluminescent detection, respectively. Lane 1, yeast cell 
lysate prior to 12500rpm centrifugation step, lane 2, "Supernatant 1", lane 3, 
resuspended "Pellet 2", and lane 4, "Supernatant 3". (+), 2ng wild type HaSV. 
Agrawal and Johnson (1995) reported an initial low yield of Nw V VLPs from a baculovirus 
expression system when they attempted to purify these particles by means of centrifugation 
through a 30% sucrose cushion. It was suggested that this protocol was too harsh for the 
purification of the inherently unstable Nw V procapsids. An improved yield was, however, 
obtained through the application of a milder glycerol gradient centrifugation protocol. This 
protocol (described in Figure 4.1) was used in an attempt to increase the yield of HaSV VLPs 
from yeast. 
Following glycerol gradient centrifugation, the majority of p71 was found in the 50 - 75% 
glycerol layers (Figure 4.7, panels C and D). Coomassie stained gels furthermore showed an 
increase in the levels of a protein, which migrated at a molecular weight of approximately 
7lkDa, in lanes cOlTesponding to these glycerol concentrations (Figure 4.7, panels A and B). 
This result is similar to what was reported for the baculovirus-expressed Nw V VLPs (Agrawal 
and Johnson, 1995), with the exception that the processed form of the NwV capsid protein was 
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predominately detected. Only a small amount of a protein that co-migrated with p64 was 
detected in the 44-68% glycerol layers (Figure 4.7, panel C). VIps similar to those described 
before, were visualized in these glycerol layers, but the preparation was much more 
heterogeneous than the CsCI density gradient fractions (Figure 4.4, panel E). 
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Figure 4.7 Separation of p71-containing fractions on a discontinuous glycerol gradient. A 
soluble fraction, derived from 0.5/ of JRY188 3#20.1 cells, was subjected to glycerol gradient 
centrifugation as described in Figure 4.1. 20[.11 of the resultant fractions were separated on 
SDS-PAGE gels. Panels A and B: Coomassie blue-stained SDS-PAGE gels of glycerol 
gradient fractions . +, 200ng wild-type HaSV. Panels C and D: Western analysis of the SDS-
PAGE gels displayed in panels A and B. +, lng wild-type HaSV. Panels E and F: Western 
analysis of these fractions after the addition of 5 volumes 70mM sodium acetate (pHS). The 
diluted samples were kept on ice for 2 hours, TCA precipitated and separated by SDS-PAGE. 
+, lng wild-type HaSV. 
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4.3.3 Maturation of procapsids 
Similar to NwV procapsids (Canady et ai., 2000), the HaSV-derived VLP preparations did not 
mature upon storage. The Type II and Type III protein species (described for VLP 
preparations from JRYl88 3#20.1 cells) did not undergo autocatalytic cleavage subsequent to 
a one week storage period at 4°C (Figure 4.5, panel B). Three strategies were used to 
determine if the yeast-derived HaSV procapsids could undergo acid-induced maturation: (a) 
sedimentation of VLP preparations through sucrose gradients that were buffered at a reduced 
pH, (b) dialysis ofVLP preparations against a buffer with a reduced pH and (c) the addition 
of a buffer with a reduced pH to VLP preparations. 
Resuspended sucrose cushion pellets (Figure 4.1) were spun through sucrose gradients made 
up in buffers with pH values ranging from 7.4 down to 5. The resulting pellets were thereafter 
separated on SDS-PAGE gels and assayed for the presence of p64 by Western analysis. No 
p64 was detected for any of the pH values that were tested (Figure 4.8, panel A). A drop in 
pH resulted in the precipitation of the p71-containing species within the solution, because a 
minimal amount ofp71 remained soluble below a pH of 5.5 (Figure 4.8, panel B). 
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Figure 4.8 Western analysis of resuspended pellets (panel A), and their respective 
supernatants (panel B) upon centrifugation for 5 min in a microfuge, subsequent to 
centrifugation through sucrose gradients that were made up in buffers with different pH 
values. The protocol described in Section 4.2.4 was used for the preparation of these gradients 
at pH 7.4, 7, 6.5, 6, 5.5 and 5. IOll1 of each of the resuspended pellets, or supernatants, were 
separated on SDS-PAGE gels. +, Ing wild-type HaSV. 
No autoproteolytic cleavage was detected after a drop' in pH for glycerol gradient fractions 
(Figure 4.7, panels E and F). In these experiments, the pH was reduced by the addition of 
5 volumes of NaAc (PHS) to each of the glycerol gradient fractions. The possibility that the 
glycerol interfered with the maturation process was also ruled out. This was done by detecting 
no autoproteolytic cleavage in experiments in which these fractions were either dialyzed 
against lysis buffer (50mM Tris pH 7.4, 250mM NaCl) , or 50mM Tris pH 7.4, prior to the 
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reduction in pH (results not shown). Furthermore, neither the protein concentration of the 
preparation nor the NaAc to sample ratio seemed to have an effect. This was because no 
autoproteolytic cleavage was evident upon a 10-fold dilution of the preparation, or upon the 
addition of 10 volumes of70mM NaAc (pH S) (results no shown). 
Dialysis of an INVScI-derived VLP preparation (similar to fraction IS in Figure 4.3 , panel C) 
against 70mM NaAc (PHS) showed that a very faint protein band, which co-migrated with p64 
in an SDS-PAGE gel, was detected upon lowering the pH of the sample (Figure 4.9, panel A). 
Similar results were obtained upon the addition of five volumes of NaAc (pH S) to the 
Type III protein species described for a VLP preparation from JRY188 3#20.1 cells 
(Figure 4.S, panel A), which resulted in the appearance of a 64kDa protein in duplicate 
experiments (Figure 4.9, panel B). Not all the p71, however, underwent cleavage in the 
experiments described in this paragraph, as it was still present in the lanes in which p64 was 
detected. 
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Figure 4.9 Western analysis of INVScI-derived (panel A) and JRY188 3#20.1-
derived (panel B) VLP preparations that were tested for their ability to undergo pH-
dependent maturation upon a reduction in pH from 7.4 to 5 (using the methods 
described in Section 4.2.4). The INVScI-derived samples (panel A) were either 
dialyzed against 70mM NaAc (PH S), or SOmM Tris-HCI (pH 7.4). 40fll of each of 
the dialysates were separated by SDS-PAGE. The JRYl88 3#20.1-derived samples 
(panel B) consisted of fractions 13, 14 and IS (Figure 4.S, panel A), which were 
combined and concentrated sixteen-fold by means of dialysis against polyethylene 
glycol 20000. 20fll of 70mM NaAc (pH S) or SOmM Tris-HCI (pH 7.4) were 
added to 4fll of each of the duplicate concentrated samples, all of which was 
separated by SDS-PAGE. (+) and (++) denote 0.1 and lng wild type HaSV, 
respectively. 
Further evidence for the autoproteolytic cleavage of p71 was obtained upon CsCI density 
gradient centrifugation of pooled glycerol gradient fractions (with buoyant densities 
corresponding to glycerol concentrations:::: 30%) (Figure 4.7, panels A - D). As expected, no 
p64 was detected in the CsCI density gradient fractions prior to the addition of 70mM NaAc 
(pH S) (Figure 4.10, panel A). However, a lowering of the pH of fraction 17 (Figure 4.10, 
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panel B) resulted in the appearance of p64. This fraction had a buoyant density of 1.297 g/ml, 
which is close to the high limit in the buoyant density range for JRYI88 3#20.1 Type III 
species (Figure 4.5) . The relatively high level of p64 detected fo r fraction 17 (Figure 4.10, 
panel B) was unexpected, since a p71 band of comparable intensity to that of p64 was absent 
for the same fraction in Figure 4.10 (panel A). 
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Figure 4.10 Western analysis of a range of fractions that were collected following 
CsCI density gradient centrifugation of combined glycerol gradient layers before 
(panel A), and after (panel B) the addition of five volumes 70mM NaAc (pHS) to each 
fraction. The diluted samples were kept on ice for 2 hours, TCA precipitated and 
separated by SDS-PAGE. A profile of the densities of these fractions is shown in 
panel C. (+), O.l ng wild type HaSV. 
4.3.4 RT-PCR analysis of encapsidated RNA 
To determine whether P71 mRNA was encapsidated by the yeast-derived VLPs, RNA was 
extracted from lNVScI- and JRY188 3#20. I-derived VLP preparations. These RNA extracts 
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were subjected to RT-PCR analysis using primers that were specific for the amplification of 
an 866bp fragment from the P71 ORF, RT-PCR analysis on extractions from INVScI-derived 
preparations showed no evidence for the presence of P71 mRNA (results not shown), A faint 
band of 886bp was however present for RT-PCR analysis of an RNA extract from Type III 
protein species (described for a VLP preparation from JRY188 3#20,1 cells in Section 4,3.2ii) 
(Figure 4, 11), Various non-specific bands were also detected for this extract. No convincing 
data identifying P71 mRNA as the encapsidated RNA species was therefore obtained, 
RT-PCR PCR 
I I I 
M Y 
+-886 
Figure 4.11 Agarose gel electrophoresis of RT-PCR and PCR 
analyses (indicated by square brackets) of RNA extracts from a 
JR YI88 3#20, I-derived VLP preparation (Y) and wild-type 
HaSV RNA (+), pAV3 (pCP) was used as a DNA template for 
the PCR positive control (Figure 2,3), Negative controls (-) for 
RT-PCR and PCR contained all the required constituents, but an 
RNA or DNA template was left out, respectively, The expected 
size of a PCR product (in bp) with the RNA2F6/AV9 
(Appendix 4) primer pair is indicated on the right-hand side of 
the gel. A PstI digest of lambda-DNA was used as a molecular 
weight marker (M), 
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4.4 Discussion 
4.4.1 Assembly of p71 into HaSV procapsids 
Results from initial purification steps for the preparation of HaSV VLPs indicated that a 
detectable amount of VLP assembly occurred in yeast. Significant amounts of p71 were 
detected in pellets following centrifugation through 30% sucrose cushions for preparations 
from INVScI cells that were transformed with pAV3 (Figure 4.3, panel B: lane "P2") and 
from JRY188 3#20.1 cells (Figure 4.6, panels A and B, lane 3). Furthermore, the 
centrifugation of p71-containing particles through glycerol density gradients produced a 
similar result to that obtained for baculoviral-expressed Nco V capsids (Agrawal and Johnson, 
1995) (Figure 4.7, panels C and D). However, Western analyses of CsCl density gradient 
fractions from INVScI-derived (Figure 4.3, panel C) and JRY188 3#20. I-derived (Figure 4.5, 
panel A) preparations demonstrated that as little as 100 - 1000pg (equivalent to 107 - 10svps) 
of the p71-containing species had the expected buoyant density values for HaSV procapsids. 
In addition, TEM examination of yeast VLP preparations (Figure 4.4) showed virus particles 
at higher concentrations than indicated by Western analyses. This discrepancy suggests that 
VLPs other than HaSV VLPs may be present in the yeast cells. This possibility is supported 
by the following experimental evidence: 
First, the capsid shells of these particles appear to be much narrower than 8.3om, which is the 
width that was computed for Nco V procapsids from the CryoEM reconstructions in Figure l.8 
(panel B). Second, the electron dense spots within the inner cores of these particles, which 
represent encapsidated nucleic acid, are uncharacteristic for tetravirus particles. According to 
Olson et al. (1990) a density distribution plot for a CryoEM reconstruction of NPV revealed 
that its genome is loosely packed within the particle. This most probably precludes the 
presence of electron dense areas inside NPV and other tetravirus capsids. Third, a number of . 
the particles in Figure 4.4 appear to contain less electron dense cores, which is indicative of 
empty particles. The assembly of particles devoid of RNA is highly unlikely for tetravirus 
particles, because baculoviral expressed Nco V particles were shown to contain RNA (Agrawal 
and Johnson, 1995). FUlihermore, RNA is probably required to neutralize the highly charged 
inner surface oftetravirus capsids (Agrawal and Johnson, 1995). 
In the light of the above evidence it is highly probable that the particles in Figure 4.4 represent 
endogenous yeast virus particles. Likely candidates are the S. cerevisiae L-A viruses, double-
stranded RNA viruses with capsid shells that are 401ID1 in diameter (Wickner, 1996). The 
T = 1 capsids of these viruses consist of 76 kDa and 180 kDa capsid proteins. Proteins of 
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similar sizes were observed on Ponceau S-stained nitrocellulose membranes, subsequent to the 
electrophoretic transfer from SDS-PAGE gels on which yeast VLP preparations were 
separated (results not shown). In addition, electron micrographs of negative-stained L-A virus 
particles also depict electron-dense spots within their inner cores (Van Regenmortel el al., 
2000). 
Techniques other than the generally used electron microscopic examination were therefore 
required to provide evidence for the assembly of HaSV procapsids in yeast. A particular 
functional property of tetraviral procapsids was used to provide proof for correct VLP 
assembly. Tetravirus procapsids differ from those of nodaviruses in the requirement for an 
external signal for the initiation of autoproteolytic cleavage (Canady e/ aI., 2000). In 
nodaviruses, cleavage occurs automatically, subsequent to the assembly of procapsids, with a 
t1/2 of 2 days at SoC (Gallagher and Rueckert, 1988). This, however, does not seem to be the 
case for p71-containing CsCI fractions, since no cleavage was detected after a one week 
storage period at 4°C (Figure 4.S, panel B). Yeast derived p71-containing particles could 
undergo pH-dependent maturation, analogous to what was recently demonstrated for 
baculoviral expressed NroV procapsids (Canady et aI., 2000) (Figures 4.9 and 4.10). This, in 
tum, provided evidence for the assembly of functional procapsids. The term "functional" in 
this context refers to the ability of these particles to carry out the biological function of 
maturation cleavage. The observation that maturation cleavage occurred exclusively for 
particles with an identical buoyant density to that of HaSV provided further support for this 
hypothesis (Figure 4.10, panels B and C). 
Yeast-derived p64 was detected more readily than p71 the by anti-HaSV IgGs (Figure 4.10, 
panels A and B). A possible explanation for this is that the anti-HaSV antibodies bound more 
readily to p64 than to p71, because these antibodies were raised against mature wild-type 
HaSV (made up of p64 protomers). This disproportionate level of detection for p64 and p7 1 
could therefore be suggestive of a serological distinction between capsid and procapsid 
monomers. 
No conclusive data identifying P71 mRNA as the encapsidated RNA species was obtained 
(Figure 4.11). It is uncertain whether this was due to the nonspecific encapsidation of yeast 
cellular RNA or insufficient levels of P71 mRNA for detection by RT-PCR, the latter being 
most likely due to the very low level of functional procapsid production in these experiments. 
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4.4.2 Requirement for RNA for maturation cleavage 
pH-dependent maturation was only detected for VLPs with a buoyant density identical to that 
of HaSV. Since the buoyant densities of virus particles are relative to their RNA contents, it 
appears as if a certain complement of RNA is required for the assembly of functional 
procapsids, Identical buoyant densities for procapsids and HaSV do, however, not imply that 
these particles require a complement of RNA equivalent to that of the viral genome for 
assembly, as is the case for nodavirus particles (Schneemann and Marshall, 1998), It is 
plausible to suggest that, within the limits of accuracy for buoyant density measurements, 
these procapsids could undergo maturation as a result of a certain amount of encapsidated 
RNA, In Section 1,2,5ii it was explained how, based on similarities between noda- and 
tetraviruses, RNA could play an important role in tetraviral maturation cleavage, The results 
discussed in this paragraph present evidence for such a requirement for the maturation of 
HaSV procapsids, 
4.4.3 Low yields of HaSV VLPs 
The results described in this chapter demonstrate that the expression of P71 in yeast failed to 
produce a significant amount of VLPs, A possible explanation for this failure could be a 
shortage of sufficient amounts of RNA for encapsidation during VLP assembly, This 
explanation is highly probable for a number of reasons: 
First, only a small fraction of the CsCI density gradient fractions that contained p71 had 
buoyant densities in the same range of that of HaSV (Figure 4,5, panel A, Figure 4.1 0, 
panel A), and an even smaller fraction of the preparations could undergo pH-dependent 
cleavage into p64 (Figure 4,10, panel B), This indicates that only a small amount of these 
p71-containing species contained significant complements of RNA, 
Second, taken that capsid precursor protein mRNA is the predominate type of RNA 
encapsidated by omegatetravirus VLPs, the more successful expression of omegatetravirus 
capsids in baculovirus expression systems (Agrawal and Johnson, 1995) could possibly be the 
result of a much higher level of capsid precursor mRNA in the baculovirus-infected insect 
cells than yeast cells, The polyhedrin promoter, which was exclusively used for the 
expression of tetraviral capsid precursors in the latter expression experiments, directs the 
expression of 25 - 50% of the total cellular protein in baculovirus-infected cells (Miller, 
1988), This is at least an order of magnitude greater that the expression levels expected for the 
PGALI-directed expression of P71 , which makes up one of three GAL promoters that 
collectively drives the expression of03 to 1.5% of the total cellular protein in yeast (Johnson, 
1987). 
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A final indication for this hypothesis comes from evidence that the replication strategy for 
omegatetraviruses is similar to that of nodaviruses, in that genomic RNA is replicated to high 
levels prior to capsid protein synthesis (Bawden et al., 1999). This indicates that a high 
cellular concentration of viral RNA is also required for the assembly of omegatetraviral VLPs 
and virions. 
Based on this hypothesis for the lack of assembly into functional VLPs, it is possible that the 
majority of the p71 detected in yeast VLP preparations form part of abberant VLPs that are 
devoid of, or that contain insufficient amounts of RNA. Another possible reason for impaired 
assembly is the absence of as yet unidentified cellular factors that could be required for the 
assembly of omegatetraviral VLPs. These factors could be nucleation structures guiding 
accurate accumulation of assembly units (Schneemal1l1 et al., 1994). They could also be as 
yet unidentified "pocket factors" that are required for capsid uncoating (Cheng et aI. , 1994). 
A number of characteristics of the p71-containing species, which did not form part of 
functional VLPs, were delineated in this chapter. First, these aberrant particles were shown to 
be very unstable. A large amolU1t of p71 is lost subsequent to centrifugation through sucrose 
cushions (Figure 4.6). The milder glycerol gradient centrifugation technique might have 
yielded a larger amount of these unstable particles (Figure 4.7, panels C and D), but they still 
did not undergo any detectable signs of maturation (Figure 4.7, panels E and F). These 
particles were furthermore shown to precipitate at a pH below 5.5 (Figure 4.8, panel B). The 
following chapter will describe how this attribute was used to separate mature HaSV particles 
from these malformed VLPs. 
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5 The preparation of infectious HaSV particles from S. 
cerevlsiae 
5.1 Introduction 
In the previous chapter, it was demonstrated that no p64 was detected in VLP preparations 
from yeast cells that were induced for the expression of P 71. These data indicated that 
autoproteolytic cleavage neither occurred in the yeast cellular milieu, nor during the extraction 
and purification steps. An inability to produce mature HaSV capsids in vivo complicated the 
effort to produce infectious HaSV, due to the requirement for maturation cleavage in RNA 
release upon infection (Munshi et aI., 1996). A solution to this problem was, however, 
presented by Canady et al. (2000), demonstrating that autoproteolytic cleavage could be 
induced in NO) V procapsids by a reduction in pH. In the previous chapter, it was 
demonstrated that this also applied for HaSV procapsids that were produced in yeast. This 
laid the foundation for the development of protocols for the purification of infectious HaSV 
from yeast, which are described in this chapter. 
Apart from an ability to undergo maturation, proof for the infectious character of the yeast-
expressed HaSV is reliant on experiments that demonstrate an ability to perform additional 
biological functions. These functions comprise the specific encapsidation of the viral nucleic 
acid and the specific attachment to, and delivery of this nucleic acid to the viral host cell. The 
main objective of this chapter is to demonstrate that yeast-derived HaSV could perform both 
of these functions. 
5.2 Materials and methods 
5.2.1 HaSV purification protocols 
Yeast-derived HaSV particles were prepared from JRYI88 3#20.1 cells that were transformed 
with either pAVI3HC or pAV13HC (G+) (Figure 2.1), and pAVI4HPTrp (Figure 2.2) as 
described in Section 3.2.2. Leucine, tryptophan and uracil were omitted from SMM for the 
selection of expression vectors. Flask cultures of these cells in SMM containing 5% glycerol 
and 0.1 % glucose to a combined volume of l.51 were grown to midlog phase at 30°C. 10% 
galactose was then added to these cultures up to a final concentration of 0.01 % and the 
cultures were grown at 20°C for a further 8 hours. The cells were centrifuged at 4000rpm for 
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10 min at 4°C in a Beckman JAIO rotor and lysed by glass bead homogenization or zymolyase 
treatment. 
i Preparation of mature HaSV particles by way of glass bead homogenization 
A protocol that is similar to the one described in Figure 4.1 was used for the purification of 
mature HaSV vims particles from yeast, with the exception that a pH-reduction step was 
introduced prior to CsCI density gradient centrifugation. Accordingly, the pellets resulting 
from centrifugation through 30% sucrose cushions ("Pellet 2" in Figure 4.1) were resuspended 
in 2ml lysis buffer and stored overnight at 4°C. Hereafter, the resuspended pellets were 
dialyzed overnight against 50mM Tris-HCI pH 7.4 at 4°C. The pH of the resulting dialysate 
was dropped by the addition of five volumes of 70mM NaAc (PHS) and the preparation was 
kept on ice for at least 2 hours. Next, the preparation was concentrated down to a volume 
lesser than Iml by means of dialysis against PEG 20000. The concentrated preparation was 
microfuged for 5 min at 4°C and the resulting supernatant fraction was layered upon a 30% 
esCI / 60% CsCI discontinuous gradient as described in Figure 4.1. The rest of the purification 
protocol was as is described in Figure 4.1. 
ii HaSV preparation by way of zymolyase treatment 
A protocol that was adapted from one described by Dunn and Wobbe (1997) was used for the 
lysis of yeast by means of zymolyase treatment. In this protocol (Figure 5.1) cells were 
enzymatically converted to spheroplasts and then lysed by a combination of Dounce 
homogenization and osmotic shock. Subsequent to the osmotic shock treatment, the cell 
Iysates were centrifuged at 12500rpm for IS min at 4°C in a Beckman JA20 rotor and the 
protocol for centrifugation through sucrose cushions in Figure 4.1 was followed. The dialysis 
step subsequent to fractionation of CsCI density gradients was altered in some experiments. In 
these instances, fractions with buoyant densities ranging from 1.23-1.36g/ml were transferred 
to a SW41 tube and diluted by the addition of 50mM Tris pH7.4. The tube was filled up to 
5mm from its rim, sealed with laboratory film, and mixed by inversion. The diluted fractions 
were centrifuged at 30000rpm for 3 hours at 4°C and the pellets were resuspended in a small 
volume (50 - 100111) of 50mM Tris pH7.4. 
5.2.2 Bioassays 
To ascertain whether yeast vims preparations contained infectious HaSV particles, droplet-
feed bioassays were carried out on 24-hour-old H armigera larvae. These larvae were 
obtained from a laboratory colony, which was maintained as described by Teakle and Jensen 
Repeat 2x 
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I Yeast cell pellets 
(- Determine the wet weight of yeast cell pellet 
(- Resuspend cells in 4 volumes ice-cold water 
(- Centrifuge: ISOOg/S min (4°C) in Beckman JA20 rotor 
1 
I Pellet I I Supernatant 
discard 
(- Resuspend cells in I volume SOmM Tris-HCI (pH7.S) 
containing 10mM MgCb, 1M sorbitol and 30mM DTT 
(- Incubate for IS min at room temperature 
(- Centrifuge: IS00g/S min (4°C) in Beckman JA20 rotor 
1 
I Pellet I I Supernatant 
discard 
(- Resuspend cells in 3 volumes zymolyase buffer (SOmM 
Tris-HCI, pH7.S, 10mM MgCb, 1M sorbitol, ImM DTT) 
(- Add 800 units of zymolyase (Sigma) per every gram of 
yeast pellet) 
(- Incubate for 1 hour at 30°C on a shaker platform at -SOrpm 
(- Centrifuge: IS00g/S min (4°C) in Beckman JA20 rotor 
1 
~I I 
·1 Pellet I Supernatant 
discard 
(- Carefully decant the supernatant 
(- Gently resuspend the pellet in 2 volumes zymolyase buffer 
(- Centrifuge: IS00g/S min (4°C) in Beckman JA20 rotor 
I L-_-I! pellet] I Supernatant 
discard 
(- Gently resuspend the pellet in 2 volumes lysis buffer 
(SOmM Tris pH7.S, 10mM MgS04, ImM EDTA, 
10mM potassium acetate, ImM DTT, ImM PMSF) 
(- Centrifuge: IS00g/10 min (4°C) in Beckman JA20 rotor 
1 
I Pellet I I Supernatant 
discard ! , 
, 
T 
Figure 5.1 Flow diagram for the purification of HaSV particles from yeast by way of 
zymolyase treatment 
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~ Thoroughly resuspend the pellet in I volume lysis buffer 
~ Lyse spheroplasts with 15 to 20 strokes of a tight-fitting 
pestle in a Dounce homogenizer 
~ Transfer the homogenate to a JA20 centrifuge tube 
~ Add an equal volume of 50mM Tris (pH7.5) containing 
0.8M (NH4)2S04, 20%glycerol, 10mM MgS04, ImM EDTA, 
10mM potassium acetate, ImM OTT and ImM PMSF) 
~ Shake the contents of the tube on a rocker for 30 min at 4°C 
~ Centrifuge: 12500rpm/lS min (4°C) in Beckman JA20 rotor 
I 
Supernatant I I Pellet I 
! 
I 
I 
I 
discard 
~ Transfer to Beckman SW28 tube and follow protocol for 
centrifugation through sucrose cushions in Figure 4.1 
HaSV preparation 
from yeast 
Figure 5.1 Continued ... 
(198S) at the CSIRO Division of Entomology in Canberra, Australia. Prior to the assay, 1/ I0lh 
volume of food colouring was added to virus preparations, droplets of which were arranged in 
a circle with a diameter of approximately 3 cm on a piece of wax paper. The coloured 
droplets were approximately O.S cm apart. The neonates were kept on a dry piece of filter 
paper in a desiccator for a few hours prior to the assay, and transferred to the centre of the wax 
paper. The insects were consequently forced to migrate past the virus specimens toward the 
periphery of the wax paper. Proof for ingestion of the viral specimens came from the 
detection of digestive tracts that had the same colour as that of the food colouring. 
The insects were thereafter transferred to jelly trays (Nu-trend containers, Jacksonville, 
Florida, USA) containing soybean-wheat germ diet (Appendix 9) and sealed with Mylar™ 
(Dupont, Wilmington, Denver, USA). The larvae were maintained at 30°C throughout the test 
and response was assessed by scoring larval development at Sand 7 days post infection. A 
description of the developmental stages of H armigera used for the scoring of the bioassays is 
provided in Appendix 10. 
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5_2.3 RNA extractions 
For total yeast RNA extractions, 200ml yeast cell cultures were grown to midlog phase at 
30°C in SMM containing 2% glucose, centrifuged for 10 min at 4000rpm in a Beckman JA20 
rotor and resuspended in SMM containing 2% galactose. The cells were then grown for a 
further 4h at 30°C and spun down as described above. RNA was extracted from the resultant 
pellets as described in Section A8.4 (Appendix 8). Total RNA extractions from H armigera 
larvae were obtained according to the protocol described by Gordon et al. (2001). RNA was 
purified from HaSV and yeast virus preparations as described in Section 4.2.5, with the 
exception that it was treated with RQI RNAse-free DNase (Promega) prior to the addition of 
phenol. RNA within the various extracts was quantitated using a Gene Quant RNA/DNA 
calculator (Pharrnacia Biotech). 
5.2.4 In vitro transcription 
A short supply of HaSV necessitated the generation of RNA 1 and RNA2 transcripts for 
positive controls in RNA analyses. These transcripts were synthesized by means of in vitro 
transcription with T7 RNA polymerase (Promega) according to the supplier's protocol. The 
T7 promoter precedes the sequences of HaSV RNA] and RNA2 in the plasmids pBJ33RIHC 
(Figure A2.1, panel B, Appendix 2) and pBJ33R2HC (Figure A2.1, panel C, Appendix 2), 
respectively. Accordingly, pBJ33RIHC was linearized by Hind III and used as a template for 
the synthesis of a 5536 nucleotide RNAI transcript. Similarly, pBJ33R2HC was linearized by 
Stu I and used as a template for the synthesis of a 1747 nucleotide RNA2 transcript. 
5.2.5 Northern analyses 
RNA was subjected to denaturing agarose gel electrophoresis in the presence of formaldehyde 
according to Sambrook et ai. (1989) and visualized by UV illumination. The RNA was 
transferred overnight to Zeta-Probe membranes (BIO-RAD) by capillary blotting (Sambrook, 
et al., 1989) and fixed to the membranes by UV illumination for 3 min. The membranes were 
washed twice for 20 min in 2 x SSC (Sambrook et al., 1989), dried between two pieces of 
filter paper and stored in plastic bags at room temperature. Pre-hybridizations and 
hybridizations on the Zeta-Probe membranes were carried out according to the formamide 
protocol described by the manufacturer (BIO-RAD). 
For the detection of RNA 1 , p12 -labelled RNA probes were prepared by in vitro transcription 
using T3 RNA polymerase (Promega) as instructed by the supplier. Accordingly, the plasmid 
pBCRI dA (Figure A2.1, panel A, Appendix 2), which carries the T3 promoter followed by the 
complementary sequence to the 5' proximal region of HaSV RNA 1, was linearized with Aft II 
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and used as a template for the synthesis of a 1347 nucleotide RNA probe. For the detection of 
P7l mRNA and RNA2, p32-labelled probes were prepared using the random primed DNA 
labelling kit from Roche. A 1954 bp Bam HI fragment was excised from the plasmid pA V3 
(Figure 2.3), gel purified by means of the Gene Clean kit (BIOIOI) and used as a template for 
the synthesis of random priming probes. Both the RNAI- and RNA2-specific probes were 
purified using Sephadex G-50 columns (Roche). 
5.2.6 RT-PCR analyses 
The Superscript™ One-Step RT-PCR system (GibcoBRL) was used for the specific 
amplification of various HaSV RNA I and RNA2 cDNA fragments from yeast and H. 
armigera RNA extracts (thermal cycling programme: Programme 4 in Appendix 5). The 
HVR1B5P I HVBll VF2, HVB II VF6 1 HVB35XFI and HB35F2C I HVRI CIa primer pairs 
were used for the detection of RNAI, while the HR236F3 1 H3RIB primer pair was used for 
the detection of RNA2 (Appendix 4). Reverse transcriptase was omitted from certain reactions 
to ensure that the amplified products were not the result of genomic DNA contamination. 
The primers RNAIF4 and RNAI R7 (Appendix 4) were used in RT-PCR for the detection of 
encapsidated RNA I transcripts. These reactions were performed on HaSV preparations from 
yeast through the application of the Titan™ One Tube RT-PCR System (Roche). A similar 
programme to Programme 3 (Appendix 5) was used for thermal cycling, with the exception 
that the annealing temperature was reduced from 50°C to 45°C. PCR analyses (using the 
Expand™ High Fidelity PCR System from Roche) were performed on these RNA extracts to 
ensure that amplified products were not the result of genomic DNA contamination. 
5.2.7 Use of pAV13HC and pAV13HC (G+) vectors in expression experiments 
pA V13HC (a defective plasmid that lacks the 5' -most nucleotide of RNAl) and pA V13HC 
(G+) (a plasmid in which this error was repaired) were used for the expression of RNA] in 
S. cerevisiae (Figure 2.1 and Table 2.2). pA VI3HC was used in experiments that led to: 
(a) the detection of RNAI, RNA2 and P71 mRNA in total yeast RNA (Section 5.3.1) and 
(b) the production of a virus preparation (denoted BZ23 in Figure 5.7, panel C) that was used 
in a droplet feed bioassays (Section 5.3 .5). pAVl3HC (G+) was used for the remainder of the 
work described in this chapter, which include: (a) studies on the effect of the expression of 
RNA] on the yield of yeast-produced VLPs (Section 5.3.2), (b) the majority of virus 
preparations from cells co-expressing P71, RNA] and RNA2 (Section 5.3.3) and (c) RT-PCR 
analysis of RNA encapsidated by yeast-produced HaSV particles (Section 5.3.4). 
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5.3 Results 
5.3.1 Detection of RNA1, RNA2 and P71 mRNA in total yeast RNA 
To test whether the co-expression of P71 , RNAI and RNA2 results in the production of viral 
genomic RNA transcripts and P7I mRNA in yeast, expression experiments were carried out 
with JRY188 cells, with or without the chromosomal copy of P71, which were transformed 
with either or both of the RNAI and RNA2 expression vectors. Henceforth, cells with these 
various combinations will be identified according to the names that are listed in Table 5.1. 
Table 5.1 Names designated to different yeast-derived preparations 
Name of 
preparation 
JRY188 
JRYI88::P71 
JRYI88::P7I; RI 
JRYI88: :P7I; R2 
JRY188: :P7I; RI , R2 
JRYI88 ::RI 
JRY188 ::R2 
JRY188::Rl ,R2 
2 
Figure 2.1 
Figure 2.2 
Northern analyses 
Yeast Plasmids Phenotype 
Strain 
JRY188 None His", Leu", Trp", Ura" 
3#20.1 
3#20.1 pAV13HC1 or P71+, RNA1 +His",Trp", 
pAV13HC (G+)I 
3#20.1 
3#20.1 
pAV14HPTrp2 
pAV13HC 1 or 
pAV13HC (G+)I 
+ pAV14HPTrp 
JRY188 pAV13HC 
JRY188 pAV14HPTrp 
JRY188 pAV13HC + 
pAV14HPTrp 
P71 +, RNA2+, His", 
Ura" 
P71 + RNA1 + RNA2+ , , , 
His" 
RNA1 +, RNA2+, His", 
Leu" 
After induction with galactose, total RNA was extracted from yeast strains that carried 
chromosomal and episomal copies of expression cassettes for RNA I , RNA2 and P71 
(Table 5.1). These RNA extracts were analyzed on formaldehyde aga.rose gels, blotted onto 
nucleic acid bonding membranes and probed for the presence of RNA 1 and RNA2 transcripts 
as well as P71 mRNA (Figure 5.2). To ensure the analysis of equivalent amounts of RNA on 
each Northern blot, the concentration of RNA in these extracts was determined 
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A 
P71+ P7r 
I I 
Rl Rl 
Rl R2 R2 Rl R2 R2 TS ++ 
-
+-RNAI 
B 1111111 1 
+-25S 
+-18S 
C 
P71+ P7r 
I I 
Rl Rl 
Rl R2 R2 Rl R2 R2 + ++ 
RNA2 
~ +-RNA2 
p71 
mRNA 1 1 1 1 1 D 
+-25S 
+-18S 
Figure 5.2 Northern analyses of total RNA extracts from yeast cells expressing HaSV 
gene constructs probed for RNA! (panel A) and RNA2 (panel C). Bands for 28S and 18S 
rRNA in the formaldehyde agarose gels below each Northern blot (panels B and D) indicate 
that equivalent amounts of RNA were loaded in each well. Total RNA was extracted from 
P71+ or P7r cells that were transformed with plasm ids carrying RNA1 (Rl), RNA2 (R2) or 
RNA] and RNA2 (Rl R2). Bands representing RNAl , RNA2 and P71 mRNA are indicated. 
lOng and lng HaSV RNA labeled ++ and +, respectively, and an RNAI sense transcript that 
was prepared by in vitro transcription (TS) were run as positive controls. 
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spectophotometrically. This was verified by RNA UV illumination of ethidium bromide 
stained gels (Figure 5.2, panels B and D), which revealed that the band intensities for 25S and 
18S rRNA in the different lanes were equivalent. 
RNAI transcripts, which were similar in size to HaSV RNAI, were exclusively detected in 
RNA extracts from yeast cells expressing RNAI (Figure 5.2, panel A). On the other hand, 
RNA2-specific probes hybridized to two RNA species of distinct molecular weights that were 
present in some of the yeast RNA extracts (Figure 5.2, panel C). The one molecule had a 
similar molecular weight to HaSV RNA2 and was only present in RNA extracts from yeast 
cells expressing RNA 2. Conversely, the other RNA molecule had a lower molecular weight 
than HaSV RNA2 and was only present in RNA extracts from yeast cells expressing P7I. The 
RNA2-specific random priming probes, which were synthesized from a complementary 
sequence to RNA2 spanning the P7I ORF, therefore hybridized to P71 mRNA and RNA2 
transcripts within the various RNA extracts. Thus the expression of the HaSV genomic 
transcripts and P7I mRNA in yeast was detected on these blots. 
The HaSV genomic RNA levels in extracts from cells transformed with both pAV13HC and 
pAVI4HPTrp (Table 5.1) were lower than those for cells transformed with only one of these 
expression vectors (Figure 5.2, panels A and C). This trend was observed for the expression 
of RNAI and RNA2 in P71+and P71" cells. The level of chromosomally expressed P7I 
mRNA, however, seemed to be unaffected by the presence, or absence, of one or both of these 
expression vectors (Figure 5.2, panel C). As a result of this, RNA2 appeared to be more 
abundant than P7I mRNA for JRYI88::P 71; R2 cells, while similar levels of these RNAs 
were detected forJRYI88::P71; RI, R2 cells. 
ii RT-PCRanalyses 
Four primer pairs were used for the amplification of RNA I and RNA2 cDNA fragments from 
yeast RNA extracts; three were specific for RNA I sequences (PPI, PP2 and PP3) and one was 
specific for RNA2 sequences (PP4) (Figure 5.3, panel A and Figure 5.4, panel A). PP3-
dependent amplification is dependent on the binding of the antisense primer (HVRI CIa) to the 
utmost 3' nucleotides of yeast-derived RNAI transcripts. Likewise, PPI-dependent 
amplification is dependent on the binding of the sense primer (HVR IB5P) to a sequence 
complementary to that of the 5'end of RNA!. The detection ofRT-PCRproducts for PPI and 
PP3 would therefore indicate that most of the 5' and 3' nucleotides of yeast-derived RNAI 
transcripts were present. 
A 
PPI 
+--HVBII VF 
~ 
1212 bp 
B 
200~ 
16S~ 100,\ . 
8S~ 6Sr 
c 
200~ 
16SIl--+ 
100~ 
8SIl----+ 
6SIl--+ 
50r 
PPI 
I RT Taq Taq RTI 
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PP2 
~HVB3SXF 
~ 
1497 bp 
PP3 
I RT Taq Taq RT I 
PP3 
~HVRICla 
~ 
l395 bp 
200'\-. 
1650---+ 
100~ 
8soIr+ 
6So';-+ 
500' 
PRIMER 
PAIRS 
RNAI 
RT-PCR 
PRODUCTS 
PP2 
Taq RTI 
Figure 5.3 (A) Schematic representation of the binding locations and amplification products 
upon RT-PCR analysis using the HVRIB5P / HVBllVF2 (PPl), HVBll VF6 / HVB35XFl 
(PP2) and HB35F2C / HVRI Cia (PP3) primer pairs. (B) RT-PCR on RNA extractions from 
JRYl88 (-RI) and JRYI88::RI (+Rl) cells using the primer pairs PPl, PP2 and PP3. RNA I 
sense transcripts that were prepared by in vitro transcription (TS) were used as positive 
controls for these reactions, while negative controls (-) contained all the required constituents 
except for an RNA template. (C) RT-PCR (RT) and PCR (Taq) on RNA extractions from 
JRYI 88::RI (+RI) cells using the primer pairs PPl, PP2 and PP3 to determine if the amplified 
products in panel B were not the result of genomic DNA contamination. pA V13HC (pRI) 
(Figure 2.1) was used as a DNA template for PCR positive controls. Negative controls for RT-
PCR (-) contained all the required constituents except for an RNA template. The lKb Plus 
DNA Ladder (Promega) was used as a molecular weight marker (M) for each of these gels. 
A 
B 
1929 \ 
1371 '-+ 
1264>* 
702-
S-JJ9 
PP4 
1129 bp 
+-H3R1B 
PRIMER 
PAIR 
RNA2 
RT-PCR 
PRODUCT 
RT RT Taq RT Taq RT Taq Taq RT Taq 
-R2 +CP +CP +R2 +R2 
129 
Figure 5.4 (A) Schematic representation of the binding locations and 
amplification product upon RT-PCR analysis using the HR236F3 / 
H3RIB (PP4) primer pair. (B) RT-PCR (RT) on RNA extractions from 
JRYI88 (-R2), JRYI88::P71 (+CP) and JRYI88::R2 (+R2) cells using 
the PP4 primer pair. PCR (Taq) was performed on these RNA extracts 
to ensure that amplified products were not the result of genomic DNA 
contamination. An RNA2 sense transcript that was prepared by in vitro 
transcription (TS) was used as a positive control for RT-PCR, while 
pAV3 (pCP) (Figure 2.3) and pAV14HPTrp (pR2) (Figure 2.2) were 
used as DNA templates for PCR positive controls. Negative controls for 
RT-PCR and PCR (-) contained all the required constituents except for 
RNA and DNA templates, respectively. A estEll digest oflambda-DNA 
was used as a molecular weight marker (M). 
RT-PCR analyses on RNA extracts from JRYI88::Rl cells led to the amplification of cDNA 
fragments with similar sizes to that expected for each of the three primer pairs (Figure 5.3, 
panel B). No RT-PCR products were obtained from reactions that were performed on RNA 
from JRY188 cells. Furthermore, amplified products were not detected for PCR, indicating 
that these products were not the result of genomic DNA contamination in the RNA isolates 
(Figure 5.3, panel C). Similar results were obtained for the RT-PCR analysis of RNA extracts 
from JRYI88::R2 and JRYI88::P71 cells (Figure 5.4, panel B). 1129 bp fragments were 
amplified from these RNA extracts, as expected for the PP4 primer pair (Figure 5.4, panel A). 
Reactions on RNA extracts from JRY188 cells did not produce bands corresponding to this 
size. Furthermore, no bands were detected if reverse transcriptase was omitted from these 
reactions, proving that the amplified products were not a result of genomic DNA 
contamination. These analyses confirmed the Northern analyses (Figure 5.2) in demonstrating 
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that RNAI and RNA2 transcripts, as well as P71 mRNA, were detected in total RNA extracts 
from yeast. 
5.3.2 The effect of yeast-expressed RNAI transcripts on VLP preparations 
A direct comparison was drawn between VLP preparations from JRYI88::P71 and 
JRYI88::P71; RI cells to determine whether the expression of RNAI had an effect on the 
yield of yeast-produced VLPs. This comparative study also tested whether the inability of the 
VLPs to mature was due to a lack of encapsidated RNA!. Accordingly, VLP preparations 
from JRYI88::P7I and JRY188::P71; RI cells were subjected to CsCI density gradient 
ultracentrifugation, fractionated and subjected to Western analysis. There was a similar 
distribution of p71 throughout the CsCI density gradient fractions from these preparations 
(Figure 5.5, panels A and B). The co-expression of RNA 1 did not result in the production of 
p64 in any of the CsCl fractions (Figure 5.5, panel B). Therefore, the presence of RNAI had 
no significant effects on VLP yield and maturation, and acid-maturation was still required for 
the preparation of mature VLPs from yeast. 
A 
10 11 12 13 14 15 16 + ++ 
..,. -
• 
.... .... .... .... .... .... .... 
N N N N N ;... ;... 
~ .... ~ -.l 
'" 
.... N 
-.l QO til QO ~ C .... 
B 11 12 13 14 15 16 17 + ++ 
j 
.... .... .... .... .... .... ~ N N N N ;... ;... ~ .... ~ 
'" 
C N 
.... ~ -.l QO C C 
Figure 5.5 Western analysis of VLP preparations from JRYI88::P7I (A) and 
JRYI88::P7I; RI (B) cell cultures, each with a total volume of 1.51. Yeast pellets 
were subjected to the sucrose cushion centrifugation purification procedure 
described in Figure 4.!. Accordingly, solutions buffered at a pH of 7.4 were used 
throughout the protocol. 20~1 (out of a total volume of 400~1) of each of the 
dialyzed CsCI fractions were separated by SDS-PAGE. The buoyant densities (in 
g/ml) of these fractions are shown below each figure. (+) and (++) denote 0.1 and 
lng wild type HaSV, respectively. 
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5.3.3 Virus preparations from JRY188::P71; Rl, R2 cells 
To detennine whether infectious HaSV virions could be prepared from yeast, ViruS 
preparations were performed on JRYI88::P71; Rl , R2 cells, which were induced for the 
expression of P71, and HaSV RNAl and RNA2. Two different protocols were followed for the 
extraction of virus particles from these cells: glass bead homogenization and zymolyase 
treatment. 
Preparation of mature HaSV by way of glass bead homogenization 
The protocol described for the preparation of VLPs in the previous chapter (Figure 4.1) was 
modified by the inclusion of a pH reduction step prior to CsCI density gradient 
ultracentrifugation. The reasoning behind the introduction of pH reduction before CsCI 
density gradient ultracentrifugation was that the stable matured particles would be more 
resilient to this harsh purification technique than the unstable immature particles. This 
protocol had the potential for an improved yield of VLPs and vps to previous protocols in 
which the particles were only matured after CsCI gradient centrifugation. 
Western analysis of virus preparations, in the presence (Figure 5.6, panel B) or absence 
(Figure 5.6, panel A) of a pH reduction step, demonstrated that all the p71-containing species 
in CsCI density gradient fractions became insoluble upon a reduction in pH. Other proteins, 
which interacted with the anti-HaSV antibodies, were also lost to the pellet fractions 
subsequent to pH reduction. These included a 69kDa protein (Fraction 14 in Figure 5.6, panel 
A), which was described as a Type II protein species (Figure 4.5), and proteins with molecular 
weights smaller than 71kDa (Figure 5.6, panel A), the latter probably representative of 
proteolytic breakdown products. Western analysis of preparations that were subjected to a 
reduction in pH demonstrated that the anti-HaSV antibodies exclusively detected a protein 
with a slightly lower electrophoretic mobility than that of p64 and a buoyant density of 
1.330glml (Figure 5.6, panel B). The concentration of this protein was less than 3 x 107 vplml 
as estimated from the band intensity of the 0.1 ng HaSV positive control. Taken that this 
protein band represented HaSV viral or subviral particles, this translates into a very low yield 
of approximately 107 HaSV particles from a l.51 yeast cell culture. A second virus 
preparation from JRYI88::P7l; Rl , R2 cells produced similar results, with the exception that 
the density of the fraction containing an equivalent protein interacting with anti-HaS V 
antibodies was 1.292 glml (results not shown). 
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Figure 5_6 Western analysis of CsCI density gradient fractions for virus 
preparations from l.51 JRYI88::P71; Rl, R2 cell cultures that were either 
not acid matured (A) or acid matured (B) prior to centrifugation. The 
sucrose cushion centrifugation purification procedure for the preparation 
of mature HaSV particles (Section 5.2.li) was followed for the fractions in 
panel B. A similar protocol was followed for the fractions in panel A, with 
the exception that the pH reduction step was omitted. 80~1 (out of a total 
volume of 400~1) of each of the dialyzed fractions were TCA precipitated 
and separated by SDS-P AGE. The respective buoyant densities (in g/ml) 
of these fractions are shown below each figure. (+) and (++) denote 0.1 
and Ing wild type HaSV, respectively. 
ii Preparation of mature HaSV by way of zymolyase treatment 
A potential disadvantage of the glass bead homogenization procedure is that it is a harsh 
technique that could lead to the denaturation of proteins (Dunn and Wobbe, 1997). A gentler 
technique for cell lysis was tested to determine if the low yield of HaSV particles was due to 
physical damage of unstable HaSV provirus particles during glass bead homogenization. This 
technique included a step in which cells were converted to spheroplasts by zymolyase 
treatment (Figure 5.1), followed by the addition of a buffer containing 0.8M ammonium 
sulphate (which induced cell lysis through osmotic shock) and homogenization with a Dounce 
homogenizer. 
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A virus preparation was performed on JRYI88::P7J; Ri, R2 cells, which were induced for the 
expression of the HaSV components and subjected to this cell lysis technique. Two protein 
bands with similar relative mobilities to that ofp64 were detected at a density of !.308g/ml in 
the resultant CsCI fractions (Figure 5.7, panel A). An estimation of the amount of virus 
particles represented by each of these two bands indicated that the use of this cell lysis 
technique did not result in an improved yield over that of glass-bead homogenization. The 
possibility that one of these bands represented p64, however, suggested that mature HaSV 
particles could be purified from yeast by the use of this cell lysis technique. This was 
confirmed by Western blots of a subsequent virus preparation, in which CsCI was removed 
from the CsCI density gradient fractions by means of ultracentrifugation, instead of dialysis 
(Figure 5.7, panel B). 
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Figure 5.7 Virus preparations from JRYI88::P7i; Ri, R2 cells that were lysed by zymolyase 
treatment, followed by osmotic shock and Dounce homogenization (described in Figure 5.1). 
(A) Western analysis of CsCI density gradient fractions that were obtained from a 31 culture. 
1 DOfll (out of a total volume of 40Dfll) of each of the dialyzed fractions were TCA precipitated 
and separated by SDS-PAGE. (B) Western analysis of equivalent amounts of fraction 16 (16) 
in panel A and a preparation in which CsCI was removed by means of ultracentrifugation 
(BZ24) instead of dialysis . (C) Western analysis of a virus preparation (BZ23) that was 
purified from a 0.51 culture using the same protocol as what was used for the preparation of 
BZ24 (panel B). 2fll (out of a total volume of 20fll) of this preparation was loaded on the 
SDS-PAGE gel. (+) and (++) denote 0.1 and 2ng wild type HaSV, respectively. 
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Not only did this preparation demonstrate the presence of matured HaSV particles (sample 
labelled "BZ24" in Figure 5.7, panel B); it also showed that a greater part of the yeast-derived 
HaSV particles were lost to the purification procedure during dialysis. As a result of a 
variable sensitivity for detection by Western analysis, p64 was detected in the same dialysed 
CsCI fraction in one blot (sample labelled "16" in Figure 5.7, panel A) and not in another 
(sample labelled " 16" in Figure 5.7, panel B). However, in the latter blot, this protein was 
clearly detected for an equivalent amount of a preparation that was subjected to 
ultracentrifugation (sample labelled "BZ24" in Figure 5.7, panel B). 
5.3A RT-PCR analysis of en caps ida ted RNA 
To determine if the yeast-derived HaSV particles were capable of the specific encapsidation of 
HaSV RNA transcripts that were expressed in trans with P71, RNA was extracted from a 
virus preparation from JRYI88::P7i; Ri, R2 cells. This RNA extract was subjected to RT-
PCR analysis using primers specific for the amplification of a 492bp fragment from HaSV 
RNA!. A faint band of this size was detected for this extract (Figure 5.8), indicating that 
RNAI transcripts were encapsidated by yeast-derived HaSV particles. This RT-PCR product 
was not amplified from yeast genomic DNA, since it was not detected for a reaction in which 
reverse transcriptase was left out. 
805bP7t 514bp 339bp 
RT-PCR PCR 
I I I 
M Y + Y pRI 
f-492bp 
Figure 5.8 Agarose gel electrophoresis of RT-PCR and PCR analyses 
(indicated by square brackets) of RNA extracts from a yeast-derived virus 
preparation (Y) and wild-type HaSV RNA (+) through the use of primers that 
were specific for RNA!. RNA was extracted from 100f.l1 of fraction 17 
(Figure 5.6, panel B) and resuspended in 1 Of.ll DEPC-treated water subsequent to 
ethanol precipitation. I f.ll of this extract was added to each reaction mix. 
pAV13HC (pR!) (Figure 2.1) was used as a positive control for PCR, while 
negative controls (-) for RT-PCR and PCR analyses contained all the required 
constituents, but an RNA or DNA template was left out, respectively. The 
expected sizes of RT-PCR and PCR products with the RNAIF4 / RNAIR7 
primer pair are indicated on the right-hand side of the gel. A Pst! digest of 
lambda-DNA was used as a molecular weight marker (M). 
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53.5 Droplet feed bioassays on H. armigera larvae 
The infectivity of yeast-derived HaSV particles was assessed by means of a droplet feed 
bioassay, in which the larval development of H armigera larvae exposed to yeast-derived 
HaSV particles was scored. The particles were purified from JRYI88::P7]; RNA], RNA2 
cells that were lysed by means of zymolyase-treatment (Figure 5.1). The detection of p64 on a 
Western blot provided evidence for the presence of mature HaSV particles within this 
preparation (sample labelled "BZ23" in Figure 5.7, panel C). 
The bioassay data demonstrated that 3 6% of the larvae remained in the first three larval instar 
stages after 7 days upon ingestion of the yeast-derived HaSV, while only 8% of the control 
larvae remained in these larval stages after this period in time (Table 5.2). The larvae also 
showed a stronger response to the yeast-derived HaSV than to the I07vp/ml HaSV positive 
control, indicating that the concentration of this sample should be in the range of 107 -
I08vp/ml. This virus particle concentration is compatible with estimations for the amount of 
p64 detected on Western blots (Figure 5.7, panels B and C). 
Table 5.2 Droplet feed bioassay of HaSV particles produced in JRY188: :P71j Rl, 
R2 cells 
Sample n Proportion of treated larvae in respective 
developmental stages' (%) 
SID E3 M3 L3 E4 M4 L4 InS 
-ve control 26 4 4 38 23 31 
Yeast-derived HaSV 25 4 32 4 24 12 24 
HaSV (lO 'vp/ml) 24 17 38 13 33 
HaSV (108vp/ml) 24 42 4 13 4 17 8 13 
HaSV (109vp/ml) 18 67 II 22 
HaSV (lOlovp/ml) 23 96 4 
n, sample number 
• SID, stunted or dead; E3, early third; M3, mid third; L3 , late third; E4, early fourth; 
M4, mid fourth; L4, late fourth; In5, fifth instar 
Further proof that the yeast produced HaSV particles were responsible for growth retardation 
was obtained from the RT-PCR analysis of RNA extracts from the larvae that were used in 
this bioassay (performed by Amir Masoumi from the CSIRO Division of Entomology in 
Canberra, Australia). Total RNA was prepared from larvae that ingested yeast-derived HaSV 
particles as well as those which served as positive and negative controls (Table 5.2). RT-PCR 
with primers specific to an 1128 nucleotide region internal to the HaSV RNA2 was used to 
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detect the presence of HaSV in these animals. The results confirmed the presence of HaSV in 
the stunted larvae fed on yeast particles or HaSV, but not in the negative control (Figure 5.9). 
M + + 1 2 3 
+-1128 
702 ___ 
Figure 5.9 Agarose gel electrophoresis of RT-PCR products for RNA 
isolates from H armigera larvae (1 - 3) fed on HaSV virus particles that 
were expressed in yeast. RT -PCR was also preformed on RNA isolates 
from two of the positive control larvae (+) and one of the negative control 
larvae (-) in the bioassay. The expected size of an RT-PCR product (in bp) 
with the HR236F3 / H3RIB primer pair is indicated on the right-hand side 
of the gel. A EstEll digest oflambda-DNA was used as a molecular weight 
marker (M). This experiment was carried out by Amir Masoumi (CSlRO 
Division of Entomology, Canberra, Australia). 
Surface contamination bioassays performed by Rachel Blaine (ZENECA Agrochemicals Ltd., 
lealott's Hill, UK) on yeast-derived HaSV preparations supported the results that were 
obtained for the above-described bioassay (Duncan, R., 1998). JRY188::P7}, RNA}, RNA2 
cells were either induced overnight, or for 4 hours, at 30°C for the expression of HaSV, and 
lysed by zymolyase treatment. The mean weight of H armigera larvae fed on a crude virus 
preparation from cells that were induced for 4 hours (0.018g, SEM ±0.003, n = 50) was 
significantly less than that of larvae fed on virus preparations from cells that were induced 
overnight (0.028g, SEM ±0.003, n = 50). A mean weight of 0.038 (SEM±0.005, n = 50) was 
obtained for negative control larvae that ingested a water control. The larvae that were tested 
in these bioassays were unfortunately not analysed for the presence ofHaSV. 
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5.4 Discussion 
5.4.1 HaSV genomic RNA and P71 mRNA levels in yeast 
RNAI and RNA2 transcripts, with similar sizes to the HaSV genomic RNAs, were detected in 
total RNA extracts from yeast cells that were transformed with RNAl and RNA2 expression 
vectors (Figure 5.2, panels A and C). In addition, mRNA was detected in cells that carried a 
chromosomal copy of the P71 expression module (Figure 5.2, panel C). RT-PCR with 
primers specific for RNAI 5' and 3'ends demonstrated that most of the nucleotides at the 5' 
and 3 'ends of yeast-derived RNAI transcripts were present (Figure 5.3, panels A and B). An 
identical expression cassette to that of RNAl was used for the expression of RNA2 
(Figure 2.5). It is therefore highly likely that similar results would have been obtained for 
corresponding RT-PCR analyses on yeast-expressed RNA2 transcripts. 
The level of RNA I or RNA2 production was dependent on whether one or both of the RNA 
expression vectors were transformed into the cells (Figure 5.2, panels A and C). The P7l 
mRNA level remained constant irrespective of the presence, or absence, of one or both of 
these expression vectors (Figure 5.2, panel C). This indicated that the decreased production of 
RNA I and RNA2 transcripts could not be attributed to a depletion of factors that were 
required for PGALI-driven transcription. It is more likely that the cellular regulation of a 
specific copy number for ARS/CEN vectors (l or 2 per cell) led to the reduction of RNA I and 
RNA2 transcripts in cells that were transgenic for both RNAl and RNA2 (Clark and Carbon, 
1980). The copy number of an expression vector for a particular RNA transcript would be 
halved upon the introduction of an expression vector for another RNA transcript, resulting in a 
twofold reduction in the expression of each RNA transcript. 
The production of HaSV RNAI transcripts (which encode the viral replicase) did not result in 
a detectable level of viral RNA replication. The co-expression of RNA land RNA2 would 
have led to a much higher level of HaSV RNA transcripts if replication occurred. It was 
recently demonstrated that a functional FHV replication system in yeast amplified FHV RNA I 
transcripts 40- to ISO-fold above the levels produced by PGALI-directed transcription from 2~­
based vectors (Price et al., 2000). Instead, yeast cells that were induced for the co-production 
of HaSV RNAI and RNA2 transcripts produced fewer RNA2 transcripts than those induced 
for the production ofRNA2 alone (Figure 5.1 , panel C). 
These results do, however, not exclude the possibility that HaSV replication occurs in yeast, 
because a much longer time course for DNA-induced replication (4 days for FHV replication 
5-128 
in yeast) than that used for these experiments (4 hours) is required to determine if this is the 
case (Price et al. , 2000). However, the lack of detectable HaSV replication in various insect 
cell lines (Bawden et aI., 1999) and plant protoplasts (Gordon et al., 2001) makes it unlikely 
that HaSV replication could be maintained in the yeast expression system that was used in this 
study. 
5.4.2 The purification of HaSV particles 
In the previous chapter, it was proposed that the low yield of HaSV VLPs could be attributed 
to a shortage of sufficient amounts of viral RNA for encapsidation. VIp preparations from 
JRYI88::P71 and JRYI88::P 71; Rl cells, however, demonstrated that the co-expression of 
RNAl did not seem to have a significant effect on VLP production (Figure 5.5). It is probable 
that the increase in the cellular concentration of encapsidatable RNA was not sufficient for a 
detectable increase in VLP production. RNA2 was present at a higher concentration than P71 
mRNA in JRYI88::P71, RNA2 cells, but at a similar concentration to that of P71mRNA in 
JRYI88: :P71; RNA1, RNA2 cells (Figure 5.2, panel C). It could therefore be assumed that 
RNA2 was present at roughly double the concentration of P71 mRNA in JRYI88::P71, RNA2 
cells. There was probably a similar increase in the concentration of RNA I transcripts in 
JRYI88::P71; RNAl cells as compared to JRYI88::P71 cells. It is possible that this slight 
increase in encapsidatable RNA transcripts did not have a significant effect on the yield of the 
yeast-expressed HaSV particles. 
The protocol described for the purification ofVLPs from JRYI88::P71 cells (Figure 4.1 ) was 
modified for that from JR Y 188: :P71; RNA 1 , RNA2 cells by the addition of a pH reduction step 
prior to CsCl density gradient centrifugation. Western analysis of resultant CsCl density 
gradient fractions showed the presence of a protein with a slightly lower electrophoretic 
mobility than that of p64 (Figure 5.6, panel B). A number of lines of evidence indicated that, 
despite its lower electrophoretic mobility, the identity of this protein was yeast-expressed p64. 
(i) It is highly likely that the chemical composition of the yeast-derived preparation (e.g. the 
presence of CsCl) could have influenced the mobility of its protein constituents. (ii) Evidence 
for the pH-dependent maturation of JRYI88::P7l-derived procapsids was provided in the 
previous chapter (Figures 4.9 and 4.10). An identical protocol to the one that was used for 
JRYI88::P71-derived procapsids was used for preparations from JRYI88::P71; RNAl, RNA2 
cells, the only difference being that the pH-reduction step was introduced at an earlier stage in 
the protocol. It is therefore feasible to conclude that this protein, which clearly had a lower 
MR than p71 and a comparable MR to p64, was generated as a result of a pH-dependent 
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processing event analogous to the autoproteolysis of p71. (iii) The yeast-expressed protein 
was detected in CsCl density gradient fractions with similar densities to that of the published 
buoyant density of HaSV (Hanzlik et al. , 1993), suggesting that this protein was associated 
with HaSV viral or subviral particles, (iv) The detection of RNA 1 in one of these fractions 
(Figure 5,8) supported the hypothesis that this protein was associated with yeast-expressed 
HaSV particles, 
The detection of mature HaSV particles in virus preparations from zymolyase-treated cells 
was unexpected, since the pH was not reduced at any stage of this protocol (Figure 5,7). This 
implies that a reduction in pH subsequent to cell lysis was not responsible for the maturation 
of these particles. It is possible that a rapid increase in ionic strength could have been 
responsible for the ex vivo maturation of the HaSV particles, Canady et at. (2000) proposed 
that electrostatically driven structural rearrangements of arginine rich interior helical domains 
mediate the maturation of Nw V procapsids, During osmotic shock, a buffer with an 
ammonium sulphate concentration of 0,8M lyses the cellular membranes of spheroplasts 
(Figure 5.1), The sudden increase in ionic strength during osmotic shock could therefore have 
had an effect on ionic interactions within the interior helical domains of the HaSV provirions, 
resulting in structural rearrangement and maturation cleavage, Results from other virus 
preparations, where maturation was not observed subsequent to fluctuations in ionic strength, 
oppose this explanation, These include the exclusive production of immature VLPs from cells 
that were lysed in a buffer containing 250 mM NaCl, and the lack of maturation in CsCl 
concentrations of approximately J ,8 M during CsCl gradient ultracentrifugation 
(Figure 4.3, panel C; Figure 4,5, panel A; Figure 4.1 0, panel A; Figure 5,5, panels A and B), 
A more likely explanation is that maturation occurred in vivo as a result of a cellular response 
to zymolyase treatment. Apali from being suspended in a nutrient depleted solution during 
this treatment, the yeast cells would suffer extensive damage during spheroplast formation. 
Agrawal and Johnson (1995) demonstrated that the maturation of Nw V procapsids in insect 
cells coincided with cellular death and the subsequent release of virus particles from the cell. 
This suggested that certain physiological processes within these dying cells initiated 
maturation, It is possible that zymolyase treatment brought about a similar response within 
yeast cells, which in tum initiated the maturation of HaSV particles, 
The use of zymolyase treatment for cell breakage did not result in an improved yield of HaSV 
particles (Figure 5,6, panel A and Figure 5,7, panel A) but the removal of CsCl by way of 
5-J30 
ultracentrifugation instead of dialysis brought about a significant 111crease 111 this yield 
(Figure 5.7, panel B). 
S.4.3 Encapsidation and delivery of viral RNA by yeast-expressed HaSV particles 
The low yield of mature HaSV particles necessitated the use of a sensitive RT-PCR teclmique 
to obtain proof for the encapsidation of genomic RNA. The amplification of a faint band with 
RNAI-specific primers demonstrated that RNAI is encapsidated by the yeast-expressed 
particles (Figure 5.8). FW1her evidence for the encapsidation of genomic RNA strands came 
from the ability of yeast-expressed HaSV particles to cause impaired larval development when 
fed to H armigera larvae in bioassays. A significant proportion of the larvae that ingested the 
yeast-expressed HaSV pa11icles lagged one to two developmental stages behind uninfected 
larvae (Table 5.2). This type of a response is typical of larvae that were exposed to a low 
concentration of HaSV (Christian, P.D. , Dorrian, S.J., Gordon, K.H.J. and Hanzlik, T.N., 
unpublished results). It is possible that the absence of the 5' most G nucleotide could have 
had an effect on the virulence of the yeast-derived particles in this bioassay, because it has 
been demonstrated that replicase enzymes have a limited tolerance for sequence variations at 
the 5' ends of viral RNAs (Boyer and Haenni, 1994). However, RT-PCR analysis of RNA 
extractions from these larvae provided evidence that the growth retardation response was 
elicited by an HaSV infection (Figure 5.9). These reactions also demonstrated that the yeast-
expressed HaSV particles were able to deliver genomic RNA to its host cells. 
The above-described bioassay results were in agreement with bioassays that were performed 
on a separate laboratory colony of H armigera. The mean weight, in stead of the 
development, of larvae were scored in these bioassays, which showed that an HaSV 
preparation from yeast cells that were induced for 4 hours had a greater stunting effect that 
from cells that were induced overnight. These results were consistent with the observation 
that prolonged induction led to the proteolytic degradation ofp71 (Chapter3). 
There was a potential risk in the placement of cis-cleaving HC ribozymes behind the viral 
sequences in the expression vectors for RNAl and RNA2, because it could have inhibited the 
export of the HaSV RNA transcripts from the nucleus. This is due to the absence of poly-A 
tails, which are required for nuclear export (Huang and Carmichael, 1996). Proof for the 
encapsidation of RNA I transcripts, however, demonstrated that at least a fraction of these 
transcripts were exp0l1ed to the cytoplasm. The detection of a very low level of P7l 
expression in cells that were transgenic for RNA2 (Figure 3.15), also demonstrated that RNA 
transcripts were exported from the nucleus. 
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Gordon et al. (2001) demonstrated that the infectivity of HaS V RNA transcripts was sensitive 
to the presence of non-viral sequences at their 3' ends. It is thus very likely that the yeast-
expressed RNA transcripts, which were exported to the cytoplasm for virion assembly, were 
cleaved, because it was demonstrated that the yeast-expressed HaSV particles were infectious 
(Table 5.2). A probable explanation for the export of these transcripts to the cytoplasm is that 
ribozyme catalysis could have been inhibited by nuclear localization (as demonstrated by 
Tsuchihashi et aI. , 1993). Accordingly, most transcripts probably remained polyadenylated in 
the nucleus for efficient transport to the cytoplasm, where cleavage took place. 
On the whole, these results provided proof for flmctional HaSV capsid expression in yeast. 
The capsids were able to encapsidate viral nucleic acid, assemble into virions, specifically 
bind to the viral host cell and deliver genomic nucleic acid to this cell. This occurred in the 
absence of detectable replication, indicating that the assembly of HaSV in the cytoplasm was 
entirely reliant on the transcription of P71 mRNA and genomic RNA in the nucleus. At 
present, the only evidence for replication independent encapsidation of viral RNA, which were 
expressed in trans with a coat protein gene in yeast, was provided for BMV (Price et al., 
1999). This study is therefore the second example for this type of encapsidation in yeast, and 
the first for a tetravirus. 
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Conclusions 
The principal objective of this research was to develop a yeast-based expression system for the 
production of HaSV. To achieve this, conditions for the expression of HaSV components in 
yeast needed to be optimized and methods for the purification of this virus from yeast 
designed. Following from this, a number of hypotheses were generated. This chapter aims to 
elucidate these hypotheses and other key factors encountered during this research. 
6.1 Expression of P71 
To ensure optimal expression, P71 was expressed from chromosomal and episomal loci in two 
different strains of yeast. The highest level of expression was attained for chromosomal 
expression in JRYI88 3#20.1 cells and episomal expression in INVScI cells, which were 
transformed with the 2}l-plasmid pAV3. Low episomal expression levels in JRYI88 could 
have been due to the lack of genes for the stable propagation of 2}l-plasmids in its genome; 
while higher chromosomal expression levels for JR Y188 3#20.1, as compared to INVScI 
3#20.1, most probably reflected differences in the regulation of galactose metabolism between 
these strains. 
It was discovered that induction time played an essential role in the expression of this protein, 
since prolonged induction periods resulted in the disappearance of p71 in yeast cell lysates. 
This disappearance could probably not be attributed to the looping out of the P71 expression 
module from . the chromosome through homologous recombination, because it was 
demonstrated that the LEU2 selectable marker, which was used for the selection of the 
JRYI88::P71 strain, was not lost to the cell during induction. It is, however possible that 
recombination occurred at a position in the chromosomal selectable marker that led to the 
looping out of leu2 together with the P71 expression module. 
Loss of the P71 gene could not be attributed to the repression of PGALrdependent 
transcription, because no difference was detected in the growth of P71 + and P71- cells during 
induction. A reduced cell growth rate would have been expected for cells that could not 
catabolize galactose (their sole carbon source) due to the repression of the galactose utilization 
pathway. Alternative explanations include a reduced rate of p71 synthesis or an increased rate 
of p71 degradation. Evidence for the complete depletion of detectable p71 levels indicated 
that proteolytic degradation was at least partly responsible for the disappearance of this protein 
in yeast celllysates. 
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A large fraction of the yeast-expressed p71 was shown to be insoluble, which is indicative of 
the aggregation of these proteins within the yeast cell. There was only a minor increase in the 
solubility of this protein when cells were grown under conditions that led to a reduced rate of 
P71 expression. It is therefore not certain whether the insolubility of yeast-expressed p71 was 
due to the improper folding of p71 polypeptides in yeast, or the tendency of non-host-
produced capsid proteins to accumulate into insoluble protein aggregates. 
6.2 Assembly and maturation of yeast-expressed HaSV VLPs 
To determine whether p71 assembled into VLPs in yeast, virus preparations were carried out 
on cells that were induced for the expression of P71. It was found that PMSF was an essential 
constituent in buffers used during the lysis of yeast cells, since it protected soluble p71 
fractions against proteolytic degradation. Analyses on yeast-derived VLP preparations were 
indicative ofa very low yield ofVLPs from yeast. A small fraction of the total expressed p71 
had a similar buoyant density to that of HaSV. An even smaller fraction of the total expressed 
p71 could undergo pH-dependent cleavage into p64. A number of hypotheses could be 
proposed from these results: 
First, the detection of maturation provided evidence that the expression of P71 was sufficient 
for the assembly of HaSV procapsids in yeast. RT-PCR analyses on VLP preparations, 
however, failed to provide conclusive evidence for the specific encapsidation of P71 mRNA in 
yeast. This was probably due to the low amount ofVLPs (::0107 VLPs) in these preparations. 
Second, these results were the first evidence of a pH-dependence for the maturation of HaSV 
procapsids. Cleavage of p71 was not detected after a one week storage period at 4°C, in 
agreement with the theory that a drop in pH is required for the initiation thereof (Canady et aI., 
2000). It was detected when the pH of VLP preparations was dropped by the addition of 5 
volumes of70mM NaAc (pH 5). 
Third, maturation was only detected for particles with an identical buoyant density to that of 
HaSV. Taken that the buoyant densities of virus particles are relative to their RNA contents, 
this result demonstrated that, as in nodavirus procapsids (Schneemann et al., 1994), tetravirus 
procapsids are dependent on a certain complement of encapsidated RNA for maturation 
cleavage. The dependence on RNA for maturation was not only observed for VLPs that were 
derived from JRYI88::P71 cells, but also for HaSV preparations from JRYI88::P71; Rl, R2 
cells. Cheng et al. (1994) proposed that the close proximity of RNA molecules to the 
cleavage sites within nodavirus capsids could increase the rate of the cleavage reaction. The 
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phosphates of the RNA could polarize water molecules for the nucleophilic attack on the 
carbonyl group of the scissile peptide bond at each of the cleavage sites. During the tetraviral 
cleavage phase, autocatalytic cleavage events with similar mechanisms occur at similar 
geometrical locations to those of nodaviruses (Munshi et aI., 1996). It is therefore possible 
that the results obtained for the maturation of yeast-derived HaSV VLPs identified a similar 
role for tetraviral RNA during the cleavage phase. 
Fourth, a certain complement of encapsidated RNA also seemed to be required for the 
assembly of stable procapsids. The majority of the p71 detected in VLP and virus 
preparations from JRYI88::P71 and JRYI88::P71; Rl , R2 cells, respectively, were shown to 
be unstable, since it became insoluble subsequent to CsCI density gradient centrifugation and 
precipitated from solution upon a reduction in pH. The only capsid proteins (P71 or p64) that 
remained soluble prior to CsCI density gradient centrifugation and pH reduction were found in 
fractions with similar buoyant densities to that of HaSV. It was therefore demonstrated that 
the encapsidation of a certain complement of RNA was not only required for maturation, but 
also for the assembly of stable HaSV procapsids. These results are in agreement with a 
proposal by Agrawal and Johnson (1995) that the highly charged inner surfaces of tetravirus 
particles need to be neutralized by encapsidated RNA for the assembly of stable VLPs. 
6.3 Expression of RNA1 and RNA2 
The RNAl and RNA2 expression cassettes contained an exact fusion between PGAL! and the 5' 
end of the viral RNA, and the ToRSV hairpin cassette ribozyme directly behind the last 
nucleotide of viral sequence. It was demonstrated that RNA transcripts with similar sizes to 
the HaSV genomic RNAs were expressed from these cassettes (through Northern blot 
analyses) and that most of the nucleotides at the 5' and 3' ends of yeast-derived RNAI 
transcripts were present (through RT-PCR analyses). Similar results were expected for 
corresponding RT-PCR analyses on yeast-expressed RNA2 transcripts, because an identical 
expression cassette to that of RNAl was used for the expression of RNA2. It was also 
demonstrated that at least a fraction of the RNA transcripts were exported to the cytoplasm 
through (a) the detection of a very low level of P7l expression in cells that were transgenic for 
RNA2, and (b) prooffor the encapsidation and delivery of RNA transcripts. 
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6.4 Production of infectious HaSV particles from yeast 
6.4.1 Development of protocols for the .purification of HaS V from yeast 
Two different protocols were developed for the purification of mature HaSV particles from 
yeast cells. In one protocol, the cells were mechanically ruptured by glass bead 
homogenization, and the provirions were matured by way of a reduction in pH. In the other, 
the cells were enzymatically converted to spheroplasts (by zymolyase) and then lysed by a 
combination of Dounce homogenization and osmotic shock. In both these protocols, 
purification was achieved through the application of sucrose cushion centrifugation and CsCI 
density gradient centrifugation. The application of ultracentrifugation was shown to be 
preferable to dialysis for the dual purposes of CsCI removal from, and concentration of, HaSV 
particles. 
The purification of mature HaSV particles by way of the zymolyase-treatment protocol was an 
unexpected result because the pH was not reduced at any stage of this procedure. The 
maturation of these palticles could either have occurred ex vivo or in vivo. Ex vivo maturation 
could have been the result of a rapid increase in ionic strength during osmotic shock, which 
involved the addition of 0.8 M ammonium sulphate to yeast spheroplasts. However, the 
addition of solutions with high NaCI (0.25 M) and CsCI (- 1.8 M) concentrations to yeast cell 
lysates and VLP preparations, respectively, did not induce VLP maturation. A more likely 
explanation is that the maturation of these particles occurred in vivo as a result of a cellular 
response to the damaging effects of, or starvation effects during, zymolyase treatment. 
Stresses associated with this treatment could have triggered a physiological response that 
brought about the maturation of the HaSV particles. 
Agrawal and Johnson (1995) demonstrated that Nro V procapsids matured in vivo III 
baculoviral infected insect cells. Pulse-chase experiments revealed that maturation coincided 
with the death (and lysis) of these insect cells, suggesting that the cellular milieu in a dying 
cell could induce maturation. It is possible that these dying cells underwent apoptosis, based 
on a correlation between the rate of sloughing and the apoptotic activity in the sloughed cells 
in all HaSV -infected midgut (Hanzlik and Gordon, 1997). During apoptosis, mitochondrial 
membranes become progressively more leaky, resulting in a drop in the cellular pH (Shrode et 
aI., 1997). Apoptosis could therefore have been responsible for the pH-dependent maturation 
of the heterologously expressed Nro V procapsids in the above-described experiment. 
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According to Madeo et al. (1997) an S. cerevisiae cell cycle gene mutant could show the 
phenotypic markers of apoptosis, i.e. DNA fragmentation, chromatin condensation and 
exposure of phosphatidyl serine at the outer layer of the cytoplasmic membrane. In yeast, 
reactive oxygen species (ROS), e.g. O2', H20 2 and OH', function as the endogenous regulators 
of apoptosis (Madeo et at. 1999). ROS are normal bypro ducts of respiration. It has therefore 
been proposed that a specific modulation of the respiratory chain of yeast cells could produce 
an increased cellular concentration of ROS, which could serve as a trigger for apoptosis 
(Frolich and Madeo, 2000). Yeast cells could therefore be capable of "cellular suicide" under 
unfavourable conditions. An example of a potential advantage for cellular suicide would be 
the death of the majority of yeast cells in a nutrient depleted medium (as described by Longo 
et al., 1997), which would spare the diminishing nutrients for healthier cells. 
In the work described in this thesis, yeast cells were suspended in a nutrient depleted solution 
during zymolyase treatment and suffered extensive damage during spheroplast formation. 
Taken that tetraviral maturation could be dependent on apoptosis, it is therefore not 
unreasonable to propose that maturation could have been a direct result of apoptosis during 
zymolyase treatment. 
6.4.2 Proof for concept of non-host-produced HaSV 
The characterization of HaSV preparations was hindered by the very low yield of viral 
particles. This necessitated the use of numerous preparations from large volumes of yeast 
cultures to produce enough material for analyses. The detection and characterization of yeast-
expressed HaSV particles was, in turn, reliant on the application of very sensitive techniques, 
such as immunoblotting, RT-PCR and droplet feed bioassays: A number of lines of evidence 
provided support for the concept of the non-host production of infectious HaSV particles from 
yeast: 
First, p64-containing particles with identical buoyant densities to HaSV were purified from 
yeast that was transgenic for P71, RNAI and RNA2. Second, it was demonstrated that these 
particles contained genomic RNA transcripts, which were expressed in trans with P7I . Third, 
the yeast-expressed particles caused impaired larval development when fed to H armigera 
larvae from two separate laboratory colonies and fourth, the presence of HaSV in these larvae 
was detected by RT-PCR-analyses. 
Proof for the encapsidation of viral genomic RNA, expressed in trans with a capsid protein 
gene in a yeast expression system, has only been reported for two other ssRNA+ viruses, 
BMV and FHV (Price et al., 1999), which belong to the Bromoviridae and Nodaviridae 
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families, respectively. Proof for the expression of infectious ssRNA+ viruses in yeast has, in 
tum, only been repOlied for FHV (Price et al., 1996, Price et al., 1999). The work described 
in this thesis is therefore the first repOli on the expression of infectious tetravirus particles in 
yeast. Comparisons between the RNA2 levels in cells co-expressing RNA1 and RNA2 and 
those expressing RNA2 alone, demonstrated that the expression of RNA 1 did not result in any 
detectable levels of viral RNA replication. This suggests that the HaSV particles assembled in 
yeast in the absence of viral replication. 
6.5 Future research 
The principal objective of this project was achieved since it was shown that infectious HaSV 
paliicles could be assembled in yeast. However, a great deal of work still needs to be done to 
reach the ultimate goal, i.e. the development of an expression system for the large-scale 
production of this vi IUS as a biopesticide. At the outset, this work should focus on: 
(a) alternative strategies for the expression of infectious HaSV particles in yeast, because it 
was demonstrated that a very low amount of HaSV was attained by the expression strategy 
that was used in this study, and (b) the characterization of the products of expression, 
including the viral components (p71, RNAI and RNA2) and the VilUS or virus-like particles. 
The main objective of the latter studies would be to demonstrate that the heterologously 
expressed HaSV paliicles are biochemically equivalent to wild-type virions. This would be 
done to satisfy some of the stringent quality and safety standards for the commercial 
application of recombinant products (Eckart and Bussineau, 1996). If the yeast-derived 
particles are shown to be of sufficient quality, the expression system could be scaled up to a 
laboratory-scale fermentation process and the expression products could be tested in insect 
bioassays and small-scale field trials. Ultimately, these studies could lead to the development 
of a large-scale industrial fermentation process for HaSV, which has a great potential to 
become an effective biological control agent against H armigera. 
Proposed research, for the studies described in points (a) and (b) above, are presented in the 
remaining paragraphs of this dissertation: 
6.5.1 The use of a dual promoter expression system for the production of HaSV 
Genomic RNA is required for the assembly of nodavirus capsids and the nodaviral capsid 
protein precursors can therefore not assemble into empty VLPs, which are devoid of any RNA 
(Schneemann et al., 1994). As a consequence, an excess of RNA is expressed in infected cells 
to ensure an optimal yield of virions (i.e. the expression of the capsid protein precursor is the 
rate-limiting step for nodavilUs assembly) (Gallagher and Rueckert, 1988). According to 
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Bawden et al. (1999), tetravirus RNA replication most probably occurs exclusively in the 
early stages in an infected cell, while capsid protein precursor synthesis and particle assembly 
occurs later. It is therefore likely that capsid protein precursor synthesis is also the rate-
limiting step for the assembly of tetraviruses, 
This hypothesis is consistent with results for the baculoviral expression of the Nw V capsid 
protein precursor (Agrawal and Johnson, 1995). The resultant VLPs were shown to be 
morphologically identical to wild-type virions and no empty VLPs were detected. The results 
obtained for the expression of P71 (in this study) are also in agreement with this hypothesis, 
because they led to the proposal (explained above) that there was a requirement for a certain 
complement of encapsidated RNA for the assembly of stable HaSV procapsids. It is therefore 
highly probable that the low yield of virus and virus-like particles from yeast was due to a 
shortage of sufficient levels of RNA for encapsidation during assembly. 
The amount of yeast-derived HaSV particles could possibly be increased though the 
implementation of a dual promoter expression system to reproduce the time-course for the 
synthesis of the viral RNAs and p71 in HaSV -infected cells. In such a system, the HaSV 
RNA1 and RNA2 transcripts would be produced up to a high cellular concentration prior to 
the induction of P71 expression through the use of two different S. cerevisiae promoters. The 
transcription of the HaSV RNAs could either be under the control of a constitutive promoter, 
e.g, the glyceraldehyde-3-phosphate-dehydrogenase promoter (PGAPDH) (Rosenberg et al., 
1990), or an inducible promoter, e.g. one of the galactose-inducible promoters (e.g. PGALI) 
(Johnston, 1987), the alcohol dehydrogenase 2 promoter (PADHl) (Price et al., 1990) and the 
copper metallothionein promoter (Peup,) (Etcheverry, 1990). It is essential that an 'inducible 
promoter (other that the one used for the transcription of the viral RNAs) should be used for 
P71 expression, because p71 was shown to be unstable in yeast (Chapter 3). 
Based on this proposal, an ARS/CEN expression vector that places the transcription of HaSV 
RNA2 under the control of P ADH2 was constructed in our laboratory (Tomasicchio, 2001). The 
following strategy has been devised for a dual promoter expression system with P ADH2 (for 
RNA2) and PGALI (for P71): 
• Grow a P71 + yeast strain, which is transformed with above-described expression vector, to 
midlog phase in a medium with a high concentration of glucose (P GALl and P ADH2 are both 
tightly repressed by glucose) (Gancedo, 1998; Price et al., 1990). 
• Transfer the cells to a medium with a very low concentration of glucose for the induction 
of P ADHl - dependent transcription of RNA2 and grow until an optimal level of cellular 
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RNA2 is detected (P ADH2 becomes derepressed to a high level upon the depletion of 
glucose, and a very low level ofPcAL!- dependent transcription is expected when cells are 
grown in a medium with depleted levels of glucose) (Gancedo, 1998; Price et al., 1990). 
• Add galactose to the medium for the PCAL! - dependent expression of P7I. 
If it is demonstrated that this dual promoter expression system could lead to a significant 
increase in the amount of yeast-expressed VLPs, a similar expression system for the 
production of both of the viral RNA transcripts (using PADH2) and p71 (using PCAL!) could be 
implemented for the production of HaSV particles. 
6.5.2 The production of mature HaSV particles from apoptotic yeast cells 
It has recently been demonstrated that an apoptotic response could be induced by the addition 
of low concentrations of H20 2 to yeast cell cultures (Madeo et ai, 1999). The ability to induce 
apoptosis in yeast presents a unique opportunity to determine if apoptosis is indeed 
responsible for the maturation of tetraviral capsids. In this study, it was demonstrated that no 
mature HaSV particles were assembled in yeast that were lysed by glass bead homogenization 
and that ex vivo maturation was required for the production of infectious virus p8.!iicles. 
Yeast cells, induced for the expression of HaSV, could therefore be treated with H20 2 (as 
described by Madeo et aI., 1999) to determine if the induction of apoptosis could circumvent 
the requirement for ex vivo maturation for the production of infectious HaSV particles. 
6.5.3 The use of virus-free yeast strains for the production of HaS V 
The purification of HaSV VLPs and virus particles from yeast was complicated by 
endogenous yeast virus particles, which co-purified with these particles in CsCI density 
gradient fractions (Chapter 4). These particles were tentatively identified as S. cerevisiae L-A 
virus p8.!iicles, double-stranded RNA viruses with a similar diameter (40nm) to that of HaSV 
(Wiclmer, 1996). A yeast strain that is free from any endogenous viruses would be more 
suitable for the expression of HaSV. Two yeast strains, which lack any dsRNA viruses, have 
been acquired from Prof. Manfred J. Schmitt (Department of Microbiology, UniversiUit des 
Saarlandes, Germany). Virus preparations from these strains could be subjected to TEM 
analysis in order to determine if the endogenous virus particles, which were visualized in our 
VLPs prep8.!·ations, were in fact yeast double-str8.!1ded RNA viruses. 
6.5.4 Analyses on yeast-expressed RNA! and RNA2 transcripts 
In this study, NOlihern analyses were used to demonstrate that RNA! and RNA2 transcripts 
with similar sizes to that of the respective HaSV genomic RNAs were transcribed from yeast 
expression cassettes. These expression cassettes were, however, designed to tr8.!1scribe 
6-141 
transcripts with natural 5' and 3' ends. More specific techniques like pnmer extension 
analyses (for the 5' ends) and RNase protection assays (for the 3' ends) could be used to 
determine if these transcripts are identical to the viral genomic RNAs. 
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I Appendix 1 Complete sequence of the HaSV genome 
1 Met Tyr Ala Lys 
1 GUUCUGCCUC CCCCGGACGG UAAAUAUAGG GGAACA AUG UAC GCG AAA 
5 Ala Thr Asp Val Ala Arg Val Tyr Ala Ala Ala Asp Val Ala 
49 GCG ACA GAC GUG GCG CGU GUC UAC GCC GCG GCA GAU GUC GCC 
19 Tyr Ala Asn Val Leu Gln Gln Arg Ala Val Lys Leu Asp Phe 
91 UAC GCG AAC GUA CUG CAG CAG AGA GCA GUC AAG UUG GAC UUC 
33 Ala Pro Pro Leu Lys Ala Leu Glu Thr Leu His Arg Leu Tyr 
133 GCC CCG CCA CUG AAG GCA CUA GAA ACC CUC CAC AGA CUG UAC 
47 Tyr Pro Leu Arg Phe Lys Gly Gly Thr Leu Pro Pro Thr Gln 
175 UAU CCG CUG CGC UUC AAA GGG GGC ACU UUA CCC CCG ACA CAA 
61 His Pro Ile Leu Ala Gly His Gln Arg Val Ala Glu Glu Val 
217 CAC CCG AUC CUG GCC GGG CAC CAA CGU GUC GCA GAA GAG GUU 
75 Leu His Asn Phe Ala Arg Gly Arg Ser Thr Val Leu Glu Ile 
259 CUG CAC AAU UUC GCC AGG GGA CGU AGC ACA GUG CUC GAG AUA 
89 Gly Pro Ser Leu His Ser Ala Leu Lys Leu His Gly Ala Pro 
301 GGG CCG UCU CUG CAC AGC GCA CUU AAG CUA CAU GGG GCA CCG 
103 Asn Ala Pro Val Ala Asp Tyr His Gly Cys Thr Lys Tyr Gly 
343 AAC GCC CCC GUC GCA GAC UAU CAC GGG UGC ACC AAG UAC GGC 
117 Thr Arg Asp Gly Ser Arg His Ile Thr Ala Leu Glu Ser Arg 
385 ACC CGC GAC GGC UCG CGA CAC AUU ACG GCC UUA GAG UCU AGA 
131 Ser Val Ala Thr Gly Arg Pro Glu Phe Lys Ala Asp Ala Ser 
427 UCC GUC GCC ACA GGC CGG CCC GAG UUC AAG GCC GAC GCC UCA 
145 Leu Leu Ala Asn Gly Ile Ala Ser Arg Thr Phe Cys Val Asp 
469 CUG CUC GCC AAC GGC AUU GCC UCC CGC ACC UUC UGC GUC GAC 
159 Gly Val Gly Ser Cys Ala Phe Lys Ser Arg Val Gly Ile Ala 
511 GGA GUC GGC UCU UGC GCG UUC AAA UCG CGC GUU GGA AUU GCC 
173 Asn His Ser Leu Tyr Asp Val Thr Leu Glu Glu Leu Ala Asn 
553 AAU CAC UCC CUC UAU GAC GUG ACC CUA GAG GAG CUG GCC AAU 
Figure Al.I RNA sequence of HaSV RNAI (Genome sequence accession number: UI8246). 
The amino acid sequence of the replicase gene is shown above the sequence. 
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Ala Phe Glu Asn His Gly Leu Hi s Met Val Arg Ala Phe Met 
GCG UUU GAG AAC CAC GGA CUU CAC AUG GUC CGC GCG UUC AUG 
His Met Pro Glu Glu Leu Leu Tyr Met Asp Asn Val Val Asn 
CAC AUG CCA GAA GAG CUG CUC UAC AUG GAC AAC GUG GUU AAU 
Ala Glu Leu Gly Tyr Arg Phe His Val Ile Glu Glu Pro Met 
GCC GAG CUC GGC UAC CGC UUC CAC GUU AUU GAA GAG CCU AUG 
Ala Val Lys Asp Cys Ala Phe Gin Gly Gly Asp Leu Ar g Leu 
GCU GUG AAG GAC UGC GCA UUC CAG GGG GGG GAC CUC CGU CUC 
His Phe Pro Glu Leu Asp Phe Ile Asn Glu Ser Gin Glu Arg 
CAC UUC CCU GAG UUG GAC UUC AUC AAC GAG AGC CAA GAG CGG 
Arg Ile Glu Arg Leu Ala Ala Arg Gly Ser Tyr Ser Arg Arg 
CGC AUC GAG AGG CUG GCC GCC CGC GGC UCC UAC UCC AGA CGC 
Ala Val Ile Phe Ser Gly Asp Asp Asp Trp Gly Asp Ala Tyr 
GCC GUC AUU UUC UCC GGC GAC GAC GAC UGG GGU GAU GCG UAC 
Leu His Asp Phe His Thr Trp Leu Ala Tyr Leu Leu Val Arg 
UUA CAC GAC UUC CAC ACA UGG CUC GCC UAC CUA CUG GUG AGG 
Asn Tyr Pro Thr Pro Phe Gly Phe Ser Leu His Ile Glu Val 
AAC UAC CCC ACU CCG UUU GGU UUC UCA CUC CAU AUA GAA GUC 
Gin Arg Arg His Gly Ser Ser Ile Glu Leu Arg Ile Thr Arg 
CAG AGG CGC CAC GGC UCC AGC AUU GAG CUG CGC AUC ACU CGC 
Ala Pro Pro Gly Asp Arg Met Leu Ala Val Val Pro Arg Thr 
GCG CCA CCU GGA GAC CGC AUG CUG GCC GUC GUC CCA AGG ACG 
Ser Gin Gly Leu Cys Arg Ile Pro Asn Ile Phe Tyr Tyr Ala 
UCC CAA GGC CUC UGC AGA AUC CCA AAC AUC UUU UAU UAC GCC 
Asp Ala Ser Gly Thr Glu His Lys Thr Ile Leu Thr Ser Gin 
GAC GCG UCG GGC ACU GAG CAU AAG ACC AUC CUU ACG UCA CAG 
His Lys Val Asn Met Leu Leu Asn Phe Met Gin Thr Arg Pro 
CAC AAA GUC AAC AUG CUG CUC AAU UUU AUG CAA ACG CGU CCU 
Glu Lys Glu Leu Val Asp Met Thr Val Leu Met Ser Phe Ala 
GAG AAG GAA CUA GUC GAC AUG ACC GUC UUG AUG UCG UUC GCG 
Arg Ala Arg Leu Arg Ala Ile Val Val Ala Ser Glu Val Thr 
CGC GCU AGG CUG CGC GCG AUC GUG GUC GCC UCA GAA GUC ACC 
Glu Ser Ser Trp Asn Ile Ser Pro Ala Asp Leu Val Arg Thr 
GAG AGC UCC UGG AAC AUC UCA CCG GCU GAC CUG GUC CGC ACU 
Figure Al. I Continued ... 
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Val Val Ser Leu Tyr Val Leu His Ile Ile Glu Arg Arg Arg 
GUC GUG UCU CUU UAC GUC CUC CAC AUC AUC GAG CGC CGA AGG 
Ala Ala Val Ala Val Lys Thr Ala Lys Asp Asp Val Phe Gly 
GCU GCG GUC GCU GUC AAG ACC GCC AAG GAC GAC GUC UUU GGA 
Glu Thr Ser Phe Trp Glu Ser Leu Lys His Val Leu Gly Ser 
GAG ACU UCG UUC UGG GAG AGU CUC AAG CAC GUC UUG GGC UCC 
Cys Cys Gly Leu Arg Asn Leu Lys Gly Thr Asp Val Val Phe 
UGU UGC GGU CUG CGC AAC CUC AAA GGC ACC GAC GUC GUC UUU 
Thr Lys Arg Val Val Asp Lys Tyr Arg Val His Ser Leu Gly 
ACU AAG CGC GUC GUC GAU AAG UAC CGA GUC CAC UCG CUC GGA 
Asp Ile Ile Cys Asp Val Arg Leu Ser Pro Glu Gln Val Gly 
GAC AUA AUC UGC GAC GUC CGC CUG UCC CCU GAA CAG GUC GGC 
Phe Leu Pro Ser Arg Val Pro Pro Ala Arg Val Phe His Asp 
UUC CUG CCG UCC CGC GUA CCA CCU GCC CGC GUC UUU CAC GAC 
Arg Glu Glu Leu Glu Val Leu Arg Glu Ala Gly Cys Tyr Asn 
AGG GAA GAG CUU GAG GUC CUU CGC GAA GCU GGC UGC UAC AAC 
Glu Arg Pro Val Pro Ser Thr Pro Pro Val Glu Glu Pro Gln 
GAA CGU CCG GUA CCU UCC ACU CCU CCU GUG GAG GAG CCC CAA 
Gly Phe Asp Ala Asp Leu Trp His Ala Thr Ala Ala Ser Leu 
GGU UUC GAC GCC GAC UUG UGG CAC GCG ACC GCG GCC UCA CUC 
Pro Glu Tyr Arg Ala Thr Leu Gln Ala Gly Leu Asn Thr Asp 
CCC GAG UAC CGC GCC ACC UUG CAG GCA GGU CUC AAC ACC GAC 
Val Lys Gln Leu Lys Ile Thr Leu Glu Asn Ala Leu Lys Thr 
GUC AAG CAG CUC AAG AUC ACC CUC GAG AAC GCC CUC AAG ACC 
Ile Asp Gly Leu Thr Leu Ser Pro Val Arg Gly Leu Glu Met 
AUC GAC GGG CUC ACC CUC UCC CCA GUC AGA GGC CUC GAG AUG 
Tyr Glu Gly Pro Pro Gly Ser Gly Lys Thr Gly Thr Leu Ile 
UAC GAG GGC CCG CCA GGC AGC GGC AAG ACG GGC ACC CUC AUC 
Ala Ala Leu Glu Ala Ala Gly Gly Lys Ala Leu Tyr Val Ala 
GCC GCC CUU GAG GCC GCG GGC GGU AAA GCA CUU UAC GUG GCA 
Pro Thr Arg Glu Leu Arg Glu Ala Met Asp Arg Arg Ile Lys 
CCC ACC AGA GAA CUG AGA GAG GCU AUG GAC CGG CGG AUC AAA 
Pro Pro Ser Ala Ser Arg Thr Gln His Val Ala Leu Ala Ile 
CCG CCG UCC GCC UCG CGU ACG CAA CAU GUC GCC CUU GCG AUU 
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Leu Arg Arg Ala Thr Ala Glu Gly Ala Pro Phe Ala Thr Val 
CUC CGU CGU GCC ACC GCC GAG GGC GCC CCU UUC GCU ACC GUG 
Val lIe Asp Glu Cys Phe Met Phe Pro Leu Val Tyr Val Ala 
GUU AUC GAC GAG UGC UUC AUG UUC CCG CUC GUG UAC GUC GCG 
lIe Val His Ala Leu Ber Pro Ber Ber Arg lIe Val Leu Val 
AUC GUG CAC GCC UUG UCC CCG AGC UCA CGA AUA GUC CUU GUA 
Gly Asp Val His GIn lIe Gly Phe lIe Asp Phe GIn Gly Thr 
GGG GAC GUC CAC CAA AUC GGG UUU AUA GAC UUC CAA GGC ACA 
Ber Ala Asn Met Pro Leu Val Arg Asp Val Val Lys GIn Cys 
AGC GCG AAC AUG CCG CUC GUU CGC GAC GUC GUU AAG CAG UGC 
Arg Arg Arg Thr Phe Asn GIn Thr Lys Arg Cys Pro Ala Asp 
CGU CGG CGC ACU UUC AAC CAA ACC AAG CGC UGU CCG GCC GAC 
Val Val Ala Thr Thr Phe Phe GIn Ber Leu Tyr Pro Gly Cys 
GUC GUU GCC ACC ACG UUU UUC CAG AGC UUG UAC CCC GGG UGC 
Thr Thr Thr Ber Gly Cys Val Ala Ber lIe Ber His Val Ala 
ACA ACC ACC UCA GGG UGC GUC GCA UCC AUC AGC CAC GUC GCC 
Pro Asp Tyr Arg Asn Ber GIn Ala GIn Thr Leu Cys Phe Thr 
CCA GAC UAC CGC AAC AGC CAG GCG CAA ACG CUC UGC UUC ACG 
GIn Glu Glu Lys Ber Arg His Gly Ala Glu Gly Ala Met Thr 
CAG GAG GAA AAG UCG CGC CAC GGG GCU GAG GGC GCG AUG ACU 
Val His Glu Ala GIn Gly Arg Thr Phe Ala Ber Val lIe Leu 
GUG CAC GAA GCG CAG GGA CGC ACU UUU GCG UCU GUC AUU CUG 
His Tyr Asn Gly Ber Thr Ala Glu GIn Lys Leu Leu Ala Glu 
CAU UAC AAC GGC UCC ACA GCA GAG CAG AAG CUC CUC GCU GAG 
Lys Ber His Leu Leu Val Gly lIe Thr Arg His Thr Asn His 
AAG UCG CAC CUU CUA GUC GGC AUC ACG CGC CAC ACC AAC CAC 
Leu Tyr lIe Arg Asp Pro Thr Gly Asp lIe Glu Arg GIn Leu 
CUG UAC AUC CGC GAC CCG ACA GGU GAC AUU GAG AGA CAA CUC 
Asn His Ber Ala Lys Ala Glu Val Phe Thr Asp lIe Pro Ala 
AAC CAU AGC GCG AAA GCC GAG GUG UUU ACA GAC AUC CCU GCA 
Pro Leu Glu lIe Thr Thr Val Lys Pro Ber Glu Glu Val GIn 
CCC CUG GAG AUC ACG ACU GUC AAA CCG AGU GAA GAG GUG CAG 
Arg Asn Glu Val Met Ala Thr lIe Pro Pro GIn Ber Pro Thr 
CGC AAC GAA GUG AUG GCA ACG AUA CCC CCG CAG AGU CCC ACG 
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Pro His Gly Ala lIe His Leu Leu Arg Lys Asn Phe Gly Asp 
CCG CAC GGA GCA AUC CAU CUG CUC CGC AAG AAC UUC GGG GAC 
GIn Pro Asp Cys Gly Cys Val Ala Leu Ala Lys Thr Gly Tyr 
CAA CCC GAC UGU GGC UGU GUC GCU UUG GCG AAG ACC GGC UAC 
Glu Val Phe Gly Gly Arg Ala Lys lIe Asn Val Glu Leu Ala 
GAG GUG UUU GGC GGU CGU GCC AAA AUC AAC GUA GAG CUU GCC 
Glu Pro Asp Ala Thr Pro Lys Pro His Arg Ala Phe GIn Glu 
GAA CCC GAC GCG ACC CCG AAG CCG CAU AGG GCG UUC CAG GAA 
Gly Val GIn Trp Val Lys Val Thr Asn Ala Ser Asn Lys His 
GGG GUA CAG UGG GUC AAG GUC ACC AAC GCG UCU AAC AAA CAC 
GIn Ala Leu GIn Thr Leu Leu Ser Arg Tyr Thr Lys Arg Ser 
CAG GCG CUC CAG ACG CUG UUG UCC CGC UAC ACC AAG CGA AGC 
Ala Asp Leu Pro Leu His Glu Ala Lys Glu Asp Val Lys Arg 
GCU GAC CUG CCG CUA CAC GAA GCU AAG GAG GAC GUC AAA CGC 
Met Leu Asn Ser Leu Asp Arg His Trp Asp Trp Thr Val Thr 
AUG CUA AAC UCG CUU GAC CGA CAU UGG GAC UGG ACU GUC ACU 
Glu Asp Ala Arg Asp Arg Ala Val Phe Glu Thr GIn Leu Lys 
GAA GAC GCC CGU GAC CGA GCU GUC UUC GAG ACC CAG CUC AAG 
Phe Thr GIn Arg Gly Gly Thr Val Glu Asp Leu Leu Glu Pro 
UUC ACC CAA CGC GGC GGC ACC GUC GAA GAC CUG CUG GAG CCA 
Asp Asp Pro Tyr lIe Arg Asp lIe Asp Phe Leu Met Lys Thr 
GAC GAC CCC UAC AUC CGU GAC AUA GAC UUC CUU AUG AAG ACU 
GIn GIn Lys Val Ser Pro Lys Pro lIe Asn Thr Gly Lys Val 
CAG CAG AAA GUG UCG CCC AAG CCG AUC AAU ACG GGC AAG GUC 
Gly GIn Gly lIe Ala Ala His Ser Lys Ser Leu Asn Phe Val 
GGG CAG GGG AUC GCC GCU CAC UCA AAG UCU CUC AAC UUC GUC 
Leu Ala Ala Trp lIe Arg lIe Leu Glu Glu lIe Leu Arg Thr 
CUC GCC GCU UGG AUA CGC AUA CUC GAG GAG AUA CUC CGU ACC 
Gly Ser Arg Thr Val Arg Tyr Ser Asn Gly Leu Pro Asp Glu 
GGG AGC CGC ACG GUC CGG UAC AGC AAC GGU CUC CCC GAC GAA 
Glu Glu Ala Met Leu Leu Glu Ala Lys Ile Asn GIn Val Pro 
GAA GAG GCC AUG CUG CUC GAA GCG AAG AUC AAU CAA GUC CCA 
His Ala Thr Phe Val Ser Ala Asp Trp Thr Glu Phe Asp Thr 
CAC GCC ACG UUC GUC UCG GCG GAC UGG ACC GAG UUU GAC ACC 
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Ala His Asn Asn Thr Ser Glu Leu Leu Phe Ala Ala Leu Leu 
GCC CAC AAU AAC ACG AGU GAG CUG CUC UUC GCC GCC CUU UUA 
Glu Arg Ile Gly Thr Pro Ala Ala Ala Val Asn Leu Phe Arg 
GAG CGC AUC GGC ACG CCU GCA GCU GCC GUU AAU CUA UUC AGA 
Glu Arg Cys Gly Lys Arg Thr Leu Arg Ala Lys Gly Leu Gly 
GAA CGG UGU GGG AM CGC ACC UUG CGA GCG AAG GGU CUA GGC 
Ser Val Glu Val Asp Gly Leu Leu Asp Ser Gly Ala Ala Trp 
UCC GUU GAA GUC GAC GGU CUG CUC GAC UCC GGC GCA GCU UGG 
Thr Pro Cys Arg Asn Thr Ile Phe Ser Ala Ala Val Met Leu 
ACG CCU UGC CGC AAC ACC AUC UUC UCU GCC GCC GUC AUG CUC 
Thr Leu Phe Arg Gly Val Lys Phe Ala Ala Phe Lys Gly Asp 
ACG CUC UUC CGC GGC GUC AAG UUC GCA GCU UUC AM GGC GAC 
Asp Ser Leu Leu Cys Gly Ser His Tyr Leu Arg Phe Asp Ala 
GAC UCG CUC CUC UGU GGU AGC CAU UAC CUC CGU UUC GAC GCU 
Ser Arg Leu His Met Gly Glu Arg Tyr Lys Thr Lys His Leu 
AGC CGC CUU CAC AUG GGC GAA CGU UAC AAG ACC AM CAU UUG 
Lys Val Glu Val Gln Lys Ile Val Pro Tyr Ile Gly Leu Leu 
AAG GUC GAG GUG CAG AM AUC GUG CCG UAC AUC GGA CUC CUC 
Val Ser Ala Glu Gln Val Va l Leu Asp Pro Val Arg Ser Ala 
GUC UCC GCU GAG CAG GUC GUC CUC GAC CCU GUC AGG AGC GCU 
Leu Lys Ile Phe Gly Arg Cys Tyr Thr Ser Glu Leu Leu Tyr 
CUC AAG AUA UUU GGG CGC UGC UAC ACA AGC GAA CUC CUU UAC 
Ser Lys Tyr Val Glu Ala Val Arg Asp Ile Thr Lys Gly Trp 
UCC AAG UAC GUG GAG GCU GUG AGA GAC AUC ACC AAG GGC UGG 
Ser Asp Ala Arg Tyr His Ser Leu Leu Cys His Met Ser Ala 
AGU GAC GCC CGC UAC CAC AGC CUC CUG UGC CAC AUG UCA GCA 
Cys Tyr Tyr Asn Tyr Ala Pro Glu Ser Ala Ala Tyr Ile Ile 
UGC UAC UAC AAU UAC GCG CCG GAG UCU GCG GCG UAC AUC AUC 
Asp Ala Val Val Arg Phe Gly Arg Gly Asp Phe Pro Phe Glu 
GAC GCU GUU GUU CGC UUU GGG CGC GGC GAC UUC CCG UUU GAA 
Gln Leu Arg Val Val Arg Ala His Val Gln Ala Pro Asp Ala 
CAA CUG CGC GUG GUG CGU GCC CAU GUG CAG GCA CCC GAC GCU 
Tyr Ser Ser Thr Tyr Pro Ala Asn Val Arg Ala Ser Cys Leu 
UAC AGC AGC ACG UAU CCG GCU AAC GUG CGC GCA UCG UGC CUU 
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Asp His Val Phe Glu Pro Arg GIn Ala Ala Ala Pro Ala Gly 
GAC CAC GUC UUC GAG CCC CGC CAG GCC GCC GCC CCG GCA GGU 
Phe Val Ala Thr Cys Ala Lys Pro Glu Thr Pro Ser Ser Leu 
UUC GUU GCG ACA UGU GCG AAG CCG GAA ACG CCU UCU UCA CUU 
Thr Ala Lys Ala Gly Val Ser Ala Thr Thr Ser His Val Ala 
ACC GCG AAA GCU GGU GUU UCU GCG ACU ACA AGC CAC GUU GCG 
Thr Gly Thr Ala Pro Pro Glu Ser Pro Trp Asp Ala Pro Ala 
ACU GGG ACU GCG CCC CCG GAG UCU CCA UGG GAU GCA CCU GCA 
Ala Asn Ser Phe Ser Glu Leu Leu Thr Pro Glu Thr Pro Ser 
GCC AAC AGC UUU UCG GAG UUA UUG ACA CCG GAG ACC CCG UCC 
Thr Ser Ser Ser Ala Val Ile Val Phe Ile Gly Leu Leu Tyr 
ACA UCA UCC UCG GCC GUC AUC GUC UUC AUC GGA CUC CUC UAC 
Ile Val Trp Lys Val Ala GIn Trp Trp Arg His Arg Lys Arg 
AUC GUG UGG AAG GUC GCU CAG UGG UGG AGA CAC CGC AAG AGG 
Thr Glu Asp Leu Asn Ser Arg Lys Pro Pro Ser GIn Asp Arg 
ACA GAA GAC UUG AAC AGC AGA AAG CCG CCU UCG CAA GAC AGG 
GIn Ser Arg Ser Ser Glu Cys Leu Asp Arg Ser Gly Glu Arg 
CAA UCA CGC UCG UCU GAA UGU CUG GAC AGA AGC GGA GAA AGG 
Thr Gly Ser Ser Leu Thr Ala Pro Thr Ala Pro Ser Pro Ser 
ACA GGC AGU UCG UUA ACU GCC CCC ACU GCU CCG AGC CCC UCA 
Phe Ser Phe Ser Glu Arg Ala Arg Leu Ala Thr Gly Pro Thr 
UUC UCA UUU UCG GAA AGA GCU CGA CUG GCG ACC GGG CCG ACU 
Val Ala Ala Ala Thr Ser Pro Ser Ala Thr Pro Ser Cys Ala 
GUC GCC GCU GCG ACA UCA CCU UCG GCA ACC CCA UCC UGC GCC 
Thr Asp GIn Val Ala Ala Arg Thr Thr Pro Asp Phe Ala Pro 
ACG GAC CAG GUU GCC GCG AGG ACC ACG CCG GAC UUU GCG CCU 
Phe Leu Gly Ser GIn Ser Ala Arg Ala Val Ser Lys Pro Tyr 
UUC CUG GGU UCC CAG UCU GCC CGU GCU GUC UCG AAG CCG UAC 
Arg Pro Pro Thr Thr Ala Arg Trp Lys Glu Val Thr Pro Leu 
CGG CCC CCC ACG ACU GCC CGU UGG AAA GAA GUC ACC CCG CUC 
His Ala Trp Lys Gly Val Thr Gly Asp Arg Pro Glu Val Arg 
CAC GCG UGG AAG GGC GUG ACC GGA GAC CGA CCG GAA GUC AGG 
Glu Asp Pro Glu Thr Ala Ala Val Val GIn Ala Leu Ile Ser 
GAG GAC CCG GAG ACA GCG GCG GUC GUC CAG GCU CUG AUC AGC 
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1615 Gly Arg Tyr Pro Gln Lys Thr Lys Leu Ser Ser Asp Ala Ser 
4879 GGC CGU UAU CCU CAG AAG ACG AAG COO UCC UCC GAC GCA UCC 
1629 Lys Gly Tyr Ser Arg Thr Lys Gly Cys Ser Gln Ser Thr Ser 
4921 AAA GGC UAC UCA AGA ACU AAG GGA UGC UCA CAA UCC ACC UCU 
1643 Phe Pro Ala Pro Ser Ala Asp Tyr Gln Ala Arg Asp Cys Gln 
4963 UUU CCU GCC CCG AGU GCG GAU UAC CAG GCC CGC GAC UGC CAG 
1657 Thr Val Arg Val Cys Arg Ala Ala Ala Glu Met Ala Arg Ser 
5005 ACA GUC CGA GUC UGC CGC GCC GCU GCA GAG AUG GCG CGC UCA 
1671 Cys Ile His Glu Pro Leu Ala Ser Ser Ala Ala Ser Ala Asp 
5047 UGU Aoo CAC GAG CCG ooG GCU UCA UCU GCC GCC AGU GCC GAC 
1685 Leu Lys Arg Ile Arg Ser Thr Ser Asp Ser Val Pro Asp Val 
5089 ooG AAG CGC AUA CGC UCU ACC UCG GAC UCU GOO CCC GAU GUA 
1699 Lys Ile Ser Lys Ser Ala 
5131 AAG AUC AGC AAG AGC GCA UGAAGGAACA AAAooAGUUU CCooGooCGU 
5179 AAACAAGGUG GUCCCUCCCA ooGAGGUAAA GACUCUGGUG AGUCCUCAAC 
5229 GooACUCGoo GAGUCUGCUG CGGooCGAoo CCAooCCCAA GCAGCAAAGG 
5279 GUGCGCAACU AGUACGGCGC CCCCUGGGAU ACCA 
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1 GUUUUUCUUU CUUUACCAAG UGUGGUAAAA UUUAAACAAA GAAGAAAACC 
51 AGGACCGUAA CCCGGCCCUU ACACACCUCG AGUCCGUGAC CACCGGAUUA 
101 UACGUCGCCC ACCACACGGC GCCUUUUCCG ACCACUCUCG AGAGUCGUUG 
151 GGAGUUUCGU CCGUGACCAC CCGGUUGGCA GUCGACAGAC GCUUCCGGAC 
201 CACUAGAACC UCCUCGAGCG ACGCACACAC AGCACACACA CCGCCUUAGC 
251 UGCACCUACG GCAGCGUUGA UAGCGCGGAU UUAUGAGCGA GCACACCAUC 
301 GCCCACUCCA UCACAUUACC ACCCGGUUAC ACCCUUGCCC UAAUACCCCC 
1 Met Gly Asp Ala Gly Val Ala Ser GIn 
351 UGAACCUGAA GCAGG AUG GGA GAU GCU GGA GUG GCG UCA CAG 
10 Arg Pro His Asn Arg Arg Gly Thr Arg Asn Val Arg Val Ser 
393 CGA CCU CAC AAC CGU CGC GGA ACC CGU AAC GUU CGG GUC AGC 
24 Ala Asn Thr Val Thr Val Asn Gly Arg Arg Asn GIn Arg Arg 
435 GCC AAC ACC GUC ACC GUC AAU GGU AGA AGA AAC CAA CGG CGU 
38 Arg Thr Gly Arg GIn Val Ser Pro Pro Asp Asn Phe Thr Ala 
477 CGG ACC GGA AGG CAA GUU UCU CCC CCU GAC AAU UUC ACC GCU 
52 Ala Ala GIn Asp Leu Ala GIn Ser Leu Asp Ala Asn Thr Val 
519 GCU GCA CAA GAC CUC GCG CAA AGC CUU GAC GCC AAC ACC GUC 
66 Thr Phe Pro Ala Asn Ile Ser Ser Met Pro Glu Phe Arg Asn 
561 ACU UUC CCC GCU AAC AUC UCU AGC AUG CCC GAA UUC CGG AAU 
80 Trp Ala Lys Gly Lys lIe Asp Leu Asp Ser Asp Ser lIe Gly 
603 UGG GCC AAG GGA AAG AUC GAC CUC GAC UCC GAU UCC AUC GGC 
94 Trp Tyr phe Lys Tyr Leu Asp Pro Ala Gly Ala Thr Glu Ser 
645 UGG UAC UUC AAG UAC CUU GAC CCA GCG GGU GCU ACA GAG UCU 
108 Ala Arg Ala Val Gly Glu Tyr Ser Lys Ile Pro Asp Gly Leu 
687 GCG CGC GCC GUC GGC GAG UAC UCG AAG AUC CCU GAC GGC CUC 
122 Val Lys Phe Ser Val Asp Ala Glu Ile Arg Glu Ile Tyr Asn 
729 GUC AAG UUC UCC GUC GAC GCA GAG AUA AGA GAG AUC UAU AAC 
136 Glu Glu Cys Pro Val Val Thr Asp Val Ser Val Pro Leu Asp 
771 GAG GAG UGC CCC GUC GUC ACU GAC GUG UCC GUC CCC CUC GAC 
150 Gly Arg GIn Trp Ser Leu Ser Ile Phe Ser Phe Pro Met Phe 
813 GGC CGC CAG UGG AGC CUC UCG AUU UUC UCC UUU CCG AUG UUC 
Figure A1.2 RNA sequence of HaSV RNA2 (Genome sequence accession number: 137299). 
The amino acid sequence of the capsid precursor protein gene is shown above the sequence. 
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164 Arg Thr Ala Tyr Val Ala Val Ala Asn Val Glu Asn Lys Glu 
855 AGA ACC GCC UAC GUC GCC GUA GCG AAC GUC GAG AAC AAG GAG 
178 Met Ser Leu Asp Val Val Asn Asp Leu lIe Glu Trp Leu Asn 
897 AUG UCG CUC GAC GUU GUC AAC GAC CUC AUC GAG UGG CUC AAC 
192 Asn Leu Ala Asp Trp Arg Tyr Val Val Asp Ser Glu GIn Trp 
939 AAU CUC GCC GAC UGG CGU UAU GUC GUU GAC UCU GAA CAG UGG 
206 lIe Asn Phe Thr Asn Asp Thr Thr Tyr Tyr Val Arg lIe Arg 
981 AUU AAC UUC ACC AAU GAC ACC ACG UAC UAC GUC CGC AUC CGC 
220 Val Leu Arg Pro Thr Tyr Asp Val Pro Asp Pro Thr Glu Gly 
1023 GUU CUA CGU CCA ACC UAC GAC GUU CCA GAC CCC ACA GAG GGC 
234 Leu Val Arg Thr Val Ser Asp Tyr Arg Leu Thr Tyr Lys Ala 
1065 CUU GUU CGC ACA GUC UCA GAC UAC CGC CUC ACU UAU AAG GCG 
248 l Ie Thr Cys Glu Ala Asn Met Pro Thr Leu Val Asp GIn Gly 
1107 AUA ACA UGU GAA GCC AAC AUG CCA ACA CUC GUC GAC CAA GGC 
262 Phe Trp lIe Gly Gly GIn Tyr Ala Leu Thr Pro Thr Ser Leu 
1149 UUU UGG AUC GGC GGC CAG UAC GCU CUC ACC CCG ACU AGC CUA 
276 Pro GIn Tyr Asp Val Ser Glu Ala Tyr Ala Leu His Thr Leu 
1191 CCG CAG UAC GAC GUC AGC GAG GCC UAC GCU CUG CAC ACU UUG 
290 Thr Phe Ala Arg Pro Ser Ser Ala Ala Ala Leu Ala Phe Val 
1233 ACC UUC GCC AGA CCA UCC AGC GCC GCU GCA CUC GCG UUU GUG 
304 Trp Ala Gly Leu Pro GIn Gly Gly Thr Ala Pro Ala Gly Thr 
1275 UGG GCA GGU UUG CCA CAG GGU GGC ACU GCG CCU GCA GGC ACU 
318 Pro Ala Trp Glu GIn Ala Ser Ser Gly Gly Tyr Leu Thr Trp 
1317 CCA GCC UGG GAG CAG GCA UCC UCG GGU GGC UAC CUC ACC UGG 
332 Arg His Asn Gly Thr Thr Phe Pro Ala Gly Ser Val Ser Tyr 
1359 CGC CAC AAC GGU ACU ACU UUC CCA GCU GGC UCC GUU AGC UAC 
346 Val Leu Pro Glu Gly Phe Ala Leu Glu Arg Tyr Asp Pro Asn 
1401 GUU CUC CCU GAG GGU UUC GCC CUU GAG CGC UAC GAC CCG AAC 
360 Asp Gly Ser Trp Thr Asp Phe Ala Ser Ala Gly Asp Thr Val 
1443 GAC GGC UCU UGG ACC GAC UUC GCU UCC GCA GGA GAC ACC GUC 
374 Thr Phe Arg GIn Val Ala Val Asp Glu Val Val Val Thr Asn 
1485 ACU UUC CGG CAG GUC GCC GUC GAC GAG GUC GUU GUG ACC AAC 
388 Asn Pro Ala Gly Gly Gly Ser Ala Pro Thr Phe Thr Val Arg 
1527 AAC CCC GCC GGC GGC GGC AGC GCC CCC ACC UUC ACC GUG AGA 
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402 Val Pro Pro Ser Asn Ala Tyr Thr Asn Thr Val Phe Arg Asn 
1569 GUG CCC CCU UCA AAC GCU UAC ACC AAC ACC GUG UUU AGG AAC 
416 Thr Leu Leu Glu Thr Arg Pro Ser Ser Arg Arg Leu Glu Leu 
1611 ACG CUC UUA GAG ACU CGA CCC UCC UCU CGU AGG CUC GAA CUC 
430 Pro Met Pro Pro Ala Asp Phe Gly GIn Thr Val Ala Asn Asn 
1653 CCU AUG CCA CCU GCU GAC UUU GGA CAG ACG GUC GCC AAC AAC 
444 Pro Lys lIe Glu GIn Ser Leu Leu Lys Glu Thr Leu Gly Cys 
1695 CCG AAG AUC GAG CAG UCG CUU CUU AAA GAA ACA CUU GGC UGC 
458 Tyr Leu Val His Ser Lys Met Arg Asn Pro Val Phe GIn Leu 
1737 UAU UUG GUC CAC UCC AAA AUG CGA AAC CCC GUU UUC CAG CUC 
472 Thr Pro Ala Ser Ser Phe Gly Ala Val Ser Phe Asn Asn Pro 
1779 ACG CCA GCC AGC UCC UUU GGC GCC GUU UCC UUC AAC AAU CCG 
486 Gly Tyr Glu Arg Thr Arg Asp Leu Pro Asp Tyr Thr Gly lIe 
1824 GGU UAU GAG CGC ACA CGC GAC CUC CCG GAC UAC ACU GGC AUC 
500 Arg Asp Ser Phe Asp GIn Asn Met Ser Thr Ala Val Ala His 
1863 CGU GAC UCA UUC GAC CAG AAC AUG UCC ACC GCU GUG GCC CAC 
514 Phe Arg Ser Leu Ser His Ser Cys Ser lIe Val Thr Lys Thr 
1905 UUC CGC UCA CUC UCC CAC UCC UGC AGU AUC GUC ACU AAG ACC 
528 Tyr GIn Gly Trp Glu Gly Val Thr Asn Val Asn Thr Pro Phe 
1947 UAC CAG GGU UGG GAA GGC GUC ACG AAC GUC AAC ACG CCU UUC 
542 Gly GIn Phe Ala His Ala Gly Leu Leu Lys Asn Glu Glu lIe 
1989 GGC CAA UUC GCG CAC GCG GGC CUC CUC AAG AAU GAG GAG AUC 
556 Leu Cys Leu Ala Asp Asp Leu Ala Thr Arg Leu Thr Gly Val 
2031 CUC UGC CUC GCC GAC GAC CUG GCC ACC CGU CUC ACA GGU GUC 
570 Tyr Pro Ala Thr Asp Asn Phe Ala Ala Ala Val Ser Ala phe 
2073 UAC CCC GCC ACU GAC AAC UUC GCG GCC GCC GUU UCU GCC UUC 
584 Ala Ala Asn Met Leu Ser Ser Val Leu Lys Ser Glu Ala Thr 
2115 GCC GCG AAC AUG CUG UCC UCC GUG CUG AAG UCG GAG GCA ACG 
598 Ser Ser lIe lIe Lys Ser Val Gly Glu Thr Ala Val Gly Ala 
2157 UCC UCC AUC AUC AAG UCC GUU GGC GAG ACU GCC GUC GGC GCG 
612 Ala GIn Ser Gly Leu Ala Lys Leu Pro Gly Leu Leu Met Ser 
2199 GCU CAG UCC GGC CUC GCG AAG CUA CCC GGA CUG CUA AUG AGU 
626 Val Pro Gly Lys lIe Ala Ala Arg Val Arg Ala Arg Arg Ala 
2241 GUA CCA GGG AAG AUU GCC GCG CGU GUC CGC GCG CGC CGA GCG 
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640 Arg Arg Arg Ala Ala Arg Ala Asn 
2283 CGC CGC CGC GCC GCU CGU GCC AAU UAGUUUGCUC GCUCCUGUUU 
2327 CGCCGUUUCG UAAAACGGCG UGGUCCCGCA CAUUACGCGU ACCCUAAAGA 
2377 CUCUGGUGAG UCCCCGUCGU UACACGACGG GUCUGCCGCG GUUCGAUUCC 
2427 AUUCCCAAGC GGCAAGAAGG ACGUAGUUAG CUCUGCGUCC CUCGGGAUAC 
2477 CA 
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I Appendix 2 Plasm ids not generated in this study 
TableA2.1 Plasmids used during this study that were acquired from other sources 
Plasmid 
pBCRldA 
pBJ33RIHC 
pBJ33R2HC 
pCR@2.1 
pDHVCAPB 
pDHVStuRlHC 
pDHVStuR2HP 
pDHVR2HP 
pKG3 
pKG4 
pKG5 
pKG6 
pYES2 
YIpLacl28 
YIpLac204 
YIpLac211 
Section Reference 
5.2,5 
5,2.4 
5.2.4 
2,2.4 
2,2.4 
2.2,2 
2,2.3 
2.2.3 
2,2,3 
2,2,2/2,2.3 
2,2.3 
2,2,2 
2,2.4 
2,2.4 
3,2,1 
3,2,) 
Obtained from 
Karl Gordon and Terry Hanzlik (CSIRO Entomology, 
Canbena, ACT, Australia) 
Karl Gordon and Terry Hanzlik (CSIRO Entomology, 
Canberra, ACT, Australia) 
Karl Gordon and Terry Hanzlik (CSIRO Entomology, 
Canberra, ACT, Australia) 
Invitrogen 
Karl Gordon and Terry Hanzlik (CSIRO Entomology, 
Canberra, ACT, Australia) 
Karl Gordon and Terry Hanzlik (CSIRO Entomology, 
Canberra, ACT, Australia) 
Karl Gordon and Terry Hanzlik (CSIRO Entomology, 
Canberra, ACT, Australia) 
Karl Gordon and Terry Hanzlik (CSIRO Entomology, 
Canbena, ACT, Australia) 
Paul Keese, CAMBIA, Canberra, ACT, Australia 
Paul Keese, CAMBIA, Canberra, ACT, Australia 
Paul Keese, CAMBIA, CanbelTa, ACT, Australia 
Paul Keese, CAMBIA, Canbena, ACT, Australia 
Invitrogen 
Gietz and Sugino (1988) 
Gietz and Sugino (1988) 
Gietz and Sugino (1988) 
A 
B 
c 
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Pvu II (530) 
Age 1(5103) , :Socl(658) 
\ , : T7 Promoter ~~~j /'~ Xbo 1(700) 
CAM-R ( ~ :~, - BOmHI(712) 
, , PsI I (728) 
Pvu II (4398) ", Eco R I (730) 
pBCR1dA P35S I ' Pst 1(1369) 
1\, 5559 bp 
Ajlll (1584) 
Xbo 1(1683) 
OR! 'xjl.., Soc 1(1948) 
Pvull(3137) / ! \. \ RNA I 5' 
Kpn 1(2919) \. Pst 1(2334) 
T3 Promoter Soc 1(2535) 
A [ (9123) Sac! (658) ge , \ T7 Promoter 
CAM R ' Pv" II (530) \ 
- \, " " ! Xbo I (700) 
Pvu II (7157)\ Pvu II (8418) ',\ ' " ~~ , ' BamH I (712) 
OR! 
Kpr. [ (6939)\ 
T3 Promo;~I" 
. ~,:.-=--~ I '. : . . :' 
.. PsI! (728) 
,\..' 
Hir<llll (6882)\,,\ 
\ \\ .... 
£ooR [(6870, \.\ " , 
. ", .. 
Soc I (6868) \\\\' 
, " , 
Kp" 1(6862) " " 
CaMV poly-A , --. 
pBJ33R1HC 
9579 bp 
\ 
PsI! (6654), ?\ 
Xba 1(6638) ' , /, ~ 
HC Ribozyme/ / " 
PsI! (6293) ,/:, '" 
Hird III (6162) ,/ \ \ - ..... ~ ... 
Sac! (5867) \ \' PSI [(4775) 
.. , EcoR I (730) 
P35S 
" , PsI! (1369) 
'. " ' . 
-., , Ajill (1584) 
, .... 'Xbol( 1683) 
, , 
'.:, Sacl(1948) 
\"PSlI (2334) 
'Sac 1 (2535) 
, Kpr. 1 (2919) 
", " RNA 1 
\ ... " Sac [ (3393) 
Sma 1 (3572) 
PsI! (5594) PI'U II (4776) 
Sac 1 (658) 
Age 1(6293) , Pvu II (530), T7 Promoter 
, ' 
CAM-R 
Pvu II (5588) 
~~ ~=--=-.. ~ ~ I\~· .. . XbaB~:~~o; (712) 
ORI 
Pvu II (4327) \1 
pBJ33R2HC 
6749 bp 
Kpn 1 (4 1 09)~ .\ 
T3 promoter:: ,,,,, 'tN-'/> 
Hin d III (4052) " , '" 
EcoRI(4046) '~,~: .'i : / ....... _ ... ~ ... 
Soc 1 (4044),,/ iii ;-
Kpn I (4038) ' ill' '" 
CaMV polyA',i,i HC Ribozyme " 
PsI I (3830) ' Xba I (3814) 
Pst 1 (728) 
, Eco R I (730) 
P35S 
£OaR 1 (1853) 
RNA2 
PSI 1(2572) 
.. 
Pvu II (2645) 
PsI 1(3191) 
Figure A2,1 Plasmids that were used as templates for in vitro transcnptlOn from 
promoters: pBCRldA (panel A) , pBJ33RIHC (panel B) and pBJ33R2HC (panel C), 
T3 or T7 
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I Appendix 3 Plasmids constructed during this study 
TableA3.1 Plasmids constructed during the course of this study 
----------------~---~------~----~~------------------Plasmid Section Reference Constructed by 
5.6615(G+) 3.2.1 Rachel Blaine, Syngenta, Jealott's Hill 
pAV3 
pAV8F 
pAVIO 
pAVll 
pAV13HC 
pAV14HP 
pAV14HPTrp 
pMJ2 
pMLY2 
pMLY3 
pVHl 
pVH4 
pVH5 
YlpLac204/5.66(G+) 
YlpLac204IHaSVRNA2 
YlpLacVCAPB320 
2.2.4 
2.2.2 
2.2.2 
2.2.3 
2.2.2 
2.2.3 
2.2.3/3.2.1 
3.2.1 
2.2.3 
2.2.3 
2.2.2 
2.2.2 
2.2.3 
3.2.1 
3.2.1 
2.2.4/3.2.1 
Research Station, Berkshire, UK 
Author 
Author 
Author 
Author 
Author 
Author 
Author 
Meesbah Jiwaji, Department of Biochemistry 
and Microbiology, Rhodes University, 
Grahamstown, South Africa 
Michelle Williams (CSIRO Entomology, 
Canberra, ACT, Australia) 
Michelle Williams (CSIRO Entomology, 
Canberra, ACT, Australia) 
Val Hodgson, Department of Biochemistry and 
Microbiology, Rhodes University, 
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I Appendix 4 Primers 
Table A4.1 Primers used during the course of this study 
Primer Gene Location Direct! Sequence 
Complement 
AVI RNA 1 * I to 25 D GTTCTGCCTCCCCCGGACGGTAAAT 
AV2 RNA2* I to 25 D GTTTTTCTTTCTTTACCAAGTGTGG 
AV4 PGAL1** -25 to-I C TTTATTACATTTGAATAAGAAG 
AV9 RNA2* 1351 to 1368 C CGTTTGTGGCGCCAGGTGA 
H3RIB RNA 2 * 1985 to 2001 C GCGCGAATTGGCCGAAA 
HBIIVF6 RNA 1 * 1538to 1554 D GCCTGTCCCCTGAACAG 
HB35F2C RNA 1 * 3917 to 3933 D AGTACGTGGAGGCTGTGA 
HR236F3 RNA 2 * 873 to 889 D GTAGCGAACGTCGAGAA 
HVBIIVF2 RNA 1 * 1192 to 1212 C CAAGACGGTCATGTCGACTAG 
HVB35XFI RNA 1 * 3016 to 3035 C AGCATGCGTTTGACGTCCTC 
HVRIB5P RNA 1 * I to 18 D GTTCTGCCTCCCCCGGAC 
HVRICla RNA 1 * 5283 to 5312 C TGGTATCCCAGGGGGCGCCGT 
RNAIF4 RNA 1 * 637 to 657 D CACATGCCAGAAGAGCTGCTC 
RNAIR7 RNA 1 * 1I09to 1129 C GGATGGTCTTATGCTCAGTGC 
RNA2F3 RNA2* 52 to 72 D GGACCGTAACCCGGCCCTTAC 
RNA2F6 RNA2* 502 to 522 D CTGACAATTTCACCGCTGC 
RNA2R2 RNA 2 * 530 to 550 C GCGTCAAGGCTTTGCGCGAGG 
* HaSV 
** S. cerevisiae 
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I Appendix 5 Thermal cycling programmes 
Programme 1 
I x 94°C for 90 sec 
lOx 94 °e for 45 sec 
40°C for 90 sec 
68°C for 4 min 
Ix 68°C for 4 min 
Programme 2 
Ix 94°C for 2 min 
30x 94°C for 45 sec 
55°C for 45 sec 
72°C for 2 min 
Ix 72°C for 7 min 
Programme 3 
Ix 50°C for 30 min 
94 °e for 2 min 
lOx 94°C for 15 sec 
50°C for 30 sec 
72°C for 1 min 
20x 94°C for 15 sec 
50°C for 30 sec 
72°C for 1 min (+5 sec per cycle) 
Ix 72°C for 7 min 
Programme 4 
I x 55°C for 30 min 
94°C for 2 min 
40x 94°C for 15 sec 
55°C for 30 sec 
70°C for 2 min 
I x 72°C for 10 min 
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I Appendix 6 Yeast strains used in this study 
Table A6.1 Yeast strains used in this study 
S. cerevisiae strain Genotype 
INVScI MATa, his3-L1l, leu2, trpl-289, ura3-52 
JRYI88 MATa, his3, leu2, Irpl, ura3 
INVScI 3#20.1 MATa, his3-L1l, 1'71: :1.H I2, trpl-289, ura3-52 
JRYI88 3#20.1 MATa, his3, ? 71::' .lill2, trpl, ura3 
INVScI R2 MATa, his3-L1l, leu2, R2::TRPI, ura3-52 
INVScI L+ MATa, his3-L1l, LEUl, Irpl-289, ura3-52 
INVScIR2L+ MATa, his3-L1l, LEU2, R2::TRPI, ura3-52 
INVScIL+T+ MATa, his3-L1l, LEU2, TRPI, ura3-52 
INVScI U+ T + L+ MATa, his3-L1l, LEU2, TRPI, URA3 
INVScI CAP T+ L+ MATa, his3-L1l, LEU2, TRPI. 1'71::UR,13 
INVScI R2 U+ L+ MATa, his3-L1l, LEU2, R2;:TRPI, URA3 
INVScI CAP R2 L+ MATa, his3-L1l, LEU2, R2:;TRPI, 1'71::URA 3 
Green text denotes plasnuds and genotypic markers carrymg P7l 
Blue text denotes plasmids and genotypic markers carrying RNA2 
Yip(s) 
vrl)LncVCA I' O.UO 
yr.,LflcVCAPIlJ20 
YII>Lllc204HIISVRNA2 
YipLacl28 
Yip LllcZ04 H IISVRNA2 
YipLac128 
YipLac128 
YIpLacZ04 
YipLaclZ8 
YIpLacZ04 
YIpLacZll 
piVU2 
YipLaclZ8 
YIpLacZ04 
YlpLllc204HIISVRNAZ 
YipLac128 
YIpLac211 
pM.JZ 
YlpLllc204HIISVRNA2 
YipLacl28 
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I Appendix 7 Preparation of media 
YPD and SMM were prepared as described by Kaiser et al. (1994) as follows: 
YPD: 
Per liter: 109 yeast extract 
20g peptone 
20g glucose 
(supplemented with 20g agar for agar plates) 
SMM: 
Per liter: 1.7g yeast nitrogen base without amino acids and ammonium sulfate (Difco) 
5g ammonium sulfate 
20g glucose 
(supplemented with 20g agar for agar plates) 
Various supplements were added to the above medium to maintain selection of plasmid-containing 
strains. All the supplements (uracil, L-tryptophan, L-histidine and L-leucine) that were used in this 
study could be added to the medium prior to autoclaving. The stock and working concentrations of 
these supplements were as follows: 
Supplement 
Uracil (Sigma) 
L-Tryptophan (Sigma) 
L-Histidine (Sigma) 
L-Leucine (Sigma) 
Stock concentration (g/ml) 
0.2 
I 
I 
I 
Working concentration (mg/I) 
20 
20 
20 
100 
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I Appendix 8 General Methods 
AS.1 Yeast protein extracts 
The following method was adapted from Kaiser et aI. , 1994: 
• Add 30 fll ESB to every 2 OD units of yeast cell pellet and resuspend the pellet with a pipette. 
• Boil the suspension for 3 min (the samples can be stored at -20°C after this). 
• Add 0.1 g of 0.2 mm glass beads (Sigma) to every 30fll of sample. 
• Vortex for 30 sec periods with 30 sec intervals and a total homogenization time of 3 min. 
• Add 2.3 volumes ofESB and vortex briefly. 
• Boil for 2 min and load on an SDS-PAGE gel. 
ESB: 2% SDS 
80mM Tris pH6.8 
10% glycerol 
1.5% DTI 
O.lmg/ml bromophenol blue 
AS.2 Preparation of acid-washed glass beads 
Acid-washed glass beads were prepared as described by Treco (1997). The 0.2 mm beads 
(obtained from Sigma) were soaked in concentrated nitric acid for 1 hour, washed extensively with 
deionized water and dried in a baking oven. 
A8.3 Yeast genomic DNA isolation 
The following method, for the isolation of yeast genomic DNA, was taken from Kaiser et aI., 
1994: 
• Grow 10m! yeast cultures to saturation in YPD a 30°C. 
• Collect the cells by centrifugation for 2 min in a microfuge. Remove the supernatant and 
resuspend the cells in 0.5 ml of distilled water. Transfer the cells to a 1.5 m! Eppendorf tube 
and collect them by centrifugation for 5 seconds in a micofuge. 
• Decant the supernatant and briefly vortex the tube to resuspend the pellet in the residua! liquid. 
• Add 0.2 m! of 2% Triton X-IOO, 1% SDS, 100mM NaCl, 10mM Tris-HCI (PH8), I mM 
Na2EDTA. Add 0.2ml of phenol:chloroform:isoamyl alcohol (25:24:1). Add 0.3g of acid-
washed glass beads (with a diameter of -0.2mm). 
• Vortex for 3-4 min. Add 0.2 ml of 10mM Tris-HCL (PH8) containing ImM Na2EDTA (TE). 
• Centrifuge for 5 minutes in a microfuge. Transfer the aqueous layer to a fresh tube. Add Iml 
of 100% ethanol. Mix by inversion. 
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• Centrifuge for S min in a microfuge. Discard the supernatant. Resuspend the pellet in 0.4 ml 
of TE plus 3111 of a 10 mg/ml solution of RNase A (Roche) , which was made DNase-free 
according to the protocol in Sambrook el al. (1989). Incubate for S min at 3rC. Add 10111 of 
4M ammonium acetate plus 1 ml of 100% ethanol. Mix by inversion. 
• Centrifuge for 2 min in a microfuge. Discard the supernatant. Air-dry the pellet and resuspend 
in SOIlI ofTE. 
A8.4 Yeast total RNA extracts 
The following method, for the isolation of total RNA from a 200 ml yeast culture, was adapted 
from Kaiser et aI., 1994: 
• After induction, add O.Olg cycloheximide to each 200 ml culture and incubate (shaking) for a 
further 15 min at 30°C. 
• Pellet the cells by centrifuging at SOOOrpm for 5 min at 4°C in a precooled Beckman JAlO 
rotor. Decant the supernatants and resuspend the cells in 2.S ml ice-cold LETS buffer. 
• Add 5.5 g of 0.2 mm acid-washed glass beads and 3 ml ice-cold phenol (equilibrated with 
LETS buffer) to the smallest chamber of a Bead Beater (Biospec Products). Disrupt the cells, 
alternating 30 sec of disrupting with 30 sec on ice for a total of S min. 
• Add 5 ml ice-cold LETS and separate the phases by centrifugation at 8000 rpm for 5 min at 
4°C in a precooled Beckman JA20 rotor. Transfer the aqueous phase to a clean tube and 
extracted twice with S ml of phenol:chloroform:isoamyl alcohol (25:24:1) and once with 
chloroform (optional). 
• Add l/IO,h volume of 5M LiCI to the resulting aqueous phase and leave the tubes overnight at -
20°C to precipitate the RNA. 
• Centrifuge the precipitated RNA at 16000 rpm for 10 min at 4°C in a precooled Beckman JA20 
rotor. Resuspend the RNA pellets in 50 - 250 III DEPC-treated H20. 
LETS buffer: O.1M LiCI 
O.OIM Na2-EDTA 
O.OIM Tris-HCI (PH7.4) 
0.2% SDS 
0.1% DEPC 
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I Appendix 9 Preparation of Helicoverpa armigera diet 
Prepare the following mixtures: 
A. 12g agar 
SOg yeast 
B. 86g soya flour 
60g wheat germ 
C. 3g nipagen 
3 g ascorbic acid 
Ig sorbic acid 
Fix the center of a piece of tubing, which has a diameter of 1 cm and is about 1 meter in length, 
into a peristaltic pump. Add 600ml hot water to mixture B and decant it into a blender. Add 
400rnl hot water to mixture A, boil for 5 min in a microwave, add to mixture B and blend W1til 
properly mixed. Add mixture C and blend fU!iher until it is dissolved in the suspension. Place 
the one end of the tubing into the diet, switch on the pump and aliquot the diet into the jelly 
trays using the other end as a nozzle. 111is procedure should be carried out swiftly, because the 
diet solidifies at room temperature. 
I Appendix 10 Helicoverpa armigera developmental stages 
Table AIO.l Developmental stages of Helicovelpa armigera used in scoring of the bioassays 
(adapted from a table in a draft by Christian, P.D., Dorrian, S.J., Gordon, 
K.H.J. and Hanzlik, T.N. for submission to 1. Bioi. Control.) . 
Developmental Abbrev. Weight in Description 
Stage grams (±SD) 
Mid first ins tar MI 0.30 (0.06) Basal colour of upper parts yellow-brown to dark amber. 
Head capsule slightly narrower than body. Length 
approximately 1.5-3.5 mm. 
Late first instar LI 0.72 (0.11) Basal colour of upper parts amber. Head capsule very narrOw 
in relation to the body with distinct pale (almost white) 
marking behind the dark head capsule created by separation of 
the head capsule from the integument of the body. Length 
approximately 3.5 mm. 
Early second instar E2 1.14 (0.37) Basal colour of upper parts very dark (nearly black). Head 
capsule nearly the same width as the body. Length 
approximately 3.5-4 .0 mm 
Mid second ins tar M2 2.11 (0.87) Basal colour of upper parts ranges from yellow-brown to dark 
amber. Head capsule slightly narrower than body. Length 
approximately 4.0-5.5 mm. 
Late second instar L2 4.38 (0.97) Basal colour of upper parts amber. Head capsule very narrow 
in relation to the body with same distinct pale (almost white) 
marking behind the dark head capsule as LI. Length 
approximately 5.5 mm. 
Early third instar E3 5.20 (1.48) Basal colour of upper parts very dark (nearly black). Head 
capsule nearly the same width as the body. Length 
approximately 5.5-6.5 mm. 
Mid third instar M3 11.61 (3.95) Basal colour of upper pal1s ranges from yellow-brown to dark 
amber. Head capsule slightly narrower than body. Length 
approximately 6.5-13 mm. 
Late third instar L3 23.5 1 (4.63) Basal colour of upper parts amber. Head capsule very narrow 
in relation to the body with same distinct pale (almost white) 
marking behind the dark head capsule as LI. Length 
approximately 13 mm. 
Early fourth instar E4 38.58 (13 .71) Basal colour of upper parts very dark (nearly black). Distinct 
"saddle" across the first and second abdominal segments 
formed by two large lateral spots . Length approximately 12-
15 mm. 
Mid fourth instar M4 80.19 (27 .18) Basal colour ranges from slightly paler than E4 (black-brown) 
to dark amber. Gap in "saddle" (see E4) on first and second 
abdominal segments formed by pale median line. Length 13-
18mm 
Late fourth instar L4 134.86 (25.87) Basal colour of the upper parts dark pink-brown to pale green-
brown. Lateral and dorsal markings darkish brown (not black) 
with pale dorso-medial line. Gap in "saddle" (see E4) on first 
and second abdominal segments formed by pale median line. 
Head capsule very narrow and amber in colour with distinct 
pale marking behind the head capsule. Length approximately 
18-23 mm. 
Fifth instar 15 455.47 (139.88) Basal colour of the upper parts dark pink-brown to pale green-
brown. Dorso-lateral markings ranging from black to dark 
brown. Length greater than 18 mm . 
Pre-pupae PP 434.06 (58.56) Very similar discolouration to 15 but with distinct 
"compressed" appearance) much paler ventral colouration and 
very narrow head capsule. Length approximately 18-22 mm. 
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